Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,rRNA binding (GO:0019843),0.7913496133601994,2.0934092882119333,0.0,0.0,0.0,17/42,7.99%,RPL23;RPS3;RPS9;RPL11;RPS14;RPS5;RPL5;RPS13;RPLP0;RPL12;CAVIN1;DDX28;ANG;EMG1;SBDS;MRPS11;MRPL11
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.7611341377443404,2.0695358469653335,0.0,0.0,0.0,42/57,18.26%,COX4I1;UQCR11;UQCR10;NDUFA2;COX6B1;COX5B;NDUFA13;NDUFB7;COX8A;NDUFB10;NDUFA4;NDUFV3;NDUFS7;NDUFB4;COX6A1;NDUFA6;NDUFS6;COX7A2L;UQCRH;NDUFA3;UQCRQ;NDUFA4L2;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;UQCRC1;NDUFS2;NDUFB9;NDUFS5;NDUFB5;NDUFA7;NDUFS8;NDUFA9;UQCRFS1;COX5A;NDUFS3;NDUFB2;NDUFV1
prerank,nucleotidyltransferase activity (GO:0016779),-0.6501887861622201,-1.97569091352755,0.0,0.22864468010721362,0.123,13/19,20.42%,REV1;NUDT5;TENT4B;CRPPA;TUT7;TUT1;TERT;PAPSS1;PAPSS2;CGAS;TUT4;TENT2;YRDC
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.7706437210067598,1.968861867093289,0.0,0.0,0.0,28/34,18.26%,NDUFA2;NDUFA13;NDUFB7;NDUFB10;NDUFA4;NDUFV3;NDUFS7;NDUFB4;NDUFA6;NDUFS6;NDUFA3;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;NDUFB9;NDUFS5;NDUFB5;NDUFA7;NDUFS8;NDUFA9;NDUFS3;NDUFB2;NDUFV1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.7706437210067598,1.968861867093289,0.0,0.0,0.0,28/34,18.26%,NDUFA2;NDUFA13;NDUFB7;NDUFB10;NDUFA4;NDUFV3;NDUFS7;NDUFB4;NDUFA6;NDUFS6;NDUFA3;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;NDUFB9;NDUFS5;NDUFB5;NDUFA7;NDUFS8;NDUFA9;NDUFS3;NDUFB2;NDUFV1
prerank,MHC protein binding (GO:0042287),0.854236997250568,1.963282471322524,0.0,0.0,0.0,8/20,6.18%,CD74;TUBB;CD81;ATP5F1B;TUBB4B;ATP5F1A;TAPBP;TAP2
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.5150866128632672,-1.9613337097526644,0.0,0.13210581517305675,0.139,21/44,15.23%,NSD1;KMT2C;SETD5;ASH1L;SMYD3;SETD2;EHMT1;KMT5C;KMT2A;KMT5B;ASH2L;NSD3;SETDB1;WDR82;KMT2D;SETD7;EHMT2;SETD4;PRDM9;SETD1B;EZH2
prerank,proton transmembrane transporter activity (GO:0015078),0.7376539962752776,1.9322444439883641,0.0,0.0009814121545716735,0.006,16/39,10.52%,COX4I1;UQCR11;UQCR10;COX6B1;COX5B;COX8A;NDUFA4;ATP6V1F;COX6A1;COX7A2L;UQCRH;UQCRQ;NDUFA4L2;UQCRC1;SLC33A1;MFSD3
prerank,histone demethylase activity (GO:0032452),-0.5721669708599326,-1.9295147817759988,0.0,0.12420204845330121,0.193,12/27,14.55%,KDM3B;KDM2A;KDM7A;JMJD1C;KDM5B;KDM3A;JARID2;FBXL19;KDM5C;KDM4C;PHF8;KDM4D
prerank,I-SMAD binding (GO:0070411),-0.7070533799266958,-1.9078193758035011,0.003676470588235294,0.11982674901915083,0.235,11/13,14.85%,SMAD3;SMAD6;AXIN1;SMAD9;TGFBR1;SMURF1;SMAD1;SMAD7;SMAD4;TGFB1I1;SMAD2
prerank,mRNA 5'-UTR binding (GO:0048027),0.789256023022401,1.8971485260700658,0.0,0.00228328542084022,0.017,6/24,0.56%,RPL41;RPL26;RPS14;RPS7;RPL5;RPS13
prerank,cytochrome-c oxidase activity (GO:0004129),0.8517739022556436,1.8949004497877977,0.0,0.001997874743235192,0.017,8/15,4.94%,COX4I1;COX6B1;COX5B;COX8A;NDUFA4;COX6A1;COX7A2L;NDUFA4L2
prerank,amyloid-beta binding (GO:0001540),0.6756999691567784,1.8793080756503187,0.0,0.002804034727347638,0.027,41/79,18.54%,APOE;CST3;CD74;CLU;PFDN5;ITM2A;C1QA;ITM2C;ITM2B;PGRMC1;NLGN1;PRNP;TREM2;ITGB2;CRYAB;GRIA2;PFDN6;SORL1;CACNA1A;GRIN1;LRPAP1;ATP1A3;GSAP;GRIN2A;GRIA4;APBB1;RAMP3;GRIA1;MSR1;LILRB1;LILRB3;VBP1;TLR6;MAPK8IP2;PFDN1;ACHE;BACE1;CLSTN1;HSPG2;APBA2;GRIN2B
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.7403885334716206,-1.8618623727287178,0.006389776357827476,0.15378471817581477,0.34,7/10,18.18%,NSD1;SETD5;ASH1L;SETD2;NSD3;PRDM9;SETD3
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.5072966482688773,-1.8547762108674117,0.008620689655172414,0.13972730450996387,0.364,11/38,11.59%,SORBS1;GAB2;LRRK2;FRS2;IRS1;AXIN1;SPAG9;DLG5;MMS19;NCK1;SAV1
prerank,MHC class II protein complex binding (GO:0023026),0.8941452062904385,1.8465031427816312,0.0,0.0076550148056590515,0.077,7/11,5.38%,HSPA8;CD74;CD81;HSP90AA1;HSP90AB1;PKM;YWHAE
prerank,R-SMAD binding (GO:0070412),-0.6202965239206018,-1.836736715266973,0.0,0.14178389687071657,0.413,7/18,10.54%,LDLRAD4;SMAD3;SMAD6;SMURF1;PMEPA1;DROSHA;SMAD4
prerank,active ion transmembrane transporter activity (GO:0022853),0.7064255997677626,1.8255993862238757,0.0,0.01085926176227358,0.118,15/37,9.23%,COX4I1;UQCR11;UQCR10;COX6B1;COX5B;COX8A;NDUFA4;COX6A1;COX7A2L;SLCO1C1;UQCRH;UQCRQ;NDUFA4L2;UQCRC1;SLCO4C1
prerank,SUMO transferase activity (GO:0019789),-0.6201479449027802,-1.8227943255868053,0.008695652173913044,0.14226780095559957,0.463,7/16,9.47%,RANBP2;NSMCE2;HDAC4;PIAS1;PIAS2;TOPORS;CBX4
prerank,MHC class I protein binding (GO:0042288),0.8544271886428708,1.8075173011917767,0.0,0.01338926582308497,0.154,6/13,6.18%,TUBB;ATP5F1B;TUBB4B;ATP5F1A;TAPBP;TAP2
prerank,lysine-acetylated histone binding (GO:0070577),-0.5703641602833767,-1.8016815200547376,0.0,0.13650934234549197,0.532,12/20,20.01%,MLLT3;BRD4;BAZ2A;ATAD2B;KMT2A;PSME4;TRIM24;BRD7;PHIP;CARM1;DPF2;TAF1
prerank,acetylation-dependent protein binding (GO:0140033),-0.5703641602833767,-1.8016815200547376,0.0,0.13650934234549197,0.532,12/20,20.01%,MLLT3;BRD4;BAZ2A;ATAD2B;KMT2A;PSME4;TRIM24;BRD7;PHIP;CARM1;DPF2;TAF1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.7560608909007022,1.7850765389896002,0.0024968789013732834,0.018571337694202435,0.222,10/22,11.49%,APOE;CLU;SNX17;HSP90B1;AP2M1;SYT1;LRPAP1;CLTC;APBB1;DNAJA1
prerank,ligand-gated channel activity (GO:0022834),0.7211004037314649,1.7830386498574422,0.00117096018735363,0.017965851074505938,0.225,19/29,22.68%,GABRB1;GRIA2;GRID2;GRIK5;GRIK2;GRIN1;GRIN3A;GRIN2A;GRIA4;CNGA3;GRID1;GRIA1;CHRNA4;CNGB1;ANXA6;GRIN2B;GRIA3;GRIK1;CHRNA3
prerank,ligand-gated ion channel activity (GO:0015276),0.7179096722409726,1.7813160890393838,0.001160092807424594,0.017553257393196218,0.232,19/30,22.68%,GABRB1;GRIA2;GRID2;GRIK5;GRIK2;GRIN1;GRIN3A;GRIN2A;GRIA4;CNGA3;GRID1;GRIA1;CHRNA4;CNGB1;ANXA6;GRIN2B;GRIA3;GRIK1;CHRNA3
prerank,lipoprotein particle receptor binding (GO:0070325),0.7289071764928631,1.7775500111460592,0.004842615012106538,0.01813859964253003,0.253,10/27,11.49%,APOE;CLU;SNX17;HSP90B1;AP2M1;SYT1;LRPAP1;CLTC;APBB1;DNAJA1
prerank,tau-protein kinase activity (GO:0050321),-0.5828034055019308,-1.7614172938089272,0.009259259259259259,0.17860459860226785,0.652,9/20,16.79%,ROCK2;ROCK1;SIK3;MARK1;MARK3;DYRK1A;MARK2;GSK3B;TAOK1
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.7122540340781603,-1.7594208452613913,0.024734982332155476,0.16527340765774515,0.658,5/10,13.99%,SETD5;ASH1L;EHMT1;SETDB1;EHMT2
prerank,glutamate receptor activity (GO:0008066),0.7743630176946416,1.7561980629131841,0.001321003963011889,0.02484044881991496,0.336,11/19,11.98%,GRM5;GRIA2;GRID2;GRIK5;GRIK2;GRM8;GRIA4;GRM7;GRID1;GRM1;GRIA1
prerank,translation elongation factor activity (GO:0003746),0.7952432990500763,1.7334739605088016,0.0013869625520110957,0.034396159322131026,0.452,6/14,5.46%,EEF1A1;EEF2;EEF1B2;EIF5A;EIF5AL1;EEF1A2
prerank,poly(U) RNA binding (GO:0008266),-0.5696899083477869,-1.716875972518229,0.015306122448979591,0.2141833926474411,0.765,14/20,26.50%,RBMS3;RBMS1;ATXN1;DAZAP1;PATL1;PABPC4L;RBMS2;PABPC4;FMR1;KHDRBS1;DIS3L2;HNRNPH1;PABPC5;PABPC1L
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.4890161100883196,-1.7115766994266464,0.0,0.20735290037236198,0.781,14/32,19.78%,FTO;KDM2A;TET2;KDM7A;TET3;TMLHE;P4HTM;KDM4C;PHF8;EGLN1;ALKBH3;EGLN3;PHYHD1;ALKBH4
prerank,cell adhesion mediator activity (GO:0098631),0.7075521697657204,1.7033867878834072,0.0024271844660194173,0.05215504592866607,0.631,13/24,15.73%,BSG;DSCAM;CNTN4;SIRPA;LRRC4C;BCAM;ESAM;ROBO4;EMB;NINJ1;JAM3;IGSF9;DSCAML1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.6456910344499472,-1.6992859219905296,0.01079136690647482,0.2115951261831695,0.811,7/12,14.55%,KDM3B;KDM7A;JMJD1C;KDM3A;KDM4C;PHF8;KDM4D
prerank,tau protein binding (GO:0048156),0.6531865410353122,1.6928592089521293,0.001141552511415525,0.05964181865068426,0.702,9/40,4.77%,APOE;ACTB;CLU;HSP90AA1;HSP90AB1;LGMN;S100B;MAP1A;PIN1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.47458467281008493,-1.6798142597702135,0.008,0.22875053412578175,0.852,11/38,10.36%,PARD3;ZFYVE1;PLA2G4A;PLEKHA4;SNX12;SESTD1;DENND1A;ATG2B;HIP1;ATG2A;KIF16B
prerank,transmitter-gated ion channel activity (GO:0022824),0.6679546212258323,1.6673046216842438,0.002421307506053269,0.08524265571136819,0.833,12/29,11.87%,GABRB1;GRIA2;GRID2;GABRG3;GRIK5;GRIK2;GABRA2;GRIA4;GRID1;GLRA2;GABRA3;GABRB3
prerank,microtubule minus-end binding (GO:0051011),-0.5956419911745594,-1.662567089544788,0.02681992337164751,0.24388765878102783,0.88,8/13,20.02%,MACF1;CEP290;CAMSAP1;NUMA1;TUBGCP6;HAUS7;TUBGCP5;CAMSAP2
prerank,phosphatidylinositol binding (GO:0035091),-0.38505305252695565,-1.6621879352373936,0.0,0.23071471424810194,0.881,35/91,16.62%,PARD3B;ITPR1;PARD3;FCHO2;PITPNC1;ITPR2;ZFYVE1;APPL2;BCAS3;PITPNM2;EEA1;SNX12;SESTD1;ZFYVE9;DENND1A;ANKFY1;HIP1;SNX24;PICALM;WDFY3;TNFAIP8L3;DENND1B;SNX9;TULP3;ESYT3;NUMA1;SNX2;PIGK;RUBCN;SNX1;ING2;SNX13;PASK;SH3YL1;APPL1
prerank,lipoprotein particle binding (GO:0071813),0.7146460815950426,1.6421605573182083,0.002551020408163265,0.11601056403781002,0.923,8/20,12.09%,PLTP;TREM2;SORL1;HSPD1;LPL;MAPT;STAB1;MSR1
prerank,retinoic acid receptor binding (GO:0042974),-0.5691903489037959,-1.6408557954282883,0.017467248908296942,0.25199941936182957,0.905,9/17,19.87%,NSD1;NRIP1;RARG;CNOT1;ASXL1;PPARG;TACC1;MED1;NCOA6
prerank,ionotropic glutamate receptor activity (GO:0004970),0.7249328975399173,1.6399041568964412,0.005141388174807198,0.11477036053587245,0.929,11/17,21.93%,GRIA2;GRIK5;GRIK2;GRIN1;GRIN3A;GRIN2A;GRIA4;GRIA1;GRIN2B;GRIA3;GRIK1
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.3577931052971191,-1.6383962585654774,0.0,0.24244804412850093,0.906,65/232,14.34%,RNF220;PDZRN3;HECTD1;RNF216;RNF152;UBR4;NSMCE2;TRIP12;SMURF2;WWP1;KCMF1;RNF19A;RNF38;UBR5;COP1;PIAS1;PRKN;PIAS2;BIRC2;CBLB;TRAF3IP2;PELI2;SH3RF1;UBR3;ARIH2;SH3RF3;UBR1;RNF144A;SMURF1;RNF24;RNF135;HUWE1;TRIM5;UFL1;ARIH1;BIRC3;UHRF2;RNF8;UBR2;RNF41;ZNRF1;SH3RF2;NEURL2;NFX1;TOPORS;CBX4;RNF138;TRIM24;ASB2;RC3H2;UBE3C;ITCH;RNF217;RNF115;PPIL2;RNF43;HECW2;RNF14;SIAH3;UBE3B;TRIM41;DTX1;WWP2;RNF185;TRIM7
prerank,endopeptidase inhibitor activity (GO:0004866),0.5841495068348607,1.6363744884455316,0.0,0.11598188640991669,0.934,21/82,13.29%,CST3;GAPDH;TIMP2;SERPINH1;A2M;SPOCK2;SERPINE2;SERPINF1;PRNP;PCSK1N;UBE2Z;AGT;SPOCK1;CSTB;TIMP1;SERPING1;SPOCK3;ITIH3;TIMP3;SERPINA9;BST2
prerank,retinoid X receptor binding (GO:0046965),-0.6408044514017086,-1.6359211708912917,0.028469750889679714,0.23477413184906482,0.91,6/11,19.87%,NSD1;NRIP1;RARG;PPARG;TACC1;NCOA6
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.5099554454282486,-1.6254186717548942,0.022222222222222223,0.2408852538907311,0.924,11/25,10.36%,FCHSD2;GAB2;ZFYVE1;MAPKAP1;PLEKHA4;ADAP2;PLEKHA2;SESTD1;HIP1;DAPP1;KIF16B
prerank,ubiquitin protein ligase binding (GO:0031625),0.5461746016610578,1.6238076485534083,0.0,0.13375245649448234,0.956,67/254,13.46%,RPL23;RPS27A;ACTG1;RPL11;HSPA8;RPL5;CLU;TUBB;UBC;GABARAP;UBB;TUBA1B;ATP6V0C;ELOB;HSP90AA1;HSP90AB1;CALR;LAPTM5;CKB;UBXN1;HSPA5;TPI1;SLC25A5;MAP1LC3B;TMBIM6;PRDX6;MAP1LC3A;PINK1;TXNIP;CCT2;GABARAPL2;AUP1;CHEK2;PSMD1;RTN4;UCHL1;HSPA1B;GABARAPL1;PRR5L;YWHAE;VCP;BAG5;RPA2;BAG1;UBA52;ISG15;ARRDC1;TRIM28;HSPD1;SCAMP3;UQCRC1;PRKAR1A;NEDD8;NDUFS2;SYT11;RBX1;JUN;MC1R;APBB1;SUMO2;DNAJA1;WFS1;FBXW7;CXCR4;RNF40;HSPA1A;YWHAZ
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.6825781617489016,1.6095477603864252,0.016795865633074936,0.15335913008801313,0.979,7/19,11.84%,GRID2;GABRG3;GRIK5;GRIK2;GABRA2;GRID1;GABRA3
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.6321977353358044,-1.603732358891822,0.033783783783783786,0.2618552278458137,0.952,4/10,12.93%,KDM2A;KDM7A;KDM4C;PHF8
prerank,disordered domain specific binding (GO:0097718),0.6783555376641728,1.6028409948250981,0.010165184243964422,0.1607335017598496,0.983,8/23,8.24%,CALM1;GAPDH;HSP90AA1;HSP90AB1;FKBP8;CALM3;FN1;CLTC
prerank,mannose binding (GO:0005537),0.7562336281957613,1.6010420355142714,0.01643835616438356,0.1589286825821679,0.984,6/12,14.20%,MBL2;LMAN2;LMAN1;CLEC6A;CLN5;CLEC4D
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.5370132630366391,1.5963403837588024,0.0,0.16331085015483313,0.988,69/269,13.46%,RPL23;RPS27A;ACTG1;RPL11;HSPA8;RPL5;CLU;TUBB;UBC;GABARAP;UBB;TUBA1B;ATP6V0C;ELOB;HSP90AA1;HSP90AB1;CALR;LAPTM5;CKB;UBXN1;HSPA5;TPI1;SLC25A5;MAP1LC3B;PTPRN;TMBIM6;PRDX6;MAP1LC3A;PINK1;TXNIP;CCT2;GABARAPL2;AUP1;CHEK2;PSMD1;RTN4;UCHL1;HSPA1B;GABARAPL1;PRR5L;YWHAE;VCP;BAG5;RPA2;BAG1;UBA52;ISG15;ARRDC1;TRIM28;HSPD1;SCAMP3;UQCRC1;PRKAR1A;NEDD8;NDUFS2;SYT11;RBX1;JUN;MC1R;APBB1;SUMO2;SUMO3;DNAJA1;WFS1;FBXW7;CXCR4;RNF40;HSPA1A;YWHAZ
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.6403590917184928,1.5846505959406236,0.018050541516245487,0.17990686810662446,0.994,9/28,12.76%,CHRNA9;GRID2;GABRG3;GRIK5;GRIK2;GABRA2;GRID1;GABRA3;CHRNA4
prerank,ribosome binding (GO:0043022),0.6052697659472842,1.5837834546190102,0.007847533632286996,0.17594865650440725,0.995,13/46,12.50%,RPSA;EEF2;RACK1;SEC61B;SHFL;TMEM147;EIF3C;SBDS;NOMO1;TMCO1;NAA10;SEC61A1;NCLN
prerank,poly-pyrimidine tract binding (GO:0008187),-0.4907495813200318,-1.5834321263514857,0.0425531914893617,0.28192453611985135,0.962,14/23,26.50%,RBMS3;RBMS1;ATXN1;DAZAP1;PATL1;PABPC4L;RBMS2;PABPC4;FMR1;KHDRBS1;DIS3L2;HNRNPH1;PABPC5;PABPC1L
prerank,nucleosomal DNA binding (GO:0031492),0.6692896560882708,1.578466827947747,0.016602809706257982,0.18249008509919346,0.996,3/21,3.81%,ACTB;H3-3A;MBD3
prerank,monocarboxylic acid binding (GO:0033293),0.6807686455446825,1.577927317006182,0.02236842105263158,0.17785227538822249,0.996,1/18,0.19%,PSAP
prerank,RNA binding (GO:0003723),0.5189568275313005,1.5771764018044265,0.0,0.17425426398273014,0.997,303/1321,14.77%,TMSB4X;RPL41;TPT1;FAU;RPL18A;RPS23;EEF1A1;RPL26;RPL19;RPS24;RPL27A;MRPL23;RPL17;RPL23;MRPL13;RPL13;RPS8;RPSA;RPS3;MRPS12;RPS12;RPL8;RPL32;RPL37A;RPS27A;RPL28;RPS11;RPS9;RPL35A;RPL11;HSPA8;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPS21;RPL38;PPIA;RPS5;RPL18;RPL39;RPL37;RPL30;RPS7;CMSS1;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPL21;RPS13;RPL34;ALDOA;EEF2;RPS20;RPS18;RPL36;RPL22;UBC;VIM;RPS25;RACK1;RPL6;RPL27;RPL29;RPL9;RPS10;RPLP0;RPL12;RPL3;RPS2;RPL15;RPL13A;RPS26;RPL7;RPS17;PCBP1;CAVIN1;TUBA1B;RPL23A;HSP90AA1;RPL14;RPL7A;HSP90AB1;HSPB1;GRN;CALR;SNRPG;RPL31;RPL36A;LGALS1;TUBB4B;RPS28;PPIB;EIF1;RPL35;RPL4;PARK7;SEC61B;RPL10;HNRNPAB;SERPINH1;RPS6;NDUFV3;RCAN3;SF3B5;RPL10A;TXN;CKAP4;SLC25A5;ATP5F1A;EIF4G2;RPN1;NME1;EIF3D;SHFL;MAGOHB;MAGOH;HNRNPK;POLR2D;NPM1;RPS27L;EIF1B;HSPE1;DDX39B;PEBP1;MRPL43;APOBEC2;EIF5A;RAN;CANX;S100A16;SYF2;RALY;SRP14;ZFP36L1;HSP90B1;LGALS3;BTF3;QKI;ELAC2;PKM;DDX28;ENO1;PLEC;SNRPD2;ANG;LSM6;LSM4;LSM8;NCL;MEX3D;ZFP36L2;RTN4;PUF60;NOP10;PARP1;EMG1;HSPA1B;MRPL4;YWHAE;FLNA;HMGB3;RBFOX3;PCBP4;RBM42;AHNAK;EIF3I;SNRPA;VCP;NUCKS1;MANF;SNRPF;MSN;MRPL28;PFN1;FBL;TFRC;EIF3C;SBDS;RPL22L1;SRSF9;PDIA3;MRPL14;SRFBP1;STRAP;LIN28B;MRPL27;MRPL41;CSTB;P4HB;RIMS1;MRPS14;MRPS11;CORO1A;TRIM28;HSPD1;MYO5A;EDF1;HNRNPA0;MRPL11;DCN;CLTC;DDX49;ZYX;NOL12;YWHAG;RBM15B;MAPT;YBX1;NHP2;IFIT1;CSRP1;RRP1B;RRP1;NPM3;METAP2;FASN;PRPF38B;SLC25A11;SARS2;SARS1;PRDX1;NELFCD;JUN;KARS1;HMGB1;RTRAF;SLC3A2;EXOSC2;EPPK1;AARS2;EIF4A1;POP7;WDR3;ZFP36;TARDBP;RNASEH1;H1-0;DEK;PRPF8;POLR2G;SRSF2;KHDRBS3;NIP7;SUMO2;RALYL;APEX1;ACAA2;SF3A2;FAM50A;KCTD12;PABPC1;DDX11;RBM4B;SSRP1;NTPCR;ACTN1;SNW1;MRPL54;RTCB;L1TD1;SF3B2;PRMT1;SORBS2;CARS1;TOE1;ATXN2L;BST2;HSPA1A;TRUB2;HEXIM1;YWHAZ;IMP4;POP4;NOL7;MTCL1;NONO;MRPL2;MRPL37;MRPL44;HNRNPU;TSN;SND1;EIF3B;RO60;NUFIP2;ZC3H8;SUCLG1;CHCHD1;ARF1;RBFOX1;RRP7A;GTPBP10;MRPS24;SNRPB;HNRNPA1;PIN4;NUDT4;TUFM;CTU1
prerank,retinoic acid binding (GO:0001972),-0.6094716975641568,-1.5763559186850005,0.06315789473684211,0.2814870061764363,0.968,1/12,3.47%,NR2F2
prerank,GTPase activator activity (GO:0005096),-0.3044774297919264,-1.563443934419079,0.0,0.2927433596586376,0.978,96/313,15.64%,ARHGAP29;AKAP13;RANBP3L;ARHGAP28;DOCK5;SIPA1L1;ARHGAP20;PLCE1;ARHGAP10;DOCK11;RAPGEF4;ASAP3;ALDH1A1;DENND4A;SBF2;ARHGEF11;ARHGAP17;ASAP1;LRRK2;ARHGAP42;DENND4C;ARFGEF1;FARP1;RANBP2;RAPGEF2;DENND2A;SGSM2;IQSEC2;NRP1;MON1A;USP6NL;ITSN1;TBC1D12;RALGAPB;ARHGEF18;SMAP1;ERRFI1;ARHGEF10L;FGD4;ANKRD27;ASAP2;FNIP1;EIF2B3;DENND5A;STARD13;RAPGEF6;SIPA1L3;TBC1D2B;DENND1A;RABGAP1;RAPGEF1;ARFGEF2;RIC8B;RAPGEF5;ARHGAP32;TBC1D9B;BCR;TBC1D4;ARHGEF6;VAV2;SYDE2;ARHGAP31;GAPVD1;CCZ1;ALS2;DENND1B;RAPGEF3;DNMBP;TBCK;DENND5B;TBC1D8B;ARHGAP18;RALGAPA1;OPHN1;DENND3;MYO9B;SIPA1;RIC1;SMAP2;DOCK1;STXBP5;ARHGEF2;DENND2C;ARHGEF17;EIF2B2;WNT11;PREX2;RAP1GDS1;RAB3GAP2;RGL1;NGEF;LARS1;RGS16;GMIP;RAB3IL1;ARHGEF28
prerank,thyroid hormone receptor binding (GO:0046966),-0.4793421969833331,-1.560165537897859,0.025477707006369428,0.2874211040469829,0.985,11/28,19.87%,NSD1;MED13;TRIP12;JMJD1C;THRAP3;NCOR1;BRD8;TACC1;TAF7;MED1;NCOA6
prerank,histone methyltransferase activity (GO:0042054),-0.4514240558108743,-1.5585654040337134,0.013245033112582781,0.27963607305175886,0.986,13/32,16.92%,KMT2C;SMYD3;SETD2;EHMT1;KMT5B;NSD3;SETDB1;SETD7;EHMT2;PRDM9;EZH2;CARM1;PRMT6
prerank,protease binding (GO:0002020),0.5435622627752881,1.5574297623013083,0.001034126163391934,0.21044681205133642,1.0,22/99,8.48%,CST3;PSAP;UBC;COL1A1;PARK7;TIMP2;A2M;PRNP;PINK1;TNF;NTRK2;ECM1;FLOT1;ADAMTS4;TNFAIP3;VCP;FN1;SELL;CSTB;COL3A1;CLTC;TIMP1
prerank,protein serine/threonine kinase activity (GO:0004674),-0.2818329927507069,-1.5566972515631532,0.0,0.27267995183156585,0.987,84/334,12.61%,ROCK2;GRK5;EGFR;MAPK4;STK3;ACVR1;BMPR1A;DAPK1;LRRK2;ROCK1;SIK3;FAM20A;BRD4;CAMK2D;BRAF;SIK2;PRKCE;MAP3K13;CSNK1A1;GRK3;CLK2;MARK1;SMG1;EIF2AK4;PDPK1;RAF1;ARAF;TLK2;TGFBR1;WNK4;CASK;STK24;SNRK;IRAK3;CDK12;TLK1;CDK6;MARK3;NEK4;CDC42BPB;EIF2AK3;MAST2;DYRK1A;MAPKAPK3;MYLK;PRKAA2;SIK1;TOP1;PRKD3;BCR;TAOK3;AAK1;STK10;CLK1;NEK7;MAPK9;NEK6;HIPK3;NRK;RIPK1;MAP4K3;CCNK;ALPK1;DMPK;TESK2;MAP4K4;PDIK1L;SLK;CDK13;TBK1;DAPK2;MAPK6;STK38;NEK3;LATS2;TRIO;CLK4;NUAK1;NLK;ULK2;CSNK2A1;CSNK2A2;ATM;PRKD1
prerank,poly-purine tract binding (GO:0070717),-0.4692228673180479,-1.555540666089153,0.011834319526627219,0.2652842844009375,0.987,11/27,15.57%,RBMS3;RBMS1;RBPMS;ATXN1;DDX1;DAZAP1;PATL1;ZC3H14;PABPC4L;RBMS2;PABPC4
prerank,Toll-like receptor binding (GO:0035325),0.7454656734913905,1.538565023534537,0.020319303338171262,0.2504470350642665,1.0,8/11,16.42%,TOLLIP;S100A8;S100A9;TIRAP;TLR6;UNC93B1;TLR1;DAB2IP
prerank,copper ion binding (GO:0005507),0.5961868448813071,1.5379362458544983,0.011363636363636364,0.24558797128223664,1.0,12/42,13.10%,ATOX1;MT3;PARK7;SOD1;PRNP;S100A13;COX17;ANG;HEPH;ATP13A2;AOC3;CUTA
prerank,Tat protein binding (GO:0030957),0.7511754648494333,1.53059127157791,0.03248587570621469,0.25760962201693,1.0,6/10,17.31%,ACTB;NPM1;GABARAPL1;DNAJA1;DLL1;TRIM32
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5987471190793746,1.5281286616381469,0.01021566401816118,0.2569142895187516,1.0,7/38,8.49%,SERPINH1;A2M;SERPINE2;SERPINF1;AGT;SPOCK1;SERPING1
prerank,peptidase inhibitor activity (GO:0030414),0.6055826748289806,1.5159798757384446,0.018161180476730987,0.2840136674462239,1.0,7/33,11.73%,CST3;TIMP2;A2M;PCSK1N;CSTB;TIMP1;ITIH3
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.4262421047886723,-1.515252761469204,0.012987012987012988,0.32436403005890735,0.995,16/34,20.11%,SMYD3;SETD2;EHMT1;KMT5B;NSD3;SETDB1;CAMKMT;SETD7;EHMT2;SETD4;PRDM9;EZH2;SETD3;VCPKMT;METTL21A;SETD6
prerank,phospholipase binding (GO:0043274),-0.5763820235895658,-1.5144879867511152,0.05714285714285714,0.31533912131453207,0.996,5/13,10.95%,ARHGAP6;PAFAH1B1;PRKN;PDPK1;DGKQ
prerank,nuclear receptor binding (GO:0016922),-0.3431966272456026,-1.5136970959479012,0.0,0.30742573150217944,0.996,35/111,14.94%,FOXP1;NSD1;SMAD3;TCF7L2;NRIP1;STAT5B;TACC2;BCAS3;MED13;NCOA1;TRIP12;BAZ2A;JMJD1C;THRAP3;ARID1A;CNOT1;NCOR1;KDM3A;LCOR;ASXL1;SMARCE1;STRN;MMS19;ESR1;DCAF1;PPID;DCAF13;KDM4C;BRD8;RNF14;SIRT1;PPARGC1B;TGFB1I1;PRKCB;CRY1
prerank,endopeptidase regulator activity (GO:0061135),0.5912491194329201,1.5123000308572623,0.012087912087912088,0.28759137638950133,1.0,10/40,14.20%,CST3;PSME1;A2M;PSME2;PCSK1N;PSENEN;CSTB;VSIR;ITIH3;ABCA2
prerank,bHLH transcription factor binding (GO:0043425),-0.5048129308096196,-1.505072194773958,0.04186046511627907,0.31238143550159836,0.997,5/19,6.08%,SMAD3;FHL2;TCF12;CREBBP;SP1
prerank,glutathione transferase activity (GO:0004364),0.6284154156263151,1.5046599270396719,0.03182374541003672,0.30361687451330605,1.0,9/23,17.18%,GSTM1;MGST1;GSTO1;GSTM5;GSTM2;MGST3;ALOX5AP;HPGDS;LTC4S
prerank,ligand-gated anion channel activity (GO:0099095),0.6553268935825556,1.503015015971094,0.028,0.30121201881608084,1.0,9/17,19.42%,GABRB1;GABRG3;GABRA2;GLRA2;GABRA3;GABRB3;GLRA1;GABRB2;GLRA3
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.5059633003656396,-1.498932114575436,0.04329004329004329,0.3135698470041786,0.997,9/18,17.52%,TGFBR3;SMAD3;SMAD6;TGFBR1;SMAD7;FERMT2;TGFB3;SMAD2;TGFBRAP1
prerank,cholesterol binding (GO:0015485),0.57198535096908,1.4976096751455164,0.023728813559322035,0.3096227891549659,1.0,17/47,18.97%,APOD;TSPO;CD81;NPC2;SCP2;ABCG1;TSPO2;STARD4;OSBPL6;PROM1;SYP;CAV1;OSBPL3;SOAT2;STARD3NL;ANXA6;VDAC2
prerank,peptidase activator activity (GO:0016504),0.6332872789609346,1.4911815373764763,0.03567035670356704,0.3224453000801294,1.0,8/22,8.99%,PSME1;PSME2;PINK1;PSENEN;MAL;VCP;PCOLCE;VSIR
prerank,insulin-like growth factor I binding (GO:0031994),0.7051327807969832,1.4882713353475368,0.034993270524899055,0.32329910833551456,1.0,4/13,3.92%,IGFBP6;IGFBP3;IGFBP4;IGFBP5
prerank,alanine transmembrane transporter activity (GO:0022858),0.7055661953798813,1.4876641204387548,0.05040871934604905,0.31812072283325693,1.0,4/12,9.97%,SLC38A5;SLC1A4;SLC6A6;SLC3A2
prerank,calcium ion binding (GO:0005509),0.4968281957749529,1.4794663715822978,0.0,0.3356780072976041,1.0,96/323,19.27%,TPT1;SPARC;S100A6;CALM1;GSN;S100A1;SPARCL1;CALR;KCNIP4;S100A11;HSPA5;RCN3;NRXN1;SPOCK2;PRNP;S100A10;S100B;CALM3;TGM2;ANXA5;GJB2;S100A13;CANX;S100A16;HSP90B1;LTBP4;BNIP2;S100A8;S100A9;CDH20;ADGRL3;SLC25A13;GRIN1;SPOCK1;SYT1;F9;SELL;CALB1;CLEC6A;ENPP2;LPL;LCP1;CDH18;CLEC3B;SDF4;TUBB4A;SYT12;SYT11;CDK5R1;RPH3A;SYT6;SYT4;AOC3;PLA2G4F;DNER;RASGRP3;PDCD6;AIF1;TRPM2;MAN1B1;HPGDS;CDH12;PCDHB8;FKBP9;CETN3;PCP4;SYT10;DCHS1;CDH19;KCNIP1;CDH24;SLC8A1;CDH7;DHH;EFHD1;SYT2;RASGRP1;CPNE6;RYR2;EFHD2;CDH10;CETN2;CDH5;SLIT3;SLIT1;TKT;SRI;SCIN;S100A4;ANXA6;GCA;NCS1;CALM2;PPP3CA;SNCA;S100G
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.7171058279694188,1.4784709179193052,0.041193181818181816,0.3317115857253739,1.0,5/11,16.24%,CNGA3;CNGA4;AQP1;HCN1;CNGB1
prerank,low-density lipoprotein particle binding (GO:0030169),0.6657348904334808,1.4768056773859801,0.052562417871222074,0.32988907760299496,1.0,5/16,12.09%,PLTP;TREM2;SORL1;STAB1;MSR1
prerank,MAP-kinase scaffold activity (GO:0005078),-0.5639858726629529,-1.4767815680041376,0.09363295880149813,0.3440490834617393,0.999,4/11,5.56%,AKAP13;KSR1;SH3RF1;SPAG9
prerank,chemokine activity (GO:0008009),0.587511075597407,1.4736063599703557,0.023557126030624265,0.33241006976609966,1.0,9/31,17.83%,CXCL12;CCL19;CXCL16;CXCL10;CCL2;PF4;CCL3;CCL28;CCL8
prerank,fibroblast growth factor binding (GO:0017134),0.6191948420124822,1.4707011065431244,0.04247104247104247,0.33476939219845403,1.0,3/21,3.22%,RPS19;RPS2;S100A13
prerank,protein phosphatase activator activity (GO:0072542),0.6870348078562238,1.4650647097818201,0.05160390516039052,0.34616602303840743,1.0,8/13,20.60%,CALM1;CALM3;IGFBP3;B3GAT3;PPP2R5D;PPP1R15A;CALM2;PPP2R5A
prerank,chemokine receptor binding (GO:0042379),0.5694074900708611,1.4593179780565644,0.027649769585253458,0.356782263113572,1.0,10/35,17.83%,CXCL12;CCL19;CXCL16;CXCL10;CCL2;CX3CR1;PF4;CCL3;CCL28;CCL8
prerank,triglyceride lipase activity (GO:0004806),0.6361765570669369,1.4586136926806401,0.035526315789473684,0.3528342388646327,1.0,4/20,8.95%,PNPLA2;LIPG;LPL;LIPE
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.6851335880490185,1.457738702528986,0.06052269601100413,0.34913236678400256,1.0,7/13,22.38%,ARHGDIA;ARHGDIB;ARHGDIG;GDI1;CCDC88A;GDI2;RANBP1
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.6742442704677848,1.4570674840475173,0.04885057471264368,0.3451914330140066,1.0,6/12,16.56%,GABRB1;GABRG3;GABRA2;GABRA3;GABRB3;GABRB2
prerank,ubiquitin protein ligase activity (GO:0061630),-0.34422794084921693,-1.4538614601914157,0.0,0.3804336208951056,0.999,62/228,14.34%,RNF220;PDZRN3;HECTD1;RNF216;RNF152;UBR4;TRIP12;SMURF2;WWP1;KCMF1;RNF19A;RNF38;UBR5;COP1;PRKN;BIRC2;CBLB;TRAF3IP2;PELI2;SH3RF1;UBE4B;UBR3;ARIH2;SH3RF3;UBR1;RNF144A;SMURF1;RNF24;RNF135;HUWE1;TRIM5;ARIH1;BIRC3;UHRF2;RNF8;UBR2;RNF41;ZNRF1;SH3RF2;NEURL2;NFX1;TOPORS;RNF138;TRIM24;ASB2;RC3H2;UBE3C;ITCH;RNF217;RNF115;PPIL2;RNF43;HECW2;RNF14;SIAH3;UBE3B;TRIM41;DTX1;WWP2;UBOX5;RNF185;TRIM7
prerank,GABA receptor binding (GO:0050811),0.6981149021687796,1.453728008563413,0.056241426611796985,0.3488122509967795,1.0,5/11,5.73%,GABARAP;GABARAPL2;SHISA7;GABARAPL1;LHFPL4
prerank,metal ion binding (GO:0046872),0.48323071379999705,1.4461324504534208,0.0,0.36562711804120085,1.0,127/477,19.27%,APOE;TPT1;SPARC;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;S100A6;CALM1;GSN;S100A1;SPARCL1;CALR;MT3;KCNIP4;MT2A;S100A11;HSPA5;RCN3;NRXN1;SPOCK2;PRNP;S100A10;S100B;CALM3;NME1;TGM2;ANXA5;PINK1;GJB2;IGFBP3;S100A13;HSPE1;RAN;CANX;S100A16;HSP90B1;LTBP4;BNIP2;S100A8;S100A9;CDH20;ADGRL3;SLC25A13;NT5C3A;GRIN1;SPOCK1;SYT1;F9;SELL;CALB1;CLEC6A;ENPP2;LPL;LCP1;CDH18;MAST1;CLEC3B;SDF4;TUBB4A;SYT12;SYT11;CDK5R1;RPH3A;SYT6;SYT4;GNAI1;NUDT3;AOC3;PLA2G4F;DNER;RASGRP3;PDCD6;APEX1;AIF1;TRPM2;MAN1B1;NUDT22;HPGDS;CDH12;PCDHB8;CDC42BPA;STK11;FKBP9;CETN3;PCP4;SYT10;DCHS1;CDH19;RRAGC;PPA1;KCNIP1;TSSK6;TSSK4;CDH24;SLC8A1;CDH7;DHH;EFHD1;SYT2;RASGRP1;CPNE6;RYR2;EFHD2;NUDT16;BRSK2;CDH10;CETN2;CDH5;SLIT3;SLIT1;TKT;SRI;SCIN;S100A4;ANXA6;GCA;NCS1;CALM2;PPP3CA;YDJC;SNCA;S100G
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.4156584610396869,-1.4449164662197824,0.051094890510948905,0.38891880674766977,0.999,12/34,10.81%,PARD3;FCHSD2;GAB2;ZFYVE1;MAPKAP1;OGT;ADAP2;MYO1B;GBF1;DAPP1;KIF16B;FERMT2
prerank,insulin-like growth factor binding (GO:0005520),0.6645826658364394,1.442614354103877,0.046753246753246755,0.37049710852444345,1.0,4/15,3.92%,IGFBP6;IGFBP3;IGFBP4;IGFBP5
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.634989536274529,1.4349383701268408,0.05897771952817824,0.3885978422062087,1.0,3/16,10.40%,RPS3;DNPH1;NEIL1
prerank,ferrous iron binding (GO:0008198),0.6081989826309383,1.4332679397461052,0.07081807081807082,0.38713317520359747,1.0,2/21,0.07%,FTH1;FTL
prerank,phosphatidic acid binding (GO:0070300),-0.4679206295190575,-1.4331365350273475,0.04782608695652174,0.4021367023348144,0.999,7/19,6.17%,PITPNC1;RAPGEF2;MAPKAP1;PACSIN2;MARK1;SESTD1;RAPGEF6
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.4202685312757553,-1.4331195448514662,0.038461538461538464,0.39208328477644405,0.999,7/26,12.36%,SLC6A13;SLC16A12;SLC6A12;SLC16A9;ABCG2;SLC16A6;SLC16A13
prerank,amino acid binding (GO:0016597),0.5606745542054059,1.4241427217815361,0.06113033448673587,0.4092822498221895,1.0,13/31,20.62%,AGXT;GRIN1;GRIN3A;GRM7;AARS2;GLRA2;GLRA1;DDAH1;DDAH2;NOS2;GRIN2B;GLRA3;SHMT2
prerank,tRNA methyltransferase activity (GO:0008175),-0.49250672858511546,-1.4232220206526547,0.10305343511450382,0.40263770496928836,0.999,6/16,14.72%,TRMT13;ALKBH8;TRMT5;THUMPD3;FTSJ1;TRMT9B
prerank,calcium channel regulator activity (GO:0005246),0.553289751876101,1.4204715634562284,0.06342015855039637,0.414072684448278,1.0,13/37,18.67%,CALM1;SLC30A1;NRXN1;FKBP1A;YWHAE;SGK1;PHPT1;NRXN2;INAFM2;CACNG8;FKBP1B;SRI;CALM2
prerank,carboxypeptidase activity (GO:0004180),0.5534581648580701,1.41976885250981,0.0514018691588785,0.4100577246277381,1.0,9/35,11.54%,CTSZ;CPXM1;CPD;CPE;VASH1;AGBL4;AEBP1;CPXM2;CTSA
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.5597826280887839,1.4171974068840587,0.06301050175029171,0.412639201353999,1.0,6/30,7.44%,CST3;MT3;UBE2Z;PRDX5;SPOCK1;CSTB
prerank,hormone activity (GO:0005179),0.5286243276946142,1.4170410938989602,0.03943044906900329,0.4069072902027296,1.0,21/54,27.03%,NPPC;TRH;POMC;AGT;AMH;PENK;CRH;CALCB;PPY;HCRT;CCK;EDN3;ADCYAP1;NMB;INHBA;INHBB;SST;ERFE;INHA;PTHLH;NPY
prerank,retinoid binding (GO:0005501),0.588805149696639,1.4162023899427039,0.07788944723618091,0.4035459566506205,1.0,3/22,7.35%,PTGDS;RBP4;RBP1
prerank,GABA-A receptor activity (GO:0004890),0.6121135145624049,1.4153526797534604,0.08,0.40017232995851687,1.0,6/18,16.56%,GABRB1;GABRG3;GABRA2;GABRA3;GABRB3;GABRB2
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.33243843506232684,-1.4147520510251952,0.0,0.4095844825130456,1.0,49/147,14.54%,AKAP13;DOCK5;PLCE1;DOCK11;RAPGEF4;DENND4A;SBF2;ARHGEF11;DENND4C;ARFGEF1;FARP1;RAPGEF2;DENND2A;IQSEC2;MON1A;ITSN1;ARHGEF18;FGD4;ANKRD27;FNIP1;EIF2B3;DENND5A;RAPGEF6;DENND1A;RAPGEF1;ARFGEF2;RIC8B;RAPGEF5;BCR;ARHGEF6;VAV2;GAPVD1;CCZ1;ALS2;DENND1B;RAPGEF3;DNMBP;DENND5B;DENND3;RIC1;DOCK1;ARHGEF2;DENND2C;ARHGEF17;EIF2B2;PREX2;RAB3GAP2;RGL1;NGEF
prerank,cadherin binding (GO:0045296),0.4751183125434431,1.412747324938133,0.0,0.4026513753193284,1.0,91/315,17.44%,BSG;HSPA8;RPL24;RPL34;ALDOA;EEF2;RACK1;RPL6;RPL29;RPS2;RPL15;RPS26;PCBP1;RPL23A;RPL14;RPL7A;HSP90AB1;PPP1CA;TAGLN2;PARK7;FXYD5;S100A11;HSPA5;PSMB6;EEF1G;EIF4G2;HNRNPK;PRDX6;ANK3;CTNNA2;CNN2;CTNNA3;LYPLA2;RAN;EEF1D;YWHAB;PKM;ENO1;PLEC;RTN4;LDHA;PUF60;TRIM29;CDH20;CTNNB1;YWHAE;FLNA;CHMP2B;AHNAK;GLOD4;PFN1;NDRG1;CDH18;KDR;YKT6;CCT8;FASN;CDK5R1;PRDX1;SLC3A2;LASP1;CHMP5;PLIN3;FNBP1L;CLIC1;PTPRB;ANLN;ATXN2L;HSPA1A;YWHAZ;DNAJB1;CDH12;SHTN1;CAPG;EVPL;SND1;PROM1;EHD1;DCHS1;CDH19;SH3GLB2;CDH24;CDH7;EFHD2;DAB2IP;SPTBN2;CDH10;USP8;CDH5;RANGAP1;NUDC
prerank,water transmembrane transporter activity (GO:0005372),0.6873338724579843,1.4070526809949455,0.07496463932107496,0.4143257510507615,1.0,2/11,8.63%,AQP4;AQP1
prerank,manganese ion binding (GO:0030145),-0.37579294046482103,-1.4046044497004082,0.021739130434782608,0.42042262109636486,1.0,8/48,10.32%,MPPED2;LARGE1;ABL1;B4GALT1;XPNPEP3;NEK4;ABL2;GALNT1
prerank,deoxyribonuclease activity (GO:0004536),0.6418356854858246,1.4042098183734457,0.08990318118948824,0.41829188045208393,1.0,2/14,2.74%,RPS3;NME1
prerank,cell-cell adhesion mediator activity (GO:0098632),0.5369279352564915,1.403131231078373,0.04022346368715084,0.41593821979566986,1.0,14/42,15.73%,BSG;PPP1CA;S100A11;DSCAM;CNTN4;TRIM29;SIRPA;LRRC4C;ESAM;ROBO4;EMB;JAM3;IGSF9;DSCAML1
prerank,ribosomal small subunit binding (GO:0043024),0.6244343803984366,1.401223951302931,0.07692307692307693,0.4165355695113736,1.0,4/17,3.18%,EIF1;NME1;NPM1;EIF1B
prerank,estrogen receptor binding (GO:0030331),-0.39893622729950506,-1.3981809365861952,0.0379746835443038,0.4244553682731051,1.0,12/32,13.15%,NSD1;NRIP1;NCOA1;CNOT1;LCOR;STRN;MMS19;ESR1;DCAF1;PPID;DCAF13;PPARGC1B
prerank,purinergic nucleotide receptor activity (GO:0001614),0.642512865321397,1.3979970945379396,0.08311688311688312,0.42060520910214577,1.0,5/15,11.00%,P2RX7;GPR34;P2RY12;P2RY1;P2RX6
prerank,sodium channel regulator activity (GO:0017080),0.5519540805446334,1.396672467319994,0.07407407407407407,0.4190224052889455,1.0,12/37,16.08%,FXYD5;FXYD1;YWHAH;FGF14;SGK1;SCN4B;FGF11;FXYD7;FGF12;RSC1A1;PRSS8;FGF13
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.43664170038903194,-1.3960518764314773,0.07017543859649122,0.4197276498033985,1.0,14/27,14.50%,DCUN1D3;RNF19A;PRKN;ZMYM2;PPARA;ARIH2;RNF144A;ARIH1;RNF217;DCUN1D4;RNF14;SIAH3;DCUN1D1;DCUN1D2
prerank,CoA-ligase activity (GO:0016405),-0.5149744260733176,-1.393901413590792,0.1,0.41443228974022484,1.0,10/14,37.87%,ACSS3;ACSL1;SLC27A2;ACSS1;AACS;ACSBG1;ACSM3;SLC27A5;ACSM2B;ACSM2A
prerank,sodium:proton antiporter activity (GO:0015385),-0.5330532316956822,-1.3828632725745154,0.10305343511450382,0.42676736745622235,1.0,4/11,12.50%,SLC9A1;SLC9A2;SLC9B2;SLC9A8
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.40951987450192245,-1.3822644508639477,0.048484848484848485,0.41893492081989925,1.0,9/29,13.14%,ABL1;ATF7;PPM1D;NFATC1;DUSP16;DUSP10;MAPKAPK3;DUSP7;SIRT1
prerank,ATPase regulator activity (GO:0060590),0.5325946288729537,1.3796909660283783,0.08196721311475409,0.4684231052122779,1.0,15/38,18.81%,ATP5IF1;BAG5;BAG1;PFN1;ATP1B2;PLN;DNAJA1;DNAJB2;DNAJB1;HSPBP1;ATP1B1;BRSK2;AHSA1;ATP1B3;DNAJC10
prerank,ligand-gated cation channel activity (GO:0099094),0.49926287973559413,1.379109411866357,0.030623020063357972,0.4643265813508662,1.0,16/75,12.76%,ASIC2;CHRNA9;GRIA2;GRIK5;GRIK2;GRIN1;KCNJ10;GRIN3A;P2RX7;GRIN2A;GRIA4;P2RX6;TRPM2;KCNN2;GRIA1;CHRNA4
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.5999985121426358,1.3767379575467027,0.08614232209737828,0.4660092752188938,1.0,5/21,12.76%,CHRNA9;GRIK2;P2RX7;P2RX6;CHRNA4
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.6605812182676803,1.3753006284995222,0.11624649859943978,0.46506317970424255,1.0,3/11,11.30%,RPS3;NEIL1;APEX1
prerank,ATPase activator activity (GO:0001671),0.5917262369709548,1.3739916051005316,0.08785529715762273,0.46369387607905443,1.0,8/20,18.81%,ATP1B2;DNAJA1;DNAJB2;DNAJB1;ATP1B1;AHSA1;ATP1B3;DNAJC10
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.6404552054889008,1.3719001025854998,0.09302325581395349,0.46440970283058874,1.0,4/13,12.96%,MIF;DDT;ECH1;HSD3B2
prerank,cholesterol transfer activity (GO:0120020),0.6138384566514153,1.3691265007700473,0.10185185185185185,0.4678852886313387,1.0,4/16,9.50%,PLTP;NPC2;ABCG1;STARD4
prerank,phospholipase inhibitor activity (GO:0004859),0.6688717682698975,1.3676917085937823,0.10775862068965517,0.4672122720345597,1.0,2/10,3.03%,APOC1;ANXA5
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.6290107852729395,1.3626849738892195,0.09217877094972067,0.478252864232028,1.0,9/13,30.02%,GABRG3;GABRA2;GLRA2;GABRA3;GLRA1;GLRA3;GABRA4;GABRG2;GABRA1
prerank,chemorepellent activity (GO:0045499),0.5634688405567863,1.3603918013617395,0.09356014580801944,0.4801550814978169,1.0,8/25,13.77%,NRG3;NRG1;SEMA3F;SEMA7A;SEMA4C;SEMA6D;SEMA4A;SEMA4G
prerank,U6 snRNA binding (GO:0017070),0.6270967423013236,1.3602950927663409,0.12178619756427606,0.4749551373863563,1.0,5/14,10.56%,DDX39B;EIF5A;LSM4;LSM8;PRPF8
prerank,glycine binding (GO:0016594),0.6536230433790784,1.3595749127114696,0.11095505617977527,0.4718425709382253,1.0,6/11,19.42%,GRIN1;GRIN3A;GLRA2;GLRA1;GRIN2B;GLRA3
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.6146664336984333,1.35678787978256,0.11462450592885376,0.4755485367540732,1.0,8/15,12.80%,SLC17A8;SLC1A4;SLC1A2;SLC25A13;SLC17A7;SLC17A6;SLC25A22;SLC1A1
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.523172159625525,-1.355768588670497,0.13358778625954199,0.4623703531056986,1.0,2/11,3.39%,EGFR;MAP3K13
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.5165281119062742,-1.3549272988801915,0.11870503597122302,0.45468111719690785,1.0,4/12,17.73%,TENT4B;TUT1;PAPOLB;TENT2
prerank,adenylate cyclase binding (GO:0008179),0.6633296535580264,1.3540267788291767,0.1235632183908046,0.47927496238068285,1.0,3/10,2.62%,CALM1;CALM3;AKAP6
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.3063043966201889,-1.3529931462529294,0.0,0.44991693915650394,1.0,24/100,10.81%,PARD3;FCHSD2;GAB2;OSBPL8;ZFYVE1;MAPKAP1;PLA2G4A;OGT;PLEKHA4;ADAP2;MYO1B;SNX12;SESTD1;DENND1A;ANKFY1;ATG2B;HIP1;GBF1;ATG2A;SNX24;DAPP1;DENND1B;KIF16B;FERMT2
prerank,metallocarboxypeptidase activity (GO:0004181),0.5500240925959397,1.35285999973522,0.08637469586374696,0.47776129718738886,1.0,7/26,11.04%,CPXM1;CPD;CPE;VASH1;AGBL4;AEBP1;CPXM2
prerank,platelet-derived growth factor binding (GO:0048407),0.6535763192801697,1.3513632259997241,0.13231197771587744,0.47759721493548646,1.0,7/11,15.68%,COL1A1;PDGFB;COL4A1;COL3A1;COL6A1;COL1A2;PDGFA
prerank,1-phosphatidylinositol binding (GO:0005545),-0.48904800488941536,-1.3507657295806321,0.12096774193548387,0.4464433946195978,1.0,7/15,10.25%,ZFYVE1;EEA1;SESTD1;ZFYVE9;PICALM;WDFY3;SNX9
prerank,protein tyrosine kinase activator activity (GO:0030296),0.5846857260213313,1.3506103111954106,0.12105263157894737,0.4748135320730954,1.0,7/19,18.55%,NRG3;NRG1;GRM5;CD24;GAS6;ERCC6;ERBB3
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.2634131157500949,-1.3502913570983577,0.0,0.4390425241080374,1.0,40/188,12.34%,ZBTB20;PBX1;SMAD3;BNC2;TCF7L2;SMAD6;PRDM5;TCF12;SOX5;GABPB2;DHX36;HDAC4;NFYC;PER2;PER3;YAP1;FOXO3;NCOR1;TBL1X;SP1;BCOR;NFKB1;FOXK2;VSX1;ARID4B;STAT3;ASH2L;ARID5B;TBL1XR1;PPARG;FOXK1;SMAD4;ATF6;HNRNPL;BRD7;MZF1;CREB3L2;KMT2D;TAF2;AR
prerank,fatty acid synthase activity (GO:0004312),0.6594672847598526,1.3498692798607896,0.11189801699716714,0.47199958603562703,1.0,4/10,11.40%,ELOVL1;ELOVL2;OXSM;ELOVL7
prerank,sterol transfer activity (GO:0120015),0.5987076108147613,1.3478851492845378,0.1243455497382199,0.47363688483504574,1.0,4/17,9.50%,PLTP;NPC2;ABCG1;STARD4
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.617762796303181,1.3469234939469368,0.1296551724137931,0.47164740374839564,1.0,7/14,13.29%,TIMP2;SPOCK2;SPOCK1;TIMP1;SPOCK3;TIMP3;BST2
prerank,leak channel activity (GO:0022840),-0.45342142140289643,-1.3467672378609732,0.12380952380952381,0.43815722648803485,1.0,3/18,2.12%,KCNK2;NALCN;KCNK5
prerank,poly(A) binding (GO:0008143),-0.4332518952232465,-1.3459813942484766,0.10606060606060606,0.4315456628986521,1.0,4/21,3.31%,RBMS3;RBMS1;RBPMS;DDX1
prerank,transaminase activity (GO:0008483),0.6515514677249998,1.34296124162039,0.10339943342776203,0.4791864088441044,1.0,3/11,6.39%,AGXT;OAT;BCAT2
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5342957679000817,1.3426652830113943,0.09239766081871345,0.47530105384497984,1.0,11/32,24.55%,KCNQ3;KCNQ2;KCNC3;KCNC1;KCNE4;KCNA2;KCNE5;KCNA1;KCNQ5;KCNC2;KCNG3
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.5806855075665132,1.3410806477747081,0.11096938775510204,0.47549631315870855,1.0,5/21,12.76%,GRM5;DRD5;GRM1;GRIA1;CHRNA4
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.49920564242244175,-1.340174127008751,0.11627906976744186,0.43521123634164066,1.0,4/12,12.50%,SLC9A1;SLC9A2;SLC9B2;SLC9A8
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.49469015363815405,-1.3396758129560078,0.10112359550561797,0.42891305488598164,1.0,3/13,9.82%,DICER1;SLX4;DNASE1L1
prerank,gap junction channel activity (GO:0005243),0.5601930758787246,1.339337412361195,0.1267605633802817,0.4762008056412673,1.0,5/22,13.64%,GJA4;GJB2;GJB5;GJD2;GJA1
prerank,phosphatase activator activity (GO:0019211),0.6127799670213034,1.3354358347127497,0.12005457025920874,0.4834294683547692,1.0,8/14,20.60%,CALM1;CALM3;B3GAT3;BMP2;PPP2R5D;PPP1R15A;CALM2;PPP2R5A
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.5990105508436762,1.331734923844503,0.13427109974424553,0.4850680618291988,1.0,12/16,28.92%,PTPRC;PTPRN2;PTPRD;PTPRR;PTPRB;PTPRZ1;PTPN6;PTPRU;PTPRO;PTPRE;PTPRT;PTPRG
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.5990105508436762,1.331734923844503,0.13427109974424553,0.4850680618291988,1.0,12/16,28.92%,PTPRC;PTPRN2;PTPRD;PTPRR;PTPRB;PTPRZ1;PTPN6;PTPRU;PTPRO;PTPRE;PTPRT;PTPRG
prerank,sterol binding (GO:0032934),0.5000032928561094,1.3311819571070767,0.09312638580931264,0.482110632371621,1.0,18/56,19.50%,APOD;TSPO;CD81;NPC2;SCP2;ABCG1;TSPO2;STARD4;OSBPL6;PROM1;SYP;CAV1;OSBPL3;SOAT2;STARD3NL;ANXA6;VDAC2;GPR183
prerank,histone acetyltransferase activity (GO:0004402),-0.3891316709939086,-1.3307618790735047,0.10126582278481013,0.4390970695749899,1.0,9/30,12.90%,KAT6B;CREBBP;EPC1;NAA40;KAT7;KAT2B;ATF2;MCM3AP;KAT6A
prerank,semaphorin receptor binding (GO:0030215),0.5561820268026084,1.3279985127654517,0.1356968215158924,0.487653685196924,1.0,6/23,13.77%,SEMA3F;SEMA7A;SEMA4C;SEMA6D;SEMA4A;SEMA4G
prerank,carboxylic ester hydrolase activity (GO:0052689),0.4698003099147382,1.3268039938724145,0.06540084388185655,0.48656880340510866,1.0,26/85,23.74%,PNPLA2;PRDX6;LYPLA2;CA2;PLAAT3;PGLS;LIPG;ENPP2;LPL;PNPLA7;LIPE;PLA2G7;AARS2;PLA2G4F;GDE1;MRPL58;ABHD8;ACHE;GDPD1;FAAH;NOTUM;BCHE;ESD;ABHD16A;APMAP;GDPD3
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.5349151137123995,-1.3231404248744436,0.16451612903225807,0.4491655128232984,1.0,6/10,23.05%,CFLAR;CASP12;CASP3;CASP8;CASP7;CASP4
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.5978783092475871,1.3227665338587435,0.14188267394270124,0.4947653761574829,1.0,6/14,17.54%,NME1;AK4;NME4;NME2;CMPK2;NME3
prerank,acetyltransferase activity (GO:0016407),-0.38614258108903377,-1.321117776076592,0.07692307692307693,0.4456595320410726,1.0,12/31,19.38%,KAT6B;CREBBP;KAT2B;PAFAH2;SMARCE1;NAA16;NAA15;ESCO1;KAT6A;SPHK1;KAT8;DBT
prerank,kinase activator activity (GO:0019209),0.5266512089723965,1.3199652698272606,0.11201866977829639,0.4984015948153352,1.0,5/30,9.55%,RPLP1;MT3;TREM2;IL2;CDK5R1
prerank,translation initiation factor activity (GO:0003743),0.5178749011616537,1.3193066726592146,0.12977983777520277,0.496105773517674,1.0,18/36,25.64%,EIF1;EIF3F;EIF4G2;EIF3D;EIF1B;EIF3K;EIF3I;EIF3C;EIF4A1;EIF3B;EIF2B5;EIF3M;EIF5B;EIF4E2;EIF3H;EIF2S1;EIF2A;EIF3G
prerank,protein kinase inhibitor activity (GO:0004860),0.508762572208646,1.3185917808733587,0.11199095022624435,0.4939205207323688,1.0,21/42,28.30%,RACK1;NPM1;CAMK2N2;YWHAB;PPP1R1B;CDKN1C;INKA2;ITPRIP;CAMK2N1;MAPK8IP1;HEXIM1;GMFB;PRKRIP1;QARS1;SNCA;SOCS3;DNAJC3;INKA1;TRIB1;CDKN1A;SPRY2
prerank,endopeptidase activator activity (GO:0061133),0.6566745008973642,1.3182789596429088,0.1539509536784741,0.49043325228533796,1.0,4/10,8.99%,PSME1;PSME2;PSENEN;VSIR
prerank,actin monomer binding (GO:0003785),0.5601289089140388,1.3174330291640612,0.12672521957340024,0.488623080059807,1.0,5/22,7.66%,TMSB4X;TMSB10;MRTFA;PFN1;CORO1A
prerank,histone methyltransferase binding (GO:1990226),0.6295146341615444,1.3155731913651327,0.1505524861878453,0.4900087907739918,1.0,6/11,21.30%,HSP90AB1;CTNNB1;PRDM12;CBX3;PHF1;NOP56
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.5724171472097994,1.315274882222515,0.145478374836173,0.4865885736598893,1.0,7/17,17.54%,NME1;AK4;AK3;NME4;NME2;CMPK2;NME3
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.5991849584186048,1.3126479140814387,0.16847826086956522,0.4903525250810841,1.0,5/14,15.33%,RACK1;RPS27L;MAL;CTSH;BAD
prerank,protein tyrosine kinase binding (GO:1990782),0.4731795211056156,1.3123133154210351,0.06932773109243698,0.48716235753558523,1.0,12/71,6.33%,RACK1;HSP90AA1;NRG3;TREM2;NRG1;GRM5;GRB14;LRP4;SIRPA;DUSP3;HYAL2;SHC3
prerank,wide pore channel activity (GO:0022829),0.5461865258033037,1.3094856391088452,0.13850063532401524,0.49102242992174255,1.0,5/23,13.64%,GJA4;GJB2;GJB5;GJD2;GJA1
prerank,GABA receptor activity (GO:0016917),0.5493753874722168,1.308855840794559,0.140485312899106,0.4886291905471063,1.0,10/21,30.02%,GABRB1;GABRG3;GABRA2;GABRA3;GABRB3;GABRB2;GABBR2;GABRA4;GABRG2;GABRA1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.6344724910707175,1.3078903605424264,0.15689149560117302,0.48729410897894637,1.0,7/10,33.47%,GABRG3;GABRA2;GABRA3;GABRA4;GABRG2;GABRA1;GABRG1
prerank,snRNA binding (GO:0017069),0.5055406829545546,1.306479344465474,0.10762331838565023,0.48724309439756236,1.0,19/42,22.78%,DDX39B;EIF5A;LSM4;LSM8;SNRPA;PRPF8;TOE1;HEXIM1;HNRNPU;PRPF31;MEPCE;LSM7;SNRPD3;RBM7;CDK9;SNRNP35;SNU13;ISG20;SNRPB2
prerank,mRNA binding (GO:0003729),0.4412150709502781,1.305702885032692,0.009036144578313253,0.4854062199127424,1.0,28/249,5.51%,RPL41;RPL26;MRPL13;RPS3;RPS14;RPS5;RPS7;RPL5;RPS13;RPS2;RPL13A;RPS26;RPL7;PCBP1;CALR;RPL35;PARK7;HNRNPAB;EIF4G2;EIF3D;SHFL;HNRNPK;ZFP36L1;QKI;PKM;NCL;RBFOX3;PCBP4
prerank,glucuronosyltransferase activity (GO:0015020),-0.4415171602925757,-1.2979860419689198,0.14349775784753363,0.48638706813821103,1.0,2/19,1.12%,LARGE1;EXT1
prerank,acid-thiol ligase activity (GO:0016878),-0.4909454020982301,-1.2909719301164129,0.1717557251908397,0.4931567992802302,1.0,9/13,37.87%,ACSS3;ACSL1;SLC27A2;ACSS1;AACS;ACSM3;SLC27A5;ACSM2B;ACSM2A
prerank,chloride channel activity (GO:0005254),0.4678702615161876,1.2876942225940045,0.11538461538461539,0.5364784966261057,1.0,15/59,19.42%,GABRB1;FXYD1;SLC1A4;GABRG3;GABRA2;TTYH1;GLRA2;GABRA3;GABRB3;GLRA1;CLIC1;TTYH3;GABRB2;ANO4;GLRA3
prerank,pentosyltransferase activity (GO:0016763),-0.36931944774565634,-1.2870750870397696,0.09154929577464789,0.4936628172614655,1.0,10/36,15.12%,LARGE1;PARP4;PARP9;PARP16;UPP2;PARP3;TNKS2;SIRT1;PARP10;ZC3HAV1
prerank,CCR chemokine receptor binding (GO:0048020),0.5256583255886895,1.286168714871977,0.12727272727272726,0.5369452938507083,1.0,7/28,18.54%,CCL19;NES;NARS1;CCL2;CCL3;CCL8;CCR2
prerank,carboxylic acid binding (GO:0031406),0.5013979976876187,1.2857535700597365,0.11880046136101499,0.5340125845950581,1.0,13/38,22.15%,PSAP;GRIN1;EPDR1;GRIN3A;GRM7;GLRA2;GLRA1;NOS2;GLUD1;GRIN2B;GLRA3;SHMT2;MAG
prerank,aspartic-type peptidase activity (GO:0070001),0.6340511378478132,1.2824863627220793,0.17739628040057226,0.5397340636865647,1.0,1/10,0.26%,CTSD
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.47986981921412686,-1.2810328088946183,0.16549295774647887,0.5001073107252457,1.0,4/12,10.33%,PAN3;CNOT1;PARN;CNOT7
prerank,small GTPase binding (GO:0031267),-0.279809810373593,-1.27985855163282,0.0,0.49504504585264403,1.0,38/169,11.94%,AKAP13;STRN3;AFDN;PLCE1;RAPGEF4;GOLGA4;LRRK2;RANBP2;RNF152;EXOC4;SGSM2;BRAF;MAPKAP1;USP6NL;EPS8;RAF1;EXOC2;FGD4;ANKRD27;NOX1;UNC13B;DOCK7;RAPGEF6;NCKAP1;CDC42EP5;RABGAP1;ANKFY1;TRIOBP;NUTF2;RNF41;GGA2;PICALM;OPTN;ALS2;GOLGA5;MYO9B;PDE6D;RIC1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.568334004023344,1.2777545551251412,0.16517285531370038,0.5457733451084961,1.0,4/16,11.39%,ATP6V0C;ATP5F1B;ATP6V0E2;ATP6V0D2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.568334004023344,1.2777545551251412,0.16517285531370038,0.5457733451084961,1.0,4/16,11.39%,ATP6V0C;ATP5F1B;ATP6V0E2;ATP6V0D2
prerank,anion channel activity (GO:0005253),0.46735505130845456,1.2763939800853694,0.12582056892778992,0.5453803731648541,1.0,16/61,19.42%,GABRB1;FXYD1;LRRC8A;SLC1A4;GABRG3;GABRA2;GLRA2;GABRA3;GABRB3;GLRA1;CLIC1;TTYH3;GABRB2;ANO4;VDAC2;GLRA3
prerank,GTP binding (GO:0005525),0.43171276552867843,1.2719089303087008,0.05141129032258065,0.5557335989163267,1.0,47/172,19.02%,EEF1A1;TUBB;TUBA1A;TUBA1B;TUBB4B;RHOB;NME1;TGM2;TUBAL3;RAN;RHOC;RAC1;ARF5;TUBA4A;RHOG;RAB14;ADSS1;ARL11;TUBB2B;TUBB4A;SCG5;ARF6;RHOV;ARL4C;GNAI1;ARL4D;HRAS;ARL1;RHEBL1;RHOA;RHOU;ARF1;GTPBP10;RRAS;ARL2;RRAGC;RAB26;ARF4;RRAGD;NUDT16;TUBB2A;RAC2;TSR1;ANXA6;GLUD1;AGAP2;RAB31
prerank,calcium channel inhibitor activity (GO:0019855),0.6047776123477442,1.2706280446866485,0.19047619047619047,0.5556453646214177,1.0,6/11,18.67%,CALM1;SLC30A1;FKBP1A;PHPT1;FKBP1B;CALM2
prerank,transcription corepressor binding (GO:0001222),-0.38160591822183265,-1.2685655887421463,0.11173184357541899,0.5108450782148486,1.0,10/27,15.23%,ZBTB16;PER2;USP11;PER3;EHMT1;LCOR;NEK6;ESR1;EHMT2;EZH2
prerank,endodeoxyribonuclease activity (GO:0004520),0.5453790315693129,1.2681700611855224,0.1760204081632653,0.559353556477261,1.0,2/20,3.49%,RPS3;ENDOG
prerank,ATP hydrolysis activity (GO:0140603),0.48333729113259616,1.266366407845868,0.14301552106430154,0.5606539981207632,1.0,20/41,30.37%,CLU;HSP90AA1;HSPA1B;ABCB6;VCP;KIF26A;ATP2B1;HSPA1A;ABCB10;CHD3;TDRD9;KIF20B;ABCA3;RUVBL2;DHX9;RHOBTB3;DNA2;TOR3A;ABCD2;MYO1E
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",-0.25599197965106935,-1.265088835881736,0.0,0.5108799320029616,1.0,30/173,11.92%,ZBTB20;FOXP1;FOXP2;ZEB1;ZNF148;KLF12;PRDM5;MXI1;ZBTB16;SKI;PPARA;ZFP90;FOXO3;NFATC4;FOXP4;NFKB1;FOXK2;ZBTB1;KCNIP3;ZFHX3;ZBTB26;NFX1;KLF8;PPARG;FOXK1;ZKSCAN3;ETV6;NFATC3;MZF1;ZBTB34
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.5896359924227552,1.2650662860675286,0.17813765182186234,0.5604105856734815,1.0,7/14,12.80%,SLC17A8;SLC1A2;SLC25A13;SLC17A7;SLC17A6;SLC25A22;SLC1A1
prerank,hexosaminidase activity (GO:0015929),0.601474214741141,1.2623762795417106,0.19571045576407506,0.5644898567532081,1.0,3/12,5.90%,HEXB;HEXA;HYAL2
prerank,potassium channel activity (GO:0005267),0.44797109095182797,1.2618401880449104,0.1115702479338843,0.5620157959964286,1.0,29/89,21.93%,KCNQ3;KCNQ2;KCNC3;KCND2;GRIK5;GRIK2;AQP1;KCNC1;KCNA2;KCNN2;KCNK9;KCNF1;ABCC8;KCNE5;KCNK3;KCNA1;HCN1;LRRC55;HCN3;KCNMA1;KCNK10;KCNH7;KCNH8;KCNK13;PKD2L1;KCNQ5;TMEM38B;KCNC2;GRIK1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.5934938649215252,1.2602130595386853,0.20637119113573407,0.5628749210809465,1.0,6/12,24.14%,RACK1;RPS27L;CTSH;BAD;PYCARD;CASP1
prerank,calcium-dependent phospholipid binding (GO:0005544),0.4731728087456245,1.259720200192037,0.1404494382022472,0.5602338580799967,1.0,25/49,32.54%,ANXA5;SYT1;SYT12;SYT11;RPH3A;SYT6;SYT4;PLA2G4F;SYT10;CPNE5;SYT2;CPNE6;DOC2B;ANXA6;CPNE4;C2CD5;SYT3;SYT5;SYT17;CPNE3;PCLO;CPNE9;SYT7;MCTP1;ANXA2
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.48604758136900017,1.2578054806508934,0.16433566433566432,0.5619651337264756,1.0,12/37,19.14%,LARS2;GARS1;SARS2;SARS1;KARS1;AARS2;WARS1;NARS1;CARS1;TARS3;EPRS1;QARS1
prerank,ion channel activity (GO:0005216),0.447711412798578,1.2575598662143952,0.13527575442247658,0.5585939770552109,1.0,27/80,22.68%,GABRB1;LRRC8A;GRIA2;GRID2;GRIK5;GRIK2;GRIN1;GRIN3A;TMEM63B;GRIN2A;GRIA4;CNGA3;GRID1;TRPM2;GRIA1;CHRNA4;TRPC1;KCNK3;CNGB1;UNC80;ANXA6;GRIN2B;CALHM6;PKD2L1;GRIA3;GRIK1;CHRNA3
prerank,iron ion binding (GO:0005506),0.4703678584367472,1.2563472727531495,0.16,0.5582993372704995,1.0,9/48,14.26%,FTH1;FTL;SCD5;DOHH;HEPH;SCD;LCN2;ISCU;EGLN2
prerank,exopeptidase activity (GO:0008238),0.46356075666303265,1.2530404128895312,0.15271493212669685,0.5644581566464143,1.0,12/50,13.92%,CTSZ;RCE1;DPEP3;METAP1;DPP10;CPE;DPEP2;DPP6;METAP2;CTSA;LAP3;CTSH
prerank,ATPase binding (GO:0051117),0.4528502635071084,1.2490019302295121,0.12234042553191489,0.5727991306097967,1.0,29/71,23.16%,S100A1;UBXN1;GABARAPL2;ATP6V1G1;ATP5IF1;FBL;ATP1B2;PLN;PIH1D1;TAF9;SYVN1;SVIP;WFS1;TMEM106B;BBC3;DNAJB1;TRPC1;NR1H2;ATP1B1;BRSK2;CAV1;ATP1B3;PPP3CA;DNAJC10;SELENOS;RALB;SNU13;ATP6V0A1;NKD2
prerank,chemoattractant activity (GO:0042056),0.509963597614327,1.2481594214323204,0.19676214196762143,0.5714289427548718,1.0,6/26,9.90%,GPNMB;PDGFB;LGALS3;MIF;CXCL10;HMGB1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.4710592156603554,-1.2456146710797564,0.2099644128113879,0.5502914555870128,1.0,3/12,4.81%,GAB2;FRS2;IRS1
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.3736991448702405,-1.2455406795088615,0.15151515151515152,0.5424389463971352,1.0,5/27,6.36%,ITPR1;ITPR2;CNNM2;SLC9B2;TUSC3
prerank,neuropeptide hormone activity (GO:0005184),0.5293267513798857,1.2421569040098008,0.19798234552332913,0.5851845223804061,1.0,8/22,18.50%,PENK;CRH;CALCB;PPY;HCRT;CCK;ADCYAP1;NMB
prerank,growth factor activity (GO:0008083),0.44762950336170076,1.2421527327338606,0.14946236559139786,0.5811603699559649,1.0,21/74,25.67%,MDK;GRN;NRG3;NRG1;AGT;PDGFB;IL2;IL11;PDGFA;IGF2;JAG2;INHBA;HGF;IL6;THPO;OSGIN1;PTN;TGFA;INHA;FGF22;CSPG5
prerank,single-stranded telomeric DNA binding (GO:0043047),0.596753341759209,1.2412306898032943,0.225531914893617,0.5799108724783817,1.0,5/11,18.20%,TERF1;RPA2;HNRNPA1;CTC1;TERF2IP
prerank,protein kinase activator activity (GO:0030295),0.4564430042523471,1.241115222183024,0.15852334419109662,0.5763206967875673,1.0,17/60,18.67%,RPLP1;CALM1;MT3;CALM3;NRG1;GRM5;CD24;CDK5R1;STK11;GAS6;IGF2;FGF13;ERCC6;MAP2K2;AGAP2;ERBB3;CALM2
prerank,kinesin binding (GO:0019894),0.5071650733723967,1.2347991443463404,0.19179734620024125,0.591888154727729,1.0,8/27,19.16%,ACTB;NEFH;MAPK8IP1;MAPK8IP2;CLSTN1;FAM83D;ATCAY;SNCA
prerank,transition metal ion binding (GO:0046914),0.4132145390843314,1.2311906549385334,0.022,0.5993934743618337,1.0,60/397,13.10%,FTH1;FTL;RPS29;CRIP1;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;RPS27;ATOX1;SCD5;CRIP2;CALR;MT3;TIMM8B;TIMM13;PARK7;SOD1;MT2A;TIMP2;PRNP;S100B;DOHH;S100A13;COX17;CA2;GLO1;CZIB;ANG;S100A8;S100A9;GALT;HEPH;CALB1;TRIM28;ENPP2;GRIN2A;TIMP1;CSRP1;EGR1;TRIM2;RPH3A;ATP13A2;ALAD;SMPD1;AOC3;SCD;LCN2;MGAT2;GLRA1;ISCU;ZCCHC4;THAP11;KLF4;MSRB1;CUTA
prerank,ankyrin binding (GO:0030506),0.5416871428463904,1.2304803210217856,0.20127388535031848,0.5976014891617834,1.0,6/19,15.44%,KCNQ2;PTPRC;PLEC;NRCAM;SLC8A1;SPTBN4
prerank,zinc ion binding (GO:0008270),0.41409377128900576,1.2261092272783654,0.04004004004004004,0.6073594928734203,1.0,39/293,10.37%,RPS29;CRIP1;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;RPS27;CRIP2;CALR;MT3;TIMM8B;TIMM13;SOD1;MT2A;TIMP2;S100B;S100A13;CA2;GLO1;CZIB;S100A8;S100A9;GALT;CALB1;TRIM28;ENPP2;GRIN2A;TIMP1;CSRP1;EGR1;TRIM2;RPH3A;ATP13A2;ALAD;SMPD1
prerank,protein kinase regulator activity (GO:0019887),0.4309521696875733,1.222560250545563,0.1441908713692946,0.6147089788237189,1.0,28/95,19.16%,RPLP1;MT3;CCNI;CCND2;NPM1;CSNK2B;YWHAB;PPP1R1B;CDKN1C;CCND1;CXCL10;PRKAR1A;CDK5R1;PRKAR1B;ELP3;ITPRIP;MAPK8IP1;CCNG1;HEXIM1;STK11;GMFB;FGF13;PRKAR2B;PRKRIP1;CCNJL;AGAP2;QARS1;SNCA
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.5734444901672955,1.2215639582918165,0.2443820224719101,0.6138361904602491,1.0,4/12,27.30%,H3-3A;TBP;RELA;RUVBL2
prerank,nucleoside-triphosphatase activity (GO:0017111),0.4089187165973288,1.2194664388655696,0.045090180360721446,0.6163395786834078,1.0,65/248,21.84%,EEF1A1;MYL6;CLU;EEF2;HSP90AA1;GNAI2;RHOB;GNB2;GNG5;RAN;RHOC;RAC1;GNG11;GNA11;PIN1;HSPA1B;ABCB6;EEF1A2;VCP;DNM3;ARHGDIB;RHOG;SAR1A;RAB14;RAB3C;KIF5A;RHOV;GNG3;GNAI1;NKIRAS1;KIF26A;GNAO1;MYL6B;ATP2B1;HRAS;ARL1;RHEBL1;RHOA;HSPA1A;RHOU;NKIRAS2;GTPBP10;RRAS;ARL2;ABCB10;RRAGC;RAB20;RRAGD;DNM1L;RAB5C;RAC2;TSR1;AGAP2;RAB31;GPN3;RAB18;RAB4A;CHD3;RAB6B;RERG;RALB;NUGGC;RAB27B;DNM1;TDRD9
prerank,CXCR chemokine receptor binding (GO:0045236),0.5891096331461702,1.2193942748738713,0.24259520451339917,0.6126019895202955,1.0,3/11,14.95%,CXCL12;CXCL10;PF4
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.4002336590721145,-1.2172793144732625,0.17727272727272728,0.6027267329260103,1.0,5/21,6.82%,PDE1A;PDE7B;PDE5A;PDE8B;PDE7A
prerank,guanyl ribonucleotide binding (GO:0032561),0.4104795871177727,1.2159328071995092,0.08862034239677745,0.6193519551518608,1.0,59/196,21.57%,EEF1A1;TUBB;TUBA1A;TUBA1B;TUBB4B;RHOB;NME1;TGM2;TUBAL3;RAN;RHOC;RAC1;ARF5;TUBA4A;RHOG;RAB14;CNGA3;ADSS1;CNGA4;ARL11;TUBB2B;TUBB4A;SCG5;ARF6;RHOV;ARL4C;GNAI1;ARL4D;HRAS;ARL1;RHEBL1;RHOA;NME2;SLC19A1;RHOU;ARF1;GTPBP10;RRAS;ARL2;RRAGC;RAB26;ARF4;CNGB1;RRAGD;NUDT16;TUBB2A;RAB5C;RAC2;TSR1;ANXA6;GLUD1;AGAP2;RAB31;RAB18;RAB4A;PDE11A;RERG;RALB;RAB27B
prerank,semaphorin receptor activity (GO:0017154),-0.4698401704400523,-1.214813087077018,0.2108843537414966,0.599891123144101,1.0,4/11,14.25%,PLXNA2;NRP1;NRP2;PLXNA4
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.49190762456726195,1.2147321481409001,0.20525657071339173,0.6190129911792471,1.0,9/27,21.36%,POLR2E;POLR2D;POLR2F;POLR1B;POLR2G;MED21;POLR1D;POLR1H;POLR3K
prerank,potassium:proton antiporter activity (GO:0015386),-0.4747666592728419,-1.2108799993231587,0.2103448275862069,0.6015331028499656,1.0,3/10,12.50%,SLC9A1;SLC9A2;SLC9A8
prerank,outward rectifier potassium channel activity (GO:0015271),-0.4682984237286395,-1.210813011336004,0.22105263157894736,0.5934089277627805,1.0,2/11,3.48%,KCNK2;KCNT2
prerank,potassium channel regulator activity (GO:0015459),0.4552449245230726,1.210723501811701,0.18861607142857142,0.6272767661518558,1.0,12/49,17.61%,KCNIP4;AKT1;DPP10;YWHAE;FLNA;SGK1;DPP6;KCNE4;KCNE5;KCNIP1;ARPP19;LRRC55
prerank,DNA polymerase binding (GO:0070182),0.534505305895609,1.2106994242362648,0.2540880503144654,0.6234268606259176,1.0,5/18,15.09%,HSP90AA1;HSP90AB1;HMGB1;PCNA;PTGES3
prerank,acylglycerol lipase activity (GO:0047372),0.5729470429762856,1.2072666876295883,0.24172661870503598,0.6300613456699005,1.0,5/11,29.22%,LIPE;FAAH;ABHD16A;ABHD12;MGLL
prerank,receptor ligand activity (GO:0048018),0.40782229382478685,1.2058948790533865,0.079,0.630437571804533,1.0,63/245,22.87%,MDK;GRN;GPNMB;NBL1;NRG3;NPPC;NRG1;POMC;AGT;TAFA1;TNF;SEMA3F;PDGFB;LGALS3;SEMA7A;AMH;MIF;SEMA4C;LRPAP1;LEFTY2;SEMA6D;TIMP1;CXCL10;TNFSF12;IL2;CRH;HMGB1;SEMA4A;WNT5A;KITLG;IL11;PPY;NTS;BMP2;WNT10B;SEMA4G;CCK;LEFTY1;GAS6;SLURP1;GDF15;PDGFA;IGF2;EDN3;CCL3;JAG2;NMB;SCGB3A1;INHBA;TGFB1;HGF;IL6;GDF11;THPO;OSGIN1;INHBB;SST;CRLF1;PTN;SCG2;ERFE;TGFA;FAM3C
prerank,SUMO binding (GO:0032183),-0.4673490092927426,-1.2040821812375417,0.2260536398467433,0.6008617404258938,1.0,5/13,20.45%,PML;TDG;CBX4;RNF111;HERC2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.5808305259391229,1.2019370164207202,0.2605729877216917,0.6390654776470392,1.0,5/10,27.95%,APOBEC2;APOBEC1;CDA;GDA;ADA
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.4894373373233916,1.1995984601754834,0.23627684964200477,0.6425041315041696,1.0,10/26,23.83%,B4GALNT1;B4GALNT4;B3GNT9;CHPF2;CHPF;B3GNT3;CHSY3;CSGALNACT2;B3GALT5;B3GALT2
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.5005906875796424,1.1971779614181395,0.24108241082410825,0.6459624025399844,1.0,8/22,24.08%,ATP6V0C;ATP5F1B;ATP6V0E2;ATP6V0D2;ATP2A2;ATP6V1A;ATP6V0A1;ATP6V0B
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.41822585167788107,-1.1968856223803015,0.22267206477732793,0.6106450167683125,1.0,5/16,12.14%,MTMR3;MTMR11;SACM1L;PTEN;MTMR10
prerank,transferrin receptor binding (GO:1990459),0.5851126933900578,1.196631793539847,0.26453488372093026,0.6436330330704181,1.0,1/10,1.12%,CD81
prerank,peptidoglycan binding (GO:0042834),0.6008473277965635,1.1965806114938309,0.2514367816091954,0.6399128191541164,1.0,7/10,32.42%,PGLYRP1;RNASE7;NLRP3;TLR2;NOD2;JCHAIN;NOD1
prerank,phosphate ion binding (GO:0042301),0.6029510009519867,1.1954970015397213,0.2524822695035461,0.6394206615979207,1.0,6/10,25.47%,ADSS1;RPH3A;PNP;CHST14;RELA;PDE2A
prerank,AMP binding (GO:0016208),-0.475854402063125,-1.1934403788856112,0.2392857142857143,0.6109002549492247,1.0,2/11,0.43%,PRKAG2;MPPED2
prerank,NAD+ binding (GO:0070403),-0.44736249096552944,-1.1924801437280208,0.2490974729241877,0.6052760276277349,1.0,5/12,20.69%,CRYL1;PARP9;SIRT1;ZC3HAV1;SIRT6
prerank,neuropeptide receptor activity (GO:0008188),0.486268647633611,1.188714661808506,0.2286401925391095,0.6569703150029408,1.0,8/29,22.27%,NPY1R;SORCS1;SSTR4;TACR1;SORCS3;GRPR;NPY5R;SSTR2
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.3743545287956267,-1.187716407726426,0.21693121693121692,0.6086986056453484,1.0,8/25,15.12%,PARP4;PARP9;PARP16;PARP3;TNKS2;SIRT1;PARP10;ZC3HAV1
prerank,ion channel inhibitor activity (GO:0008200),0.4691318028422683,1.1876890596314285,0.22235157159487776,0.6562138122694944,1.0,7/35,12.58%,RACK1;CALM1;SLC30A1;FKBP1A;PHPT1;VAMP8;RSC1A1
prerank,amino acid:sodium symporter activity (GO:0005283),-0.4542037550617868,-1.178382769455008,0.26148409893992935,0.6245333498549686,1.0,3/11,3.41%,SLC1A3;SLC6A13;SLC6A12
prerank,phospholipase activity (GO:0004620),0.42838160112753726,1.1783098371980634,0.21221864951768488,0.6808707641979758,1.0,14/67,14.15%,PRDX6;LYPLA2;PLD3;PLAAT3;LIPG;PDIA3;ENPP2;LPL;PNPLA7;SMPD1;PLA2G4F;GDE1;SMPDL3A;PLBD2
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.28401390336822996,-1.178046494658486,0.14084507042253522,0.6176581983451812,1.0,19/72,13.25%,PARD3;SVIL;FCHO2;SLC9A1;ACTN2;FRMPD4;MAPKAP1;PLEKHA4;ADAP2;MARK1;MYO1B;SESTD1;HIP1;PICALM;KRIT1;TULP3;KCNJ2;STXBP6;PLCD1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.554640815907166,1.1772811020496148,0.26193724420190995,0.6802243893403416,1.0,3/13,9.14%,SLC38A5;SLC25A29;SLC15A4
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.503149264592094,1.1745852569490347,0.29044585987261146,0.6848333140667099,1.0,4/20,7.14%,SLC30A1;SLC39A1;SLC39A10;SLC39A7
prerank,G protein-coupled receptor binding (GO:0001664),0.4092479617746599,1.1744969164052563,0.15858585858585858,0.6812005266907156,1.0,25/132,13.96%,HSPA8;GNAI2;CXCL12;CCL19;POMC;HOMER2;GNA11;HSPA1B;FLNA;S1PR1;PENK;INSL5;PDYN;GNAI1;WNT5A;REEP2;GNAO1;CALCB;DNAJA1;PPY;NTS;GPRASP2;HSPA1A;WNT10B;SDCBP
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.28093241395934104,-1.1740809604732516,0.08571428571428572,0.6204247780650427,1.0,16/60,10.89%,EGFR;EPHA7;EPHA3;ROR1;CRIM1;NRP1;NTRK3;EPHA4;EFEMP1;IGF2R;INSR;MET;FGFR2;NRP2;PDGFRB;EPHB2
prerank,voltage-gated potassium channel activity (GO:0005249),0.41710677511344857,1.1704577849763105,0.21533613445378152,0.6898505574391193,1.0,23/80,24.70%,KCNQ3;KCNQ2;KCNC3;KCND2;KCNJ10;KCNC1;KCNE4;KCNA2;KCNN2;KCNF1;KCNE5;KCNA1;HCN1;LRRC55;HCN3;KCNMA1;KCNH7;KCNH8;KCNQ5;KCNC2;KCNJ3;KCNG3;KCNJ6
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.4603835486702067,-1.1673631686345234,0.27017543859649124,0.6302703173867772,1.0,6/11,20.52%,PRMT9;FBXO11;CARM1;PRMT6;NDUFAF7;PRMT8
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.2905251402583217,-1.1661802999492779,0.06349206349206349,0.6255742934446094,1.0,17/71,12.15%,EYA2;PTPN13;EYA1;PTPN21;PTPN9;PTPN14;TNS2;MTMR3;PTPN3;PALD1;EYA4;CDC14A;PTPN12;CDC25B;PTEN;EYA3;PTPN2
prerank,neurexin family protein binding (GO:0042043),0.5648415409057788,1.1645286831168986,0.2838235294117647,0.7048285782883362,1.0,4/10,18.86%,NLGN1;CPE;SYTL2;SYTL1
prerank,cAMP response element binding (GO:0035497),-0.4679901929805459,-1.1602901875892209,0.29102167182662536,0.6329868683673602,1.0,4/10,11.54%,ATF7;CREB5;ATF2;CREB3L2
prerank,adenyl nucleotide binding (GO:0030554),0.5532652849920574,1.1593687746746537,0.3050847457627119,0.7129472161336845,1.0,4/11,14.42%,BAG5;BAG1;PFN1;HSPBP1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.5532652849920574,1.1593687746746537,0.3050847457627119,0.7129472161336845,1.0,4/11,14.42%,BAG5;BAG1;PFN1;HSPBP1
prerank,anion:anion antiporter activity (GO:0015301),0.5161057378502547,1.1584720517049947,0.29905277401894453,0.71182469444251,1.0,6/17,18.74%,SLC25A5;SLC25A4;SLC26A4;SLC25A11;SLC19A1;SLC4A2
prerank,potassium ion antiporter activity (GO:0022821),-0.41054520378791354,-1.1583219653976236,0.233201581027668,0.6308799879350412,1.0,3/15,2.56%,SLC24A3;SLC9A1;SLC9A2
prerank,lysine N-methyltransferase activity (GO:0016278),-0.37221019032601155,-1.1582240605204863,0.2391304347826087,0.6239577433106674,1.0,9/20,20.11%,SETD2;EHMT1;SETD7;EHMT2;SETD4;SETD3;VCPKMT;METTL21A;SETD6
prerank,5'-3' RNA polymerase activity (GO:0034062),0.46624996398628427,1.1573674261495037,0.2783882783882784,0.7114008418264203,1.0,9/27,21.36%,POLR2E;POLR2D;POLR2F;POLR1B;POLR2G;MED21;POLR1D;POLR1H;POLR3K
prerank,metalloendopeptidase activity (GO:0004222),-0.27931850124529584,-1.154000532304462,0.19148936170212766,0.626869931386325,1.0,17/76,11.91%,ADAMTS10;TRABD2B;ADAMTS12;ADAMTSL3;ADAMTS2;THSD4;ADAMTSL5;ADAMTS9;ADAMTSL4;NRDC;ADAMTS5;ADAM9;ADAM33;ADAMTS6;NLN;ADAM19;ADAMTS14
prerank,voltage-gated cation channel activity (GO:0022843),0.4020094452497154,1.1534590600587988,0.21730175077239958,0.7196134522528611,1.0,32/97,25.75%,KCNQ3;KCNQ2;KCNC3;KCND2;CACNA1A;GRIN1;GRIN3A;HVCN1;GRIN2A;KCNC1;KCNA2;KCNF1;KCNE5;KCNA1;HCN1;CACNG8;LRRC55;HCN3;KCNMA1;GRIN2B;CACNG5;NCS1;KCNH7;KCNH8;KCNQ5;CACNB4;KCNC2;CACNA1E;CACNA2D1;KCNG3;CACNG2;CACNA1B
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.27697183323569274,-1.1532798592688804,0.0,0.6216902741433681,1.0,81/346,13.54%,RNF220;PDZRN3;UBE2E2;HECTD1;CNOT4;BIRC6;TTC3;MIB1;RNF216;RNF152;UBR4;TRIP12;SMURF2;WWP1;KCMF1;RNF19A;RNF38;UBR5;COP1;PRKN;BIRC2;CBLB;TRAF3IP2;RNF146;PELI2;SH3RF1;UBR3;ARIH2;SH3RF3;UBR1;RNF144A;RNF213;SMURF1;TRAF5;BCOR;UBE2Q2;UBE2R2;RNF24;RNF135;HUWE1;TRIM5;ARIH1;BIRC3;UHRF2;PML;RNF8;UBR2;DDB2;RNF41;FBXO11;FBXO10;ZNRF1;SH3RF2;NEURL2;BTRC;NFX1;TOPORS;RNF138;UBE2J2;TRIM24;FBXO4;ASB2;ZFP91;RC3H2;UBE3C;ITCH;RNF217;RNF115;FBXW11;CUL4B;CUL4A;PPIL2;RNF43;HECW2;RNF14;SIAH3;ERCC8;UBE3B;TRIM41;DTX1;WWP2
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.4455316372909904,-1.1532230827119796,0.27586206896551724,0.6147811099079187,1.0,4/12,5.83%,TGFBR3;ACVR1;BMPR1A;TGFBR1
prerank,snoRNA binding (GO:0030515),0.4594055547392857,1.1508763330460208,0.29607609988109396,0.7237105187952257,1.0,14/30,23.51%,NOP10;NHP2;WDR3;IMP4;NUDT4;GAR1;NUDT16;TSR1;DKC1;NOP56;SNU13;IMP3;ISG20;NOP14
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.45063596066448264,-1.150824781956706,0.28321678321678323,0.6135957563436878,1.0,9/11,43.41%,SLC2A9;SLC5A11;SLC23A2;SLC23A1;SLC2A10;SLC5A10;SLC5A1;SLC5A2;SLC5A9
prerank,GTPase activity (GO:0003924),0.38692550722543884,1.1507712480380492,0.1676706827309237,0.7200807400181383,1.0,50/192,21.75%,EEF1A1;EEF2;GNAI2;RHOB;GNB2;GNG5;RAN;RHOC;RAC1;GNG11;GNA11;EEF1A2;DNM3;ARHGDIB;RHOG;SAR1A;RAB14;RAB3C;RHOV;GNG3;GNAI1;NKIRAS1;GNAO1;HRAS;ARL1;RHEBL1;RHOA;RHOU;NKIRAS2;GTPBP10;RRAS;ARL2;RRAGC;RAB20;RRAGD;DNM1L;RAB5C;RAC2;TSR1;AGAP2;RAB31;GPN3;RAB18;RAB4A;RAB6B;RERG;RALB;NUGGC;RAB27B;DNM1
prerank,kinase binding (GO:0019900),0.38483964155058764,1.1506413224340502,0.078,0.7165411955151189,1.0,78/434,13.56%,ACTB;EEF1A1;RPS3;RPS7;RPS19;EEF2;CALM1;GSN;HSP90AB1;HSPB1;ACTA2;PGAM1;PARK7;RHOB;ATF4;RPS6;CALM3;ITGB2;CCND2;NPM1;PEBP1;CAMK2N2;PFKL;EMP2;RHOC;RAC1;PTPRC;TOLLIP;ACVRL1;HCLS1;TUBA4A;DLG2;CHEK2;PARP1;CAV2;NEFH;DUSP3;CTNNB1;FLNA;EEF1A2;ADD2;SNAP91;BAG5;BTG1;MSN;SHC3;FRMD5;TFRC;RHOG;CCND1;INKA2;HNRNPA0;THY1;CEBPA;CLTC;MAPT;CD24;UNC5C;CDK5R1;CADPS;ARHGEF7;PIH1D1;ZFP36;PIK3IP1;CDC37;FBXW5;WARS1;ATF5;DOK7;ATP1A4;CAMK2N1;SYN1;PTPRR;FBXO5;DCTN1;RHOA;YWHAZ;SRCIN1
prerank,serotonin receptor activity (GO:0099589),0.4761876599633562,1.1502619668661602,0.30445544554455445,0.7061780555358746,1.0,5/22,17.29%,HTR2C;CHRM3;CHRM2;HTR7;CHRM5
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.4761876599633562,1.1502619668661602,0.30445544554455445,0.7061780555358746,1.0,5/22,17.29%,HTR2C;CHRM3;CHRM2;HTR7;CHRM5
prerank,G protein-coupled amine receptor activity (GO:0008227),0.4761876599633562,1.1502619668661602,0.30445544554455445,0.7061780555358746,1.0,5/22,17.29%,HTR2C;CHRM3;CHRM2;HTR7;CHRM5
prerank,ubiquitin-dependent protein binding (GO:0140036),0.5683504457434947,1.150235130171573,0.3174825174825175,0.7024601821663601,1.0,4/10,22.71%,LAPTM5;DNAJB2;ANKRD13D;FAAP20
prerank,ubiquitin binding (GO:0043130),0.4073865798789648,1.147580867484598,0.2587117212249208,0.7067465124731362,1.0,25/73,22.53%,HSPB1;UBXN1;TOLLIP;AUP1;UCHL1;TNFAIP3;USP5;UBAP1L;RBCK1;BUB3;DNAJB2;VPS28;FBXW7;CXCR4;RNFT1;OTUB1;SQSTM1;TRIM32;RAE1;RAD23A;WDR48;SIRT2;USP13;UBXN11;VPS36
prerank,titin binding (GO:0031432),0.5256827842739382,1.1450134208289864,0.3116710875331565,0.7109029186605506,1.0,2/13,2.56%,CALM1;CALM3
prerank,actinin binding (GO:0042805),-0.36135476052237675,-1.1442987324416853,0.23880597014925373,0.6221889829860929,1.0,7/21,13.72%,CACNA1C;PDLIM5;NFKB1;PDLIM4;PPARG;SYNPO2;CACNA1D
prerank,acetylcholine receptor activity (GO:0015464),0.48464102934334696,1.1442610550596597,0.3132832080200501,0.7095299957925438,1.0,7/22,27.91%,CHRM3;CHRM2;CHRNA4;CHRM5;CHRNA3;CHRNA7;CHRFAM7A
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.5272817714345603,1.142894203854475,0.32647462277091904,0.7102942942193565,1.0,5/13,17.04%,PRKAR1A;PRKAR1B;SOX9;RYR2;PRKAR2B
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.3887045103526233,-1.1401955228452083,0.24761904761904763,0.6256616826186604,1.0,8/18,16.55%,TGFBR3;ACVR1;BMPR1A;TGFBR1;LTBP1;ACVR2A;BMPR2;ACVR2B
prerank,galactosyltransferase activity (GO:0008378),-0.4460550375153572,-1.138207679026399,0.2873134328358209,0.6241426106439207,1.0,2/11,1.58%,A4GALT;B4GALT1
prerank,ubiquitin-specific protease binding (GO:1990381),0.49197432837333094,1.1377908862584856,0.31679389312977096,0.7225559361948716,1.0,7/19,22.02%,PARK7;VCP;CLTC;SYVN1;RAD23A;SELENOS;AMFR
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.46718622010377875,1.1368933661311778,0.33454545454545453,0.721558043071938,1.0,8/28,16.49%,ELAC2;RNASEH2A;POP7;RNASEH1;APEX1;POP4;MRPL44;NUDT16
prerank,GTPase regulator activity (GO:0030695),-0.26054811416951046,-1.1361863316106524,0.0,0.6218450626115258,1.0,54/212,14.12%,ARHGAP29;RANBP3L;ARHGAP28;SIPA1L1;ARHGAP20;ARHGAP10;ASAP3;ALDH1A1;ARHGAP17;ASAP1;LRRK2;ARHGAP42;ARFGEF1;RANBP2;RAPGEF2;SGSM2;SLIT2;NRP1;USP6NL;TBC1D12;RALGAPB;SMAP1;ERRFI1;ARHGEF10L;ASAP2;STARD13;SIPA1L3;TBC1D2B;RABGAP1;RIC8B;ARHGAP32;TBC1D9B;BCR;TBC1D4;ARHGEF6;SYDE2;ARHGAP31;ALS2;KRIT1;TBCK;TBC1D8B;ARHGAP18;RALGAPA1;OPHN1;MYO9B;SIPA1;PDE6D;SMAP2;DOCK1;STXBP5;WNT11;PREX2;RAP1GDS1;RAB3GAP2
prerank,protein kinase C binding (GO:0005080),0.434237289992542,1.136103955008156,0.28752886836027713,0.7202235466128681,1.0,14/43,17.06%,RACK1;HSPB1;HINT1;TIRAP;CAVIN3;NELL1;PKN1;YWHAG;HDAC5;ADCY4;CCDC88A;DACT3;SQSTM1;HDAC9
prerank,protein kinase binding (GO:0019901),0.3784311827143765,1.135939110572958,0.099,0.7170046214815325,1.0,154/479,25.99%,ACTB;EEF1A1;RPS3;RPS7;RPS19;EEF2;RACK1;CALM1;HSP90AA1;HSPB1;ACTA2;PGAM1;RHOB;ATF4;RPS6;CALM3;TREM2;ITGB2;CCND2;HINT1;GRM5;NPM1;PINK1;PEBP1;CAMK2N2;EMP2;RHOC;RAC1;PTPRC;ACVRL1;HCLS1;TUBA4A;CHEK2;PIN1;PARP1;CAV2;NEFH;SIRPA;DUSP3;TIRAP;EEF1A2;ADD2;PDE3B;CAVIN3;SNAP91;BAG5;MSN;SHC3;FRMD5;TFRC;RHOG;CCND1;NELL1;INKA2;HNRNPA0;PKN1;THY1;CLTC;YWHAG;MAPT;PRKAR1A;CD24;UNC5C;CDK5R1;CADPS;ARHGEF7;PIH1D1;ZFP36;PRKAR1B;FBXW5;WARS1;DOK7;CAMK2N1;SYN1;PTPRR;FBXO5;DCTN1;RHOA;SOX9;HDAC5;YWHAZ;SRCIN1;ADCY4;CCDC88A;MAPK8IP2;BAD;DCTN2;MAPRE3;RYR2;DACT3;DAB2IP;SQSTM1;CASS4;CAV1;PRKAR2B;HDAC9;SKAP1;CDH5;PRKRIP1;RAC2;DUSP2;CDC25A;FAM83D;PPP1R15A;MAP4K2;AGAP2;CALM2;CIR1;WDR45;ACSL3;QARS1;DCX;PTPN6;ANKRA2;CNKSR2;ARHGAP33;PTN;MAP2K7;BANK1;DNM1;STX1B;AP2A1;IRF5;LLGL1;PTPN1;TBL2;DUSP1;TNIP1;RCC2;ADIPOR1;CDKN2B;TRIM68;PARD6A;TWF2;ELAVL1;RELA;LYST;TCF3;PPP1CB;DNAJC3;FOXM1;CAVIN2;CCNA2;PRKACA;VRK1;MAPRE1;INKA1;DUSP6;BLNK;USF1;ITGB1;DUSP8;TRIB1;CRK
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.5026658371735716,1.1347633607671754,0.3211009174311927,0.7167584870988332,1.0,10/16,30.27%,SLC1A4;SLC25A13;SLC25A11;SLC25A22;SLC1A1;SLC25A18;SLC25A14;SLC13A5;SLC25A12;SLC25A30
prerank,G protein-coupled receptor activity (GO:0004930),0.38413953160261155,1.1325932858054146,0.1813627254509018,0.7195978663745543,1.0,46/239,20.12%,MTNR1A;MTNR1B;GRM5;GPR37L1;ADGRB3;C5AR1;SCTR;ADGRL3;S1PR5;APLNR;S1PR1;DRD5;GPR6;SSTR4;ADGRG1;GRM8;P2RY6;RXFP1;GPR34;TPRA1;VIPR1;P2RY12;LGR6;P2RY1;MC1R;ADGRB1;GRM1;GPR18;ADGRB2;CXCR4;GRPR;CX3CR1;F2RL1;MC5R;ADGRL4;ADRA1A;ADRA1D;ADGRE1;HCRTR1;ADGRA1;GRM4;GPR83;GPR149;GPR183;NTSR2;GABBR2
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.4525875566243142,-1.131895843119412,0.3010752688172043,0.6259604961594055,1.0,5/10,15.67%,DSE;RPE;GLCE;GNE;RENBP
prerank,metal ion:proton antiporter activity (GO:0051139),-0.416494923131806,-1.130934560094861,0.27734375,0.6215924393686308,1.0,4/13,12.50%,SLC9A1;SLC9A2;SLC9B2;SLC9A8
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.45046681343865014,1.1285891642687171,0.32402912621359226,0.7286751578134062,1.0,8/30,15.19%,SLC30A1;SLC39A1;SLC39A10;SLC39A7;TTYH1;SLC40A1;SLC11A1;SLC31A1
prerank,ephrin receptor activity (GO:0005003),-0.36952361112262433,-1.1271397427590037,0.2687224669603524,0.6175653060431724,1.0,4/17,10.89%,EPHA7;EPHA3;EPHA4;EPHB2
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.36952361112262433,-1.1271397427590037,0.2687224669603524,0.6175653060431724,1.0,4/17,10.89%,EPHA7;EPHA3;EPHA4;EPHB2
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.4403947746032665,-1.1242759996042895,0.32764505119453924,0.6181532529976768,1.0,6/11,23.05%,CFLAR;CASP12;CASP3;CASP8;CASP7;CASP4
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.5540051166714298,1.1219179318404722,0.35624123422159887,0.7459000096653359,1.0,4/11,27.91%,CHRNA9;CHRNA4;CHRNA3;CHRNA7
prerank,kinase inhibitor activity (GO:0019210),0.44842919046865215,1.1205853053539596,0.31524249422632794,0.7461704651555705,1.0,16/33,27.12%,NPM1;YWHAB;PPP1R1B;CDKN1C;WARS1;ITPRIP;MAPK8IP1;HEXIM1;GMFB;PRKRIP1;QARS1;SNCA;SOCS3;DNAJC3;TRIB1;CDKN1A
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.4179063290209264,1.1154803745397528,0.2864983534577388,0.7586880946910963,1.0,12/53,12.80%,SLC38A5;SLC17A8;SLC7A5;SLC1A4;SLC1A2;SLC25A13;SLC15A4;SLC3A2;SLC17A7;SLC17A6;SLC25A22;SLC1A1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.34061250927158787,-1.1142980084038954,0.2714285714285714,0.6365806627044244,1.0,2/25,0.89%,MICAL3;MICAL2
prerank,hexose transmembrane transporter activity (GO:0015149),0.5144282665336838,1.1131260280768032,0.3670886075949367,0.7625572441021902,1.0,8/12,36.97%,SLC2A1;SLC2A2;SLC2A3;SLC2A6;PPBP;SLC2A4;SLC2A8;SLC5A3
prerank,FAD binding (GO:0071949),-0.35448751740106527,-1.1129207772386362,0.27314814814814814,0.6332124507171611,1.0,6/24,9.75%,MICAL3;MICAL2;DDO;MTHFR;SQOR;PRODH
prerank,cytokine activity (GO:0005125),0.38687834072873417,1.112104492876084,0.2739307535641548,0.761871429697201,1.0,39/131,26.61%,CXCL12;CCL19;NRG1;TNF;MIF;LEFTY2;CXCL16;TIMP1;CXCL10;IL2;HMGB1;WNT5A;KITLG;IL11;BMP2;CCL2;WNT10B;LEFTY1;PF4;SLURP1;GDF15;CCL3;CCL28;CCL8;SCGB3A1;INHBA;TGFB1;IL6;GDF11;INHBB;CRLF1;SCG2;FAM3C;WNT7A;IL33;INHA;CX3CL1;TGFB2;WNT2
prerank,cysteine-type endopeptidase activity (GO:0004197),0.40133795788136284,1.1097790660498683,0.3109691160809372,0.7652004591907635,1.0,9/78,7.55%,CTSB;CTSL;CTSZ;CAPNS1;CTSS;LGMN;UCHL1;PDIA3;USP5
prerank,death domain binding (GO:0070513),0.5337918938602753,1.1077401298905358,0.3765867418899859,0.7675819375514152,1.0,2/11,10.85%,RACK1;BAX
prerank,nuclear receptor coactivator activity (GO:0030374),-0.28017567707907987,-1.1044989192707502,0.2804878048780488,0.64697976148856,1.0,19/52,22.14%,ZMIZ1;MED13;NCOA1;CCAR1;THRAP3;DCAF6;BRD8;PPARGC1B;PRKCB;CARM1;TACC1;NCOA7;HELZ2;MED1;FGF2;NCOA6;SS18;WDR77;NCOA3
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.5273202333841838,1.104415523365021,0.36617842876165113,0.7744036102342807,1.0,4/11,28.23%,KCNE4;KCNE5;KCNJ3;KCNQ1
prerank,potassium ion leak channel activity (GO:0022841),-0.38437967918451654,-1.1040507789586294,0.3333333333333333,0.642096088709571,1.0,2/15,2.12%,KCNK2;KCNK5
prerank,sodium channel activity (GO:0005272),0.4315900938531185,1.1031701051921594,0.3418903150525088,0.7747019655263617,1.0,10/37,21.93%,ASIC2;SCN1A;GRIK5;GRIK2;SCN4B;HCN1;HCN3;PKD2L1;SCN9A;GRIK1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.5134921952775447,1.102966068261435,0.3685636856368564,0.7716285660638835,1.0,4/14,16.12%,CYBA;CYBB;MICAL1;NCF1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.3377340456550418,-1.1018885006801822,0.2731707317073171,0.6414753525230159,1.0,5/24,16.45%,OSBPL8;PLA2G4A;SESTD1;PLEKHA8;GOLPH3L
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.44880164033327835,1.0998440239498493,0.35344827586206895,0.7777815426995955,1.0,8/24,18.77%,NME1;AK4;AK3;NME4;NME2;CMPK2;NME3;IP6K1
prerank,death receptor binding (GO:0005123),-0.3881446733315848,-1.098994423261813,0.34108527131782945,0.6420278096865907,1.0,4/15,15.02%,EDA;RIPK1;NGF;BDNF
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.5150279831336181,1.098809510344132,0.3657219973009447,0.7771782823233601,1.0,3/12,13.83%,SLC25A5;LRRC8A;SLC19A1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.4390046663084458,1.0987560145587631,0.33488372093023255,0.7736185630846917,1.0,12/32,27.43%,SLC38A5;SLC7A5;SLC1A4;SLC6A6;SLC3A2;SLC1A1;MFSD12;SLC7A10;SFXN1;SLC43A2;SLC38A3;SLC6A9
prerank,carbohydrate kinase activity (GO:0019200),-0.42809915371610585,-1.0982484575879865,0.33455882352941174,0.6378403654702981,1.0,5/11,18.91%,GALK2;HK2;FGGY;GNE;NAGK
prerank,mRNA 3'-UTR binding (GO:0003730),0.3945356859945493,1.0972314702016894,0.3410526315789474,0.7747111474557737,1.0,17/79,15.89%,RPL41;RPS7;RPL5;ZFP36L1;MEX3D;ZFP36L2;PCBP4;HNRNPA0;ZFP36;TARDBP;PABPC1;ELAVL4;RNF40;HNRNPU;ELAVL3;YBX3;CIRBP
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.38812128637891746,1.0889589818498884,0.3503184713375796,0.7968632267206484,1.0,24/75,24.33%,MDH1;LDHA;HSD17B6;RDH5;PHGDH;HSD17B13;PRXL2B;SPR;GRHPR;HSD17B4;DCXR;AKR1B10;HSD3B2;UGDH;PGD;AKR1A1;CBR3;IMPDH1;CBR1;HSD17B11;EHHADH;KCNAB1;NSDHL;IMPDH2
prerank,calcium-activated potassium channel activity (GO:0015269),0.5307816831376051,1.088629293245507,0.38589211618257263,0.7941144274542651,1.0,5/11,27.02%,KCNN2;KCNMA1;PKD2L1;KCNMB4;KCNN4
prerank,phosphatidate phosphatase activity (GO:0008195),-0.40526829674068693,-1.0857389466795386,0.3271375464684015,0.6632199443746798,1.0,8/13,26.64%,PLPP3;PLPP5;PLPP1;PLPP2;PLPPR1;PLPPR3;LPIN2;LPIN3
prerank,cation transmembrane transporter activity (GO:0008324),0.41267910402526164,1.0851841248756333,0.3609865470852018,0.8009066576558151,1.0,8/48,12.80%,SLC38A5;SLC39A1;SLC7A5;SLC1A4;SLC6A6;SLC15A4;SLC3A2;SLC1A1
prerank,lipase activator activity (GO:0060229),-0.4414290828790342,-1.0849232157032431,0.3280757097791798,0.6589451861059676,1.0,2/10,4.70%,ARHGAP6;PDPK1
prerank,calcium-release channel activity (GO:0015278),-0.3867115135548641,-1.082491352284229,0.35,0.6592238666822049,1.0,2/17,1.55%,ITPR1;ITPR2
prerank,cysteine-type peptidase activity (GO:0008234),0.39145549438742505,1.0807329239498862,0.3533834586466165,0.8109034761928757,1.0,19/73,21.59%,CTSB;CTSL;CTSZ;CTSS;LGMN;UCHL1;PDIA3;USP5;OTULIN;TINAGL1;USP29;CTSH;USP26;USP8;CTSC;SFRP1;CAPN3;ATG4D;USP13
prerank,metalloexopeptidase activity (GO:0008235),0.3975303657255549,1.0790234971095551,0.348993288590604,0.8122526217803926,1.0,13/51,16.49%,CPXM1;METAP1;CPD;CPE;VASH1;AGBL4;METAP2;AEBP1;CPXM2;LAP3;MMP14;RNPEPL1;NUDT16
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.41462840126123857,-1.0772971004883216,0.3433962264150943,0.6654560992750015,1.0,4/12,16.48%,LARP1;EIF4E3;CYFIP2;AGO2
prerank,telomerase RNA binding (GO:0070034),-0.3391601302134125,-1.077175332811026,0.3333333333333333,0.6597661640197476,1.0,8/22,11.10%,SMG6;DHX36;TEP1;TENT4B;PARN;XRN1;SMG7;TERT
prerank,phospholipase A2 activity (GO:0004623),0.44268156070010245,1.0751759904108695,0.38705738705738707,0.820508152637016,1.0,4/26,10.75%,PRDX6;PLAAT3;PLA2G7;PLA2G4F
prerank,methylated histone binding (GO:0035064),-0.28444529933243196,-1.0743251193957464,0.29333333333333333,0.6604534658520207,1.0,27/62,25.29%,KDM7A;ZMYND11;TDRD3;CDYL;PYGO1;CHD1;MBTD1;TRIM24;ZCWPW2;MORC3;LRWD1;PHF8;ING2;KAT8;L3MBTL2;FMR1;TAF7;MORC4;ZCWPW1;DPF2;TAF1;NCAPD3;CHD5;RRP8;ZMYND8;CBX8;ING4
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.2606164129698858,-1.0741538047642527,0.34782608695652173,0.6549984375854043,1.0,24/83,16.87%,USP3;USP47;OTUD4;USP24;USP11;MINDY3;USP34;OTUD7B;USP50;MYSM1;USP49;USP40;USP16;USP36;USP4;OTUD3;ZRANB1;USP28;USP46;UCHL5;STAMBPL1;USP45;USP53;USP37
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.44490766091898604,-1.0737268819924246,0.38562091503267976,0.6503076632652992,1.0,2/10,3.41%,SLC6A13;SLC6A12
prerank,BMP binding (GO:0036122),0.5108075052968583,1.072732937605421,0.4027586206896552,0.8247011836040994,1.0,1/11,2.00%,NBL1
prerank,single-stranded DNA helicase activity (GO:0017116),0.4655423721417337,1.0725284638490404,0.39,0.8215910970415359,1.0,11/19,35.43%,MCM5;RFC2;RFC4;RAD51;PIF1;MCM7;MCM2;DHX9;DNA2;CHTF18;RFC3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.39733360337552365,1.0697114727275725,0.3853820598006645,0.8266015241542096,1.0,18/54,21.92%,HDAC11;HINT1;TGM2;AMDHD2;HDAC5;MIER2;GLS2;GLS;ACY1;PDF;NAAA;NIT1;HDAC9;FAAH;SIRT2;ACY3;ASAH2;SUDS3
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.385078076273935,-1.068490940297645,0.34980988593155893,0.6579812156618347,1.0,4/14,12.14%,MTMR3;MTMR11;PTEN;MTMR10
prerank,Hsp90 protein binding (GO:0051879),0.4276119336280995,1.0682791687386635,0.38698224852071006,0.8271409844980188,1.0,8/33,23.63%,RPS3;KDR;MAPT;UNC45B;PTGES3;AHSA1;STUB1;CYP2E1
prerank,double-stranded RNA binding (GO:0003725),0.3905657063944686,1.0669993452262152,0.38405036726128017,0.8274643609669082,1.0,17/70,19.51%,VIM;TUBA1B;HSP90AB1;TUBB4B;MSN;TFRC;HSPD1;CLTC;SLC3A2;EIF4A1;ACTN1;MRPL44;HNRNPU;PRKRIP1;AGO1;OAS3;EIF4H
prerank,neuropeptide binding (GO:0042923),0.4729206941293117,1.0665960731598179,0.418848167539267,0.8249833190209845,1.0,7/18,31.28%,SORL1;SSTR4;GPR149;SSTR2;NMUR2;OPRL1;GPR37
prerank,lysophospholipase activity (GO:0004622),0.4595686073704445,1.0661987887603712,0.3934010152284264,0.8224906823645185,1.0,10/20,29.22%,LYPLA2;ENPP2;PNPLA7;GDE1;GDPD1;ABHD16A;GDPD3;ABHD12;PLA2G6;MGLL
prerank,NADPH binding (GO:0070402),0.4898480861125548,1.0620099403925314,0.40963855421686746,0.8314322776351645,1.0,7/13,32.66%,GRHPR;QDPR;CBR3;KCNAB1;CRYZ;DHFR;MTRR
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.41552718990019083,-1.0605331644181377,0.3474903474903475,0.6713480865906634,1.0,5/11,14.56%,ITPR1;ITPR2;TRPC4;TRPC6;TRPC3
prerank,GTPase binding (GO:0051020),-0.23932675676122328,-1.058633945705123,0.2222222222222222,0.6705173524891507,1.0,35/194,8.15%,AKAP13;STRN3;AFDN;PLCE1;RAPGEF4;GOLGA4;LRRK2;RANBP2;RNF152;EXOC4;SPTBN1;SGSM2;BRAF;MAPKAP1;USP6NL;EPS8;RAF1;EXOC2;FGD4;ANKRD27;NOX1;UNC13B;DOCK7;RAPGEF6;NCKAP1;RRAGB;CDC42EP5;RADIL;RABGAP1;ANKFY1;TRIOBP;NUTF2;AMBRA1;RNF41;GGA2
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.42793196313859855,1.0585966791256285,0.3872901678657074,0.8380234536243104,1.0,8/29,13.83%,SLC1A4;SLC25A13;SLC26A4;SLC25A11;SLC25A22;SLC25A21;SLC1A1;SLC19A1
prerank,ribonuclease activity (GO:0004540),0.3949398174942875,1.0577535183859212,0.4067982456140351,0.836882611973793,1.0,15/56,21.34%,ENDOG;RNASE1;ELAC2;ANG;RNASE4;RNASEH2A;RNASEK;EXOSC2;RNASEH1;SND1;AGO1;EXOSC9;RNASE7;EXOSC4;TSNAX
prerank,omega peptidase activity (GO:0008242),-0.2462303077182399,-1.0574883381128954,0.3191489361702128,0.6675190293625979,1.0,24/89,16.87%,USP3;USP47;OTUD4;USP24;USP11;MINDY3;USP34;OTUD7B;USP50;MYSM1;USP49;USP40;USP16;USP36;USP4;OTUD3;ZRANB1;USP28;USP46;UCHL5;STAMBPL1;USP45;USP53;USP37
prerank,metalloaminopeptidase activity (GO:0070006),-0.36347646037340364,-1.0574469919622294,0.36507936507936506,0.662037718012272,1.0,3/16,6.22%,NPEPPS;XPNPEP3;ANPEP
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.351172387657461,1.0558310199641971,0.309,0.8390945352309915,1.0,98/431,19.02%,EEF1A1;HSPA8;TUBB;TUBA1A;TUBA1B;HSP90AA1;HSP90AB1;ATP5F1D;TUBB4B;NDUFA13;RHOB;HSPA5;AKT1;ATP5F1A;NME1;TGM2;PINK1;TUBAL3;RAN;PFKL;RHOC;RAC1;ARF5;ACVRL1;TUBA4A;HSPA1B;ABCG1;ABCB6;UHMK1;TAP2;PGK1;RHOG;ATP1A3;RAB14;EPB42;P2RX7;ADSS1;ARL11;MAST1;TUBB2B;TUBB4A;SYN2;SCG5;P2RY1;SARS2;ARF6;RHOV;ARL4C;AARS2;MYO1F;GNAI1;BCKDK;P2RX6;ARL4D;ATP1A1;HRAS;ARL1;SYN1;RHEBL1;RHOA;CARS1;HSPA1A;CDC42BPA;STK11;RHOU;HNRNPU;ABCA2;ARF1;GTPBP10;RRAS;ARL2;RRAGC;TSSK6;TSSK4;PRPS1L1;PRPS1;RAB26;PEX6;ARF4;EIF4A3;RRAGD;NUDT16;BRSK2;TUBB2A;GUK1;RAC2;HSPA4L;VPS4A;ERCC6;TSR1;OAS3;MAP4K2;ANXA6;GLUD1;AGAP2;PSMA6;MKNK1;RAB31
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.3351383567579701,-1.0557633088544587,0.37755102040816324,0.6608678087247019,1.0,5/23,6.82%,PDE1A;PDE7B;PDE5A;PDE8B;PDE7A
prerank,regulatory RNA binding (GO:0061980),-0.2934671129710194,-1.0550438567557,0.390625,0.6572537250758691,1.0,12/38,19.01%,ZNF346;DICER1;ZC3H7A;TUT7;RBM4;ZC3H7B;PUM2;TUT4;TARBP2;AGO2;FMR1;AGO4
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.4862330536563114,1.0528843682808675,0.4214765100671141,0.8445240557646961,1.0,1/14,1.50%,CAPNS1
prerank,ADP binding (GO:0043531),0.4366949620646098,1.0516048420552917,0.4261294261294261,0.8445424854452306,1.0,5/25,7.04%,ATP5F1D;ATP5F1A;ABCG1;PGK1;MYO3A
prerank,magnesium ion binding (GO:0000287),-0.23056504721220733,-1.050806838490921,0.25,0.6618756778064131,1.0,23/135,12.07%,EYA2;ABL1;STK3;LRRK2;SIK3;CLYBL;DHX36;SIK2;MARK1;NUDT5;SNRK;IRAK3;FOXK2;CDC42BPB;MAST2;SIK1;TDG;NEK6;ABL2;SRR;STK38;EPHX2;NLK
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.4101514241573619,-1.049852503138925,0.3939393939393939,0.658477401228971,1.0,5/11,19.24%,SASH1;PPEF2;STK38;TRAF6;ROR2
prerank,peptide hormone receptor binding (GO:0051428),0.5110923261135878,1.048695579452503,0.42,0.8500249980605614,1.0,4/11,27.56%,CCK;ADCYAP1;PTHLH;PSMC5
prerank,sulfotransferase activity (GO:0008146),-0.2931182655727481,-1.0477964044313237,0.32919254658385094,0.6580568723348532,1.0,6/33,10.48%,UST;HS3ST3A1;CHST15;HS2ST1;CHST11;TPST1
prerank,actin binding (GO:0003779),0.3553254121784232,1.0475287170779706,0.40080563947633435,0.8496658465280443,1.0,46/170,17.97%,TMSB4X;ALDOA;TMSB10;GSN;FXYD5;PRICKLE4;TPM2;MAP1A;MOBP;ANG;MRTFA;ADD2;IQGAP2;PFN1;CCR5;P4HB;CORO1A;LCP1;VASH1;FMN2;TLNRD1;MAPT;COTL1;SLC6A2;MICAL1;MYO1F;FHDC1;GC;MSRB1;CXCR4;ANLN;FLII;CDK5R2;HNRNPU;CCDC88A;TMOD1;SPTBN4;CAP1;DMTN;ADCY8;PFN2;RUSC1;SYNE1;KLHL1;KCNMA1;SCIN
prerank,pyridoxal phosphate binding (GO:0030170),0.44637998832598624,1.045373399303815,0.4193138500635324,0.8524804808584386,1.0,6/20,20.73%,AGXT;OAT;SDS;PNPO;SHMT2;PYGL
prerank,chloride channel inhibitor activity (GO:0019869),-0.4181692444062317,-1.0445417852251382,0.3787375415282392,0.661057499125976,1.0,3/10,12.70%,STX8;WNK4;STX1A
prerank,voltage-gated chloride channel activity (GO:0005247),-0.41196063874309186,-1.0438111804705033,0.37282229965156793,0.6576525349162571,1.0,1/10,1.65%,ANO6
prerank,protein tyrosine kinase activity (GO:0004713),-0.22871789616470123,-1.0429192744689344,0.4,0.6542211765540729,1.0,23/108,10.96%,EGFR;EPHA7;FER;ABL1;EPHA3;ROR1;NTRK3;EPHA4;INSR;YES1;DYRK1A;TYK2;BAZ1B;MET;FGFR2;WEE1;CLK1;FRK;HIPK3;PDGFRB;ABL2;EPHB2;PTK2
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.516884307765836,1.0422195845301745,0.4460227272727273,0.858421225398871,1.0,4/10,22.71%,LAPTM5;DNAJB2;ANKRD13D;FAAP20
prerank,"DNA binding, bending (GO:0008301)",0.48089581547573096,1.0397733559447644,0.44054054054054054,0.8618628468613917,1.0,3/14,9.90%,TERF1;HMGB3;HMGB1
prerank,Hsp70 protein binding (GO:0030544),0.4170168050988986,1.0394286896564728,0.43508771929824563,0.8591633392814109,1.0,10/31,23.63%,RPS3;DNAJA1;DNAJB2;DNAJB1;SACS;DNAJC10;SNCA;STUB1;IQCG;CYP2E1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.36688365882526663,-1.0380735747265175,0.4046692607003891,0.6599468787631588,1.0,2/15,2.29%,ALDH1A1;ALDH1A2
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.41189123048358894,1.0374876839775684,0.44575471698113206,0.8613923992460834,1.0,9/35,20.73%,H3-3A;PARK7;NPM1;DRAP1;PIH1D1;UBTF;AGO1;TBP;MYC
prerank,heme binding (GO:0020037),0.37294271866206047,1.0356568026998612,0.4200426439232409,0.8630607708244263,1.0,17/65,25.42%,HMOX1;PGRMC1;NR1D1;ABCB6;STEAP4;CYBB;PGRMC2;SLC48A1;CAT;NOS2;CYCS;CYB5A;TBXAS1;CYP2E1;SUOX;SDHD;HEBP2
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.4109962531558945,1.0313892490851688,0.44958481613285883,0.8721985069848921,1.0,5/33,7.95%,RPS3;PARK7;TOLLIP;AUP1;FOXL2
prerank,endonuclease activity (GO:0004519),0.3887082599829943,1.0306217624149632,0.45642201834862384,0.8707225928346536,1.0,6/49,14.13%,RPS3;ENDOG;ANG;RNASEK;APEX1;SND1
prerank,receptor tyrosine kinase binding (GO:0030971),0.3808714289268311,1.0301437727058618,0.4368932038834951,0.8685984218614468,1.0,8/56,6.33%,RACK1;NRG3;NRG1;GRB14;LRP4;DUSP3;HYAL2;SHC3
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.48808491984961744,1.0279698148905152,0.4755927475592748,0.8712205133294478,1.0,5/12,27.92%,NDUFS7;DCXR;CBR1;NQO2;CRYZ
prerank,protein phosphatase 2A binding (GO:0051721),-0.3161752861177138,-1.0269409365809736,0.3827751196172249,0.6827042618946311,1.0,10/23,18.27%,STRN3;ANKLE2;STRN;ENSA;SMG7;BOD1L1;SPHK1;TP53;FOXO1;CTTNBP2NL
prerank,endopeptidase activity (GO:0004175),0.3468999235387507,1.0267304616612432,0.4264264264264264,0.8712181865651528,1.0,57/257,20.10%,CTSB;CTSL;CTSZ;PSMB4;CTSS;MMP3;LGMN;PSMB6;PSMB8;CD5L;RCE1;MMP27;UCHL1;ADAMTS4;PSMA7;HP;HPR;OMA1;MMP21;F9;PDIA3;USP5;KLK8;KLK1;KLK6;PCSK2;PMPCB;PIK3IP1;PSMB9;PLAT;PSMB3;USP29;PSMB11;PSMB10;CTSH;ADAMTS16;SPG7;USP26;GZMM;MMP14;PSMB1;PSMB5;NAPSA;BACE1;PLAU;USP8;PSEN2;ADAMTS1;F10;ADAM17;CTSC;SFRP1;PSMA6;PRSS12;HGF;ADAMTS20;PSMA4
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.37957369343470493,-1.0250441518885023,0.4031620553359684,0.6817389641396168,1.0,2/13,2.29%,ALDH1A1;ALDH1A2
prerank,protein heterodimerization activity (GO:0046982),0.3486465284102055,1.024856732692426,0.4521651560926485,0.8730562411791682,1.0,62/178,25.91%,ATF4;CYBA;TPM2;HEXA;RAN;FZD9;PDGFB;TRMT112;LSM6;EPAS1;YWHAH;PPP2R1A;ABCG1;YWHAE;TENM3;ADD2;TENM2;CYBB;ATP1B2;P4HB;TUBB2B;MLXIPL;MLX;BHLHE41;TENM4;AOC3;BAX;NPAS3;SUPT4H1;ATP1A1;SDCBP;TLR6;RRAGC;PDGFA;ATP1B1;RRAGD;ADRA1A;ADCY8;SRI;ZHX1;GCA;ERBB3;VAPA;TFAP2B;GABBR2;MEF2C;GADD45A;BAK1;DDIT3;KATNA1;MTTP;VAPB;RCC1;TCF3;LSM5;BARD1;USF2;METTL3;BOK;ABCG5;USF1;ITGB1
prerank,myosin II binding (GO:0045159),0.5122851179894278,1.0231692629689897,0.4823008849557522,0.8742022804597183,1.0,2/10,10.31%,GSN;STXBP5L
prerank,sialyltransferase activity (GO:0008373),-0.34076669201906334,-1.018305149188848,0.40825688073394495,0.6927345549801874,1.0,8/20,19.42%,ST3GAL4;ST3GAL3;ST6GAL1;ST3GAL5;ST6GALNAC6;ST3GAL6;ST3GAL2;ST6GALNAC5
prerank,tubulin binding (GO:0015631),0.3422154282380472,1.0169664619408938,0.44644644644644643,0.8886519612228573,1.0,66/295,19.48%,RPS3;ALDOA;GABARAP;GAPDH;TPPP3;PRNP;MAP1LC3B;TERF1;MAP1LC3A;MAP1A;GABARAPL2;S100A8;S100A9;NEFH;GABARAPL1;STMN3;DNM3;SBDS;NEFM;NAV3;NDRG1;PAK1;ABRAXAS2;KIF26B;AGBL4;CLASP1;MAST1;MAPT;STMN4;MAP2;UNC5C;CDK5R1;KIF5A;ARL4C;ARHGEF7;REEP2;KIF26A;ATF5;FHDC1;DCTN1;CLIP3;GJA1;MTCL1;VBP1;STMN1;TTLL7;CCDC88A;KIF21B;CETN3;TBCA;CDK5;MAPRE3;FGF13;DNM1L;PDCD5;HOOK1;TOGARAM2;BRCA2;KIF5C;FAM83D;SNCA;RAE1;KIFC2;DCX;TTLL5;VAPA
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.2345600396698669,-1.0141566731560718,0.5,0.6966605808698805,1.0,21/91,13.25%,PARD3;SVIL;FCHO2;SLC9A1;ACTN2;FRMPD4;MAPKAP1;PLEKHA4;ADAP2;MARK1;MYO1B;SESTD1;HIP1;GBF1;PICALM;KRIT1;KIF16B;TULP3;KCNJ2;STXBP6;PLCD1
prerank,protein homodimerization activity (GO:0042803),0.3350554202651831,1.0120737629541394,0.45,0.899372656272634,1.0,105/589,15.87%,APOE;PSAP;S100A6;RACK1;B2M;S100A1;TYROBP;HSP90AA1;HSP90AB1;HSPB1;HMOX1;PARK7;PGRMC1;S100A11;GSTM1;AKT1;TXN;S100A10;TPI1;S100B;TPM2;CRYAB;ERBB4;TERF1;NPM1;AGXT;S100A13;S100A16;RASIP1;FZD9;PDGFB;CHEK2;ENO1;NTRK2;ANG;ATP5IF1;CAV2;ABCG1;FLNA;TENM3;ADD2;HES1;TENM2;SPPL2B;TFRC;RDH5;SDS;CEBPB;BNIP3L;CORO1A;LPL;CEBPA;PLN;TRIM9;GRHPR;HSD17B4;HSPB8;MLXIPL;MLX;SARS1;KARS1;SYT6;BHLHE41;MFSD1;TENM4;BAX;CSF1R;GSTM2;KLHL7;PDCD6;WARS1;PECAM1;MGAT2;BANF1;CRYM;CEP131;KCNN2;CLN6;FLT4;CADM3;ACTN1;GNPTG;MAP3K21;ACOT7;ODC1;SYNDIG1;SLC11A1;BST2;HPGDS;RNF40;LILRB1;MTCL1;RIPK2;PNPO;CAT;CCDC88A;IKZF3;ABCB10;MFF;PRPS1L1;PRPS1;GDF15;PDGFA;DSCAML1;ACHE
prerank,cytokine receptor activity (GO:0004896),0.3616493676879005,1.0107180663702429,0.4947033898305085,0.8994329898803266,1.0,26/83,23.91%,CD74;IL2RB;CSF3R;EPOR;CCR5;IL3RA;IL2RG;GFRA1;MPL;CX3CR1;IFNGR1;CSF2RB;IL17RB;GFRA2;CCR2;IL20RA;IFNGR2;CSF2RA;FLT3;IL10RB;IL1RAP;CRLF2;CRLF1;PRLR;IL12RB1;IL21R
prerank,mechanosensitive ion channel activity (GO:0008381),-0.3800652715407023,-1.0104152679078344,0.4185185185185185,0.7006294433204558,1.0,7/12,29.14%,PIEZO2;PIEZO1;TMC6;TMC7;TMC3;TMC4;TMC8
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3675052081730241,1.0088455640520453,0.4878048780487805,0.9012358288056768,1.0,13/73,17.16%,GPR37L1;SCTR;APLNR;SORCS1;RXFP1;VIPR1;MC1R;SORCS3;GRPR;CX3CR1;MC5R;CCKBR;HCRTR1
prerank,lipase activity (GO:0016298),0.3829338316531174,1.0086677828369197,0.47314285714285714,0.898104394536706,1.0,14/43,32.35%,PNPLA2;LIPG;LPL;LIPE;PLBD2;FAAH;ABHD16A;ABHD12;MGLL;PLBD1;PITPNM3;PNPLA8;CEL;LIPA
prerank,C-C chemokine binding (GO:0019957),0.43328468162482525,1.007395085793352,0.477124183006536,0.8981456757157692,1.0,5/22,18.54%,CCR5;ZFP36;CXCR4;CX3CR1;CCR2
prerank,organic anion transmembrane transporter activity (GO:0008514),0.3476633465862484,1.0039238156391763,0.49949545913218973,0.9041582270479422,1.0,47/134,28.43%,SLC38A5;SLC17A8;LRRC8A;SLC7A5;SLC1A4;SLC1A2;SLCO1C1;SLC25A13;SLC6A6;SLC26A4;MFSD2A;SLC15A4;SLCO4C1;SLC3A2;SLC17A7;SLC17A6;SLC25A22;SLC25A21;SLC1A1;GJA1;SLC19A1;SLC35A3;SLC16A1;SLC25A1;SLC2A2;MFSD10;SLC19A2;SLC52A1;SLC35A1;SLC25A18;SLCO1B1;SLC35B4;SLC25A23;MFSD12;SLC35B1;SFXN1;SLC6A8;SFXN5;SLC4A8;SLC38A3;ABCC5;SLC2A6;SLC13A5;SLC6A9;SLC25A12;SLC16A7;RTBDN
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.4854246847660113,1.0037512302286433,0.48148148148148145,0.9010986386467646,1.0,2/11,6.95%,PPP1R14A;PPP1R14B
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.2869412136490837,-1.0026394267328576,0.46099290780141844,0.7146757762289822,1.0,8/35,10.96%,FER;ABL1;YES1;DYRK1A;CLK1;FRK;ABL2;PTK2
prerank,hormone receptor binding (GO:0051427),0.453019959354703,1.0008667658387622,0.4946949602122016,0.905558066900342,1.0,3/14,17.62%,NPPC;CCK;ADCYAP1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.43854538364425466,1.0001212832551383,0.47114093959731546,0.9040514652267089,1.0,3/18,12.96%,HSD17B6;RDH5;HSD3B2
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.5010251403079415,1.0000062303649484,0.4928774928774929,0.9008283425512679,1.0,3/10,16.12%,CYBA;CYBB;NCF1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),-0.269792330427975,-1.0,1.0,0.6856457570370297,1.0,135/732,12.95%,ZBTB20;PBX1;NFIA;FOXP1;NFAT5;NSD1;SMAD3;FOXP2;NFIB;TEAD1;ZEB1;GLIS3;HIVEP2;ZNF148;NR3C2;DNMT3A;HOXB6;RARB;PKNOX2;TCF4;TCF7L2;KLF12;PRDM5;ZNF423;HOXB3;ZBTB7C;PRRX1;TCF12;ARNT;SOX5;FOXD1;PBX3;NRIP1;STAT5B;FOXN3;MXI1;ZBTB16;HLF;NR6A1;HOXA3;GLI3;ZIC4;DHX36;GLI2;ARNT2;SKI;MGA;ELF1;HDAC4;HOXB4;NFYC;ATF7;CCAR1;THRB;NR2F2;CHD2;HOXA5;ZKSCAN2;HIVEP3;KLF3;NRF1;CREB5;TEF;THRAP3;HOXC4;PPARA;RARG;NFATC1;NFIX;FOXO3;NFATC4;SMAD9;TBX15;ZNF182;TFCP2;MEOX2;FOXP4;SP1;NFKB1;ZSCAN26;HOXB5;NR1D2;HIF3A;FOXK2;STAT3;SMAD1;ZIC2;ZFP30;ZBTB1;TOP1;KCNIP3;ZFHX3;EBF4;ZBTB38;MEF2A;MYNN;ZFHX4;STAT2;PRDM15;ZBTB26;EBF1;MYBL1;TEAD2;ATF2;ESR1;KLF8;SP4;PPARG;FOXK1;HOXC6;NR2C2;ZKSCAN3;ZNF23;SMAD4;ATF6;GMEB1;HOXA6;ZIC1;NFATC3;ELF4;MZF1;PRRX2;RBPJ;ZBTB34;HOXC5;AR;MKX;IKZF2;KLF7;RREB1;SIX5;ZNF8;SIX1;ZKSCAN7;HIVEP1
prerank,sequence-specific DNA binding (GO:0043565),-0.23273024418315189,-1.0,1.0,0.6856457570370297,1.0,108/590,14.58%,ZBTB20;PBX1;FOXP1;NFAT5;SMAD3;FOXP2;NFIB;TEAD1;ZNF148;NR3C2;HOXB6;RARB;PKNOX2;TCF4;TCF7L2;ABL1;KLF12;PRDM5;ZNF423;TCF12;ARNT;FOXD1;MBNL2;KDM2A;CUX1;SMG6;HLF;BBX;NR6A1;GLI3;ZIC4;GLI2;ARNT2;ELF1;HDAC4;HOXB4;ATF7;THRB;NR2F2;HOXA5;TET3;KLF3;SMG1;CREB5;TEF;HOXC4;PPARA;RARG;NFATC1;NFIX;FOXO3;KDM5B;NFATC4;KMT2A;TBX15;TFCP2;MEOX2;SP1;FBXL19;HOXB5;NR1D2;FOXK2;VSX1;ELF2;ZBTB38;MEF2A;UPF2;ZBTB26;TEAD2;ATF2;ESR1;SP4;PPARG;FOXK1;NR2C2;XPA;ZKSCAN3;ZNF23;SMAD4;ATF6;GMEB1;HOXA6;SMG7;ZIC1;NFATC3;TERT;ELF4;TERF2;PRRX2;RBPJ;LRWD1;SLTM;SIX1;HIVEP1;STN1;CXXC5;TINF2;BCL2;NR2F1;HSF2;NFIC;ZBTB21;CBFB;PBX4;TFCP2L1;GMEB2;ZNF276;HEY2
prerank,double-stranded DNA binding (GO:0003690),-0.20278295458222195,-1.0,1.0,0.6856457570370297,1.0,73/531,11.22%,ZBTB20;PBX1;FOXP1;NFAT5;RBMS1;NFIB;TEAD1;EGFR;NR3C2;HOXB6;RARB;PKNOX2;TCF4;ABL1;KLF12;TCF12;ARNT;MBNL2;CUX1;HLF;BBX;NR6A1;GLI3;ZIC4;GLI2;ARNT2;ELF1;ZMYND11;HOXB4;ATF7;THRB;HOXA5;KLF3;CREB5;TEF;HOXC4;RARG;NFATC1;NFIX;FOXO3;KDM5B;NFATC4;TBX15;TFCP2;MEOX2;SP1;HOXB5;NR1D2;HDGFL3;VSX1;ELF2;MSH3;TOP1;RBBP8;ZNF638;TDG;ZBTB26;TEAD2;ATF2;ESR1;ERCC5;FBH1;PPARG;FOXK1;NR2C2;XPA;ZNF23;ATF6;GMEB1;HOXA6;ZIC1;NFATC3;ELF4
prerank,sequence-specific double-stranded DNA binding (GO:1990837),-0.23902626600641366,-1.0,1.0,0.6856457570370297,1.0,94/597,11.57%,ZBTB20;PBX1;FOXP1;NFAT5;SMAD3;NFIB;TEAD1;BNC2;NR3C2;HOXB6;RARB;PKNOX2;TCF4;TCF7L2;SMAD6;ABL1;KLF12;PRDM5;TCF12;ARNT;SOX5;MBNL2;GABPB2;CUX1;HLF;BBX;NR6A1;GLI3;ZIC4;DHX36;GLI2;ARNT2;ELF1;HDAC4;HOXB4;NFYC;ATF7;PER2;THRB;HOXA5;MLH3;PER3;KLF3;CREB5;TEF;HOXC4;RARG;YAP1;NFATC1;NFIX;FOXO3;KDM5B;KAT7;NFATC4;TBX15;NCOR1;TFCP2;MEOX2;TBL1X;SP1;BCOR;NFKB1;HOXB5;NR1D2;FOXK2;VSX1;ELF2;ARID4B;STAT3;ASH2L;ARID5B;ZBTB26;TBL1XR1;TEAD2;ATF2;ESR1;CENPC;PPARG;FOXK1;NR2C2;XPA;ZNF23;SMAD4;ATF6;GMEB1;HOXA6;ZIC1;NFATC3;HNRNPL;BRD7;ELF4;MZF1;CREB3L2;KMT2D
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.25901009013785864,-1.0,1.0,0.6856457570370297,1.0,59/254,16.32%,NFIA;NFAT5;SMAD3;NFIB;TCF4;HOXB3;PRRX1;TCF12;ZBTB16;HLF;ELF1;NFYC;HOXA5;NRF1;HOXC4;PPARA;NFATC1;FOXO3;TFCP2;MEOX2;SP1;NFKB1;MDM4;FOXK2;STAT3;SMAD1;MEF2A;PRDM15;CREBRF;MYBL1;TFDP1;ATF2;ESR1;NR2C2;SMAD4;ATF6;GMEB1;NFATC3;ELF4;MZF1;RBPJ;AR;KLF7;RREB1;SIX1;HSF2;NFIC;RLF;TFCP2L1;ZFP62;SMAD2;IRF2;NFYB;MLXIP;MDM2;TP53;HINFP;NR3C1;FOXO1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),-0.2691128319573714,-1.0,1.0,0.6856457570370297,1.0,136/731,12.95%,ZBTB20;PBX1;NFIA;FOXP1;NFAT5;NSD1;SMAD3;FOXP2;NFIB;TEAD1;ZEB1;GLIS3;HIVEP2;ZNF148;NR3C2;DNMT3A;HOXB6;RARB;PKNOX2;TCF4;TCF7L2;KLF12;PRDM5;ZNF423;HOXB3;ZBTB7C;PRRX1;TCF12;ARNT;SOX5;FOXD1;PBX3;NRIP1;STAT5B;MXI1;ZBTB16;HLF;NR6A1;HOXA3;GLI3;ZIC4;DHX36;GLI2;ARNT2;SKI;MGA;ELF1;HDAC4;HOXB4;NFYC;ATF7;CCAR1;THRB;NR2F2;CHD2;HOXA5;ZKSCAN2;HIVEP3;KLF3;NRF1;CREB5;TEF;THRAP3;HOXC4;PPARA;RARG;NFATC1;NFIX;FOXO3;NFATC4;SMAD9;TBX15;ZNF182;TFCP2;MEOX2;FOXP4;SP1;NFKB1;ZSCAN26;HOXB5;NR1D2;HIF3A;FOXK2;STAT3;SMAD1;ZIC2;ZFP30;ZBTB1;TOP1;KCNIP3;ZFHX3;EBF4;ZBTB38;MEF2A;MYNN;ZFHX4;STAT2;PRDM15;ZBTB26;EBF1;MYBL1;TEAD2;ATF2;ESR1;KLF8;TRIM24;SP4;PPARG;FOXK1;HOXC6;NR2C2;ZKSCAN3;ZNF23;SMAD4;ATF6;GMEB1;HOXA6;ZIC1;NFATC3;ELF4;MZF1;CREB3L2;PRRX2;RBPJ;ZBTB34;HOXC5;AR;MKX;IKZF2;KLF7;RREB1;SIX5;ZNF8;SIX1;ZKSCAN7;HIVEP1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),-0.24397627699243132,-1.0,1.0,0.6856457570370297,1.0,144/831,12.97%,ZBTB20;PBX1;NFIA;FOXP1;NFAT5;NSD1;SMAD3;FOXP2;NFIB;TEAD1;ZEB1;GLIS3;HIVEP2;ZNF148;NR3C2;DNMT3A;HOXB6;RARB;PKNOX2;TCF4;TCF7L2;KLF12;PRDM5;ZNF423;HOXB3;ZBTB7C;PRRX1;TCF12;ARNT;SOX5;FOXD1;PBX3;NRIP1;STAT5B;CUX1;MXI1;ZBTB16;HLF;BBX;NR6A1;HOXA3;GLI3;ZIC4;DHX36;GLI2;ARNT2;SKI;MGA;ELF1;HDAC4;HOXB4;NFYC;ATF7;CCAR1;THRB;NR2F2;CHD2;HOXA5;NFXL1;ZKSCAN2;HIVEP3;KLF3;NRF1;CREB5;TEF;THRAP3;HOXC4;PPARA;ZFP90;RARG;NFATC1;NFIX;FOXO3;NFATC4;SMAD9;TBX15;ZNF182;TFCP2;MEOX2;FOXP4;SP1;NFKB1;ZSCAN26;HOXB5;NR1D2;HIF3A;FOXK2;STAT3;SMAD1;ZIC2;ZFP30;ZBTB1;TOP1;KCNIP3;ZFHX3;EBF4;ZBTB38;MEF2A;MYNN;ZFHX4;STAT2;PRDM15;RBAK;ZBTB26;EBF1;CREBRF;MYBL1;NFX1;TEAD2;TFDP1;ATF2;ESR1;KLF8;SP4;PPARG;FOXK1;HOXC6;NR2C2;ZKSCAN3;ZNF23;SMAD4;ATF6;GMEB1;HOXA6;ETV6;ZIC1;NFATC3;ELF4;MZF1;PRRX2;RBPJ;ZBTB34;HOXC5;AR;MKX;IKZF2;KLF7;RREB1;SIX5;ZNF8;SIX1;ZKSCAN7;HIVEP1;ZBTB8A
prerank,thioesterase binding (GO:0031996),0.485397096987203,0.999552028901773,0.4958100558659218,0.8986898696094211,1.0,3/11,15.51%,RAC1;ARF6;TRAF3
prerank,phospholipase activator activity (GO:0016004),-0.40311957530138903,-0.9992788651052626,0.4919093851132686,0.6826302022209785,1.0,2/10,4.70%,ARHGAP6;PDPK1
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.40274377192149474,0.9976556687139398,0.4619105199516324,0.9005563516461015,1.0,9/29,22.25%,HYAL2;OVGP1;GUSB;GAA;MOGS;HPSE;NEU1;HPSE2;ENGASE
prerank,motor activity (GO:0003774),0.3665565164504874,0.9940671813345411,0.4966960352422907,0.9069089518660466,1.0,11/60,14.56%,MYL6;PIN1;DYNLRB1;KIF26B;KIF5A;KIF26A;MYL6B;DNAH1;DNAH2;DYNLRB2;KIF21B
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.36409102397880244,-0.9937977514680335,0.44672131147540983,0.6907900008937184,1.0,2/15,6.13%,PLA2G4A;SESTD1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.35136748017529823,-0.9928693775003409,0.44166666666666665,0.6883569211910897,1.0,9/15,18.18%,KMT2C;KMT2A;ASH2L;WDR82;KMT2D;SETD4;PRDM9;SETD1B;SETD3
prerank,nuclease activity (GO:0004518),0.3670698800621966,0.9922926261454124,0.494949494949495,0.9083783305237452,1.0,10/52,14.17%,NME1;ENDOG;RNASE1;ANG;RNASE4;RNASEH2A;RNASEH1;APEX1;SND1;PDE12
prerank,tRNA binding (GO:0000049),0.3782180363916105,0.9919897261832122,0.5090497737556561,0.905675390634466,1.0,13/43,25.04%,EEF1A1;SARS2;SARS1;KARS1;AARS2;CARS1;CTU1;SEPSECS;RPUSD4;YARS2;TRNT1;TRMT10C;EIF2A
prerank,histone deacetylase binding (GO:0042826),0.35293531174415205,0.9919804288711541,0.5020964360587002,0.9022477505639587,1.0,25/88,21.92%,HSP90AA1;HSP90AB1;YWHAB;SPI1;HSPA1B;YWHAE;HES1;NCOR2;CCND1;GMNN;PKN1;BHLHE41;HDAC5;HSPA1A;MIER2;IKZF3;HDAC9;MTA2;CIR1;HIC1;ANKRA2;MEF2C;SIRT2;TFAP4;SUDS3
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.4034439104424588,-0.99070561597671,0.44964028776978415,0.6888891925089781,1.0,1/11,0.16%,ITPR1
prerank,pre-mRNA binding (GO:0036002),-0.29801756540079216,-0.9904439290740475,0.4146341463414634,0.6847971971633199,1.0,6/28,11.09%,CELF2;RBM41;ZRSR2;TRA2B;RBM4;HNRNPL
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.39385172621844716,0.9889351045386614,0.4934601664684899,0.906898118095509,1.0,11/31,20.32%,SLC12A5;AQP1;KCNA2;KCNK9;KCNF1;ABCC8;KCNK3;KCNA1;HCN1;KCNK10;TMEM38B
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.4267388555549557,0.9883549811876949,0.49093264248704666,0.905088445545895,1.0,2/18,2.97%,MT3;PRDX5
prerank,miRNA binding (GO:0035198),-0.28698941196905914,-0.9880763006134892,0.45806451612903226,0.6852312272459775,1.0,11/30,21.47%,ZNF346;ZC3H7A;TUT7;RBM4;ZC3H7B;PUM2;TUT4;AGO2;FMR1;AGO4;SOX2
prerank,gamma-tubulin binding (GO:0043015),0.42492768096689376,0.9877326894308739,0.4851228978007762,0.9033208415634353,1.0,10/21,31.87%,NDRG1;PAK1;ARHGEF7;BRCA2;GIT1;BLOC1S2;B9D2;DIXDC1;DDX3X;TUBGCP2
prerank,serine-type endopeptidase activity (GO:0004252),0.3568866860707633,0.9875760112794902,0.5241596638655462,0.9003471955439715,1.0,16/80,19.79%,CD5L;HP;HPR;F9;KLK8;KLK1;KLK6;PCSK2;PIK3IP1;PLAT;CTSH;GZMM;PLAU;F10;PRSS12;HGF
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.32058211421848737,-0.9874930802825138,0.4444444444444444,0.6818143163557451,1.0,2/21,3.60%,FGF1;FRS2
prerank,methylation-dependent protein binding (GO:0140034),-0.26785416876268625,-0.9860955125960066,0.4634146341463415,0.6805120411960559,1.0,18/57,18.98%,KDM7A;ZMYND11;TDRD3;CDYL;PYGO1;CHD1;MBTD1;TRIM24;ZCWPW2;MORC3;LRWD1;PHF8;ING2;KAT8;L3MBTL2;FMR1;MORC4;ZCWPW1
prerank,adenylyltransferase activity (GO:0070566),-0.3137094435995355,-0.9836585630366456,0.47668393782383417,0.6812482357663572,1.0,9/21,20.38%,ABL1;TENT4B;FLAD1;TUT1;OAS2;PAPOLB;TENT2;NMNAT2;NMNAT3
prerank,protein kinase C activity (GO:0004697),-0.36660975900436044,-0.9831765841821132,0.47580645161290325,0.6778358573911818,1.0,6/14,14.78%,PRKCE;SMG1;PRKD3;PRKD1;PRKCI;PRKCB
prerank,chemokine binding (GO:0019956),0.39461008452642904,0.9819944569464099,0.5217917675544794,0.9120635628689387,1.0,10/30,31.38%,CCR5;HMGB1;ZFP36;CXCR4;CX3CR1;CCR2;ITGB1;ACKR1;PLP2;ACKR3
prerank,protein phosphatase regulator activity (GO:0019888),0.36713904336206465,0.9785965385824994,0.5369127516778524,0.9179544511899848,1.0,15/53,21.57%,CALM1;RCAN3;CALM3;PPP1R15B;LGALS3;PPP1R1B;PPP2R1A;SET;B3GAT3;ARPP19;PPP2R5D;PPP1R15A;CALM2;PPP2R5A;PTN
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.4174787009694651,0.97784780142511,0.5141451414514145,0.9163928204327645,1.0,9/22,20.65%,ZFP36L1;MEX3D;ZFP36L2;HNRNPA0;ZFP36;ELAVL4;ELAVL3;EXOSC9;EXOSC4
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.4517125789081456,0.9759068802624544,0.5204755614266843,0.9182106603960835,1.0,3/14,13.64%,ELAC2;POP7;POP4
prerank,protein phosphatase inhibitor activity (GO:0004864),0.39838301261125,0.9725809524173523,0.5325301204819277,0.9236304830761457,1.0,5/26,9.57%,LGALS3;PPP1R1B;PPP1R14A;PPP1R14B;SET
prerank,PDZ domain binding (GO:0030165),-0.2545919800164695,-0.9720855270611074,0.5,0.6981351087776544,1.0,13/61,11.60%,ARHGAP29;TGFBR3;CRIM1;RAPGEF2;PRKN;PLEKHA2;SLC22A4;DLG4;GNG12;PTEN;KIDINS220;SRR;PSEN1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.36965429608040284,-0.9715191737808707,0.4597315436241611,0.6946680346380093,1.0,6/12,14.99%,BRD4;CDK12;CDK6;CCNK;CDK13;CDK7
prerank,glucose transmembrane transporter activity (GO:0005355),0.42565935762174406,0.9700402811166491,0.5173333333333333,0.9266903383925891,1.0,8/17,36.97%,SLC2A1;SLC2A2;SLC2A3;SLC2A6;PPBP;SLC2A4;SLC2A8;SLC5A3
prerank,damaged DNA binding (GO:0003684),0.36986528646185923,0.9670706734584666,0.5355504587155964,0.9312444938402734,1.0,13/44,26.50%,RPS3;RPA2;DDB1;HMGB1;APEX1;PCNA;DCLRE1C;ERCC1;PNKP;POLD1;RPA3;XPC;ERCC2
prerank,myosin V binding (GO:0031489),0.43066309175798057,0.9655776807317982,0.5223274695534507,0.9320152591657256,1.0,6/15,21.57%,RAB14;RAB3C;RAB3D;RAB39B;RAB6B;RAB27B
prerank,glutamate receptor binding (GO:0035254),0.42502502426017424,0.9639622373580983,0.5255754475703325,0.9330456033887607,1.0,10/17,37.09%,HOMER2;SHISA7;SYNDIG1;SQSTM1;SHISA6;HOMER1;SHANK1;HOMER3;NSF;GNAS
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.4250823712808658,0.9632258471485345,0.535483870967742,0.9315327296058512,1.0,3/18,4.93%,PPP1CA;S100A11;TRIM29
prerank,sequence-specific mRNA binding (GO:1990825),0.46470565610681885,0.9590266061288237,0.5287517531556802,0.9389269938700151,1.0,4/10,28.79%,SHFL;ETF1;DHX9;DHFR
prerank,voltage-gated sodium channel activity (GO:0005248),0.4023542486287339,0.9588845664000984,0.5330012453300125,0.9359445807131761,1.0,8/22,29.44%,SCN1A;SCN4B;HCN1;HCN3;SCN9A;SCN8A;SCN2A;SCN1B
prerank,channel activity (GO:0015267),0.36774539585189275,0.957198266963203,0.570615034168565,0.9370092632231494,1.0,8/41,23.24%,AQP4;AQP1;BAX;P2RX6;SLC14A1;KCNK3;PANX2;MPV17
prerank,dynactin binding (GO:0034452),-0.3636159838265117,-0.9564627402752274,0.48507462686567165,0.7243714216095059,1.0,2/12,2.43%,SNX6;PAFAH1B1
prerank,leucine zipper domain binding (GO:0043522),0.46528677102030913,0.9541085853994483,0.5437853107344632,0.9413384070216543,1.0,2/10,5.44%,ATF4;MRTFA
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.36638419783375326,-0.949961909180215,0.49491525423728816,0.7345585959477866,1.0,3/11,9.99%,NAA40;NAA16;NAA15
prerank,alpha-actinin binding (GO:0051393),-0.27980429831488174,-0.9392116542207568,0.5287356321839081,0.7545708716434739,1.0,6/24,13.72%,CACNA1C;PDLIM5;PDLIM4;PPARG;SYNPO2;CACNA1D
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.42664030162343314,0.9343790336603788,0.56,0.98746469336081,1.0,3/14,18.52%,HSD17B6;RDH5;AKR1A1
prerank,signal sequence binding (GO:0005048),0.36281389631597166,0.9299247524985871,0.5771495877502945,0.9948011726885103,1.0,10/35,20.69%,PEX5L;KDELR1;AP2M1;SEC61A1;IPO4;TOMM20L;CAT;CABP1;BRAP;NFKBIA
prerank,androgen receptor binding (GO:0050681),0.3777809839744133,0.9273794301176743,0.5679611650485437,0.9975037594964309,1.0,5/25,12.31%,CALR;PARK7;PKN1;ZBTB7A;SNW1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.30051710184784336,-0.9261583798140934,0.5804878048780487,0.7796141725250398,1.0,9/22,15.24%,OTUD7B;UIMC1;ZBTB1;RNF169;OPTN;TAB2;ZRANB1;PARP10;TAB3
prerank,O-methyltransferase activity (GO:0008171),0.45299299691967143,0.9255255742142673,0.5680555555555555,0.9984311695589222,1.0,3/10,21.52%,CMTR1;MEPCE;FTSJ3
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.4228115956097116,0.9254637446514979,0.5983493810178817,0.9951019227178116,1.0,8/14,32.50%,PYCR2;CRYM;QDPR;ALDH4A1;BLVRB;NOXRED1;DHFR;ALDH1L1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.29304312201962096,-0.9244749749403888,0.5837837837837838,0.7783780966387814,1.0,6/23,10.36%,MAPKAP1;PLEKHA4;SESTD1;HIP1;GBF1;KIF16B
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.312292248303211,-0.9242255249591057,0.5688888888888889,0.7740152357470567,1.0,4/18,12.34%,ALDH1A1;ALDH1A2;FAR1;AKR1B1
prerank,CoA hydrolase activity (GO:0016289),0.41151980863485726,0.9233240708167315,0.5698778833107191,0.9966819311409125,1.0,4/16,16.78%,ACAA2;ACOT1;ACOT7;ACOT4
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.35280800291277836,0.9232079139089718,0.6138952164009112,0.9935162378113906,1.0,16/42,27.64%,CCNI;CCND2;CCND1;CDK5R1;CCNG1;HEXIM1;CDK5R2;CCNJL;CDKN2B;CCNC;CCNG2;CCNQ;CCNA2;CCNH;CDKN1A;CNPPD1
prerank,serine-type peptidase activity (GO:0008236),0.32505695745977076,0.9173030026239537,0.668724279835391,1.0,1.0,18/96,19.79%,CD5L;HP;HPR;F9;KLK8;KLK1;KLK6;PCSK2;PIK3IP1;PLAT;CTSH;GZMM;PRSS8;KLK10;PLAU;F10;PRSS12;HGF
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.2766585092868397,-0.9172267363278503,0.625,0.7857332090276968,1.0,4/27,7.19%,SLC9A1;SLC9A2;SLC9B2;SLC8B1
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.3436936117500267,-0.9147120448478309,0.5691056910569106,0.7868701206358214,1.0,7/12,23.36%,SULF1;ARSK;SULF2;ARSB;ARSI;ARSA;ARSJ
prerank,beta-tubulin binding (GO:0048487),0.3649641025940628,0.9134812881421767,0.6289752650176679,1.0,1.0,7/31,17.14%,GABARAP;GABARAPL2;GABARAPL1;CDK5R1;TTLL7;FGF13;PDCD5
prerank,gated channel activity (GO:0022836),-0.333548202944993,-0.9123829504981389,0.6041666666666666,0.7874598056861196,1.0,3/14,10.91%,PIEZO2;PIEZO1;TMC6
prerank,myosin binding (GO:0017022),0.3357097237894564,0.9110768707791501,0.6396895787139689,1.0,1.0,19/55,23.35%,GSN;MOBP;RAB14;CORO1A;RAB3C;STXBP5L;RAB3D;HAP1;RHOA;CXCR4;RAB39B;TRIM32;RAB6B;PYCARD;RAB27B;LLGL1;USH2A;NKD2;NCKIPSD
prerank,single-stranded DNA binding (GO:0003697),0.3226727800789211,0.911030172735563,0.646875,1.0,1.0,37/93,29.98%,PCBP1;PARK7;POLR2D;MCM5;NUCKS1;RPA2;HSPD1;MAPT;HMGB1;POLR2G;DDX11;HNRNPU;HNRNPA1;SUB1;BRCA2;CTC1;RAD23A;WDR48;POU4F1;FAM111A;ERCC1;POLR2H;RADX;BLM;CDC45;LONP1;PCBP2;PURB;RPA3;RAD51;XPC;MCM7;MCM2;DHX9;WBP11;SMC6;POLR3C
prerank,WW domain binding (GO:0050699),0.36723863811883584,0.9110263645660012,0.5978128797083839,1.0,1.0,9/26,29.22%,TCEAL9;DAZAP2;TCEAL7;TCEAL5;TCEAL8;TNK2;KIF20B;ENAH;WBP11
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.3148216790818058,-0.9071397671944976,0.5757575757575758,0.7944324611205286,1.0,6/17,18.50%,DPYD;PTGR2;BDH2;PECR;TM7SF2;PTGR1
prerank,acyl-CoA hydrolase activity (GO:0047617),0.39521024042793773,0.905798320586345,0.6025806451612903,1.0,1.0,5/17,20.06%,ACAA2;ACOT1;ACOT7;ACOT4;THEM4
prerank,hydro-lyase activity (GO:0016836),0.352622470588447,0.9046401862951405,0.6304347826086957,1.0,1.0,13/41,22.93%,PARK7;CA2;ENO1;HSD17B4;ALAD;CA4;FAHD2A;ENO3;ECHS1;NAXD;CA3;EHHADH;TBXAS1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.35930129638622044,0.9035183393424594,0.6205673758865248,1.0,1.0,5/34,7.85%,UBE2Z;UBE2G2;UBE2Q1;CDC34;UFC1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.43110686245163665,0.9017503939853221,0.5978260869565217,1.0,1.0,5/12,22.49%,SPPL2B;NAPSA;BACE1;SPPL2A;CTSE
prerank,voltage-gated calcium channel activity (GO:0005245),-0.2516502295170725,-0.9011657033274613,0.676056338028169,0.8035301095348676,1.0,3/37,3.78%,CACNA2D3;CACNA1C;CACHD1
prerank,pseudouridine synthase activity (GO:0009982),0.4268113898649226,0.8991084880952698,0.5967523680649527,1.0,1.0,5/13,20.90%,TRUB2;PUSL1;DKC1;PUS7;RPUSD4
prerank,mannosyltransferase activity (GO:0000030),-0.2919894078435791,-0.898604739795982,0.6391752577319587,0.804901126402117,1.0,10/21,23.92%,TMTC1;TMTC4;PIGM;DPY19L4;POMT1;DPM1;TMTC3;POMT2;ALG1;PIGB
prerank,palmitoyltransferase activity (GO:0016409),0.3702157269346138,0.8977470980813863,0.6163895486935868,1.0,1.0,10/28,29.83%,GLUL;YKT6;ZDHHC5;GOLGA7B;GOLGA7;ZDHHC12;ZDHHC8;ZDHHC2;ZDHHC14;ZDHHC16
prerank,C-C chemokine receptor activity (GO:0016493),0.387787733321312,0.895910294019761,0.6122715404699739,1.0,1.0,4/21,18.54%,CCR5;CXCR4;CX3CR1;CCR2
prerank,mRNA methyltransferase activity (GO:0008174),0.42191697690433483,0.8926033180438799,0.6059743954480796,1.0,1.0,5/12,24.90%,PCIF1;CMTR1;TRMT10C;METTL3;METTL14
prerank,ribonuclease P RNA binding (GO:0033204),0.435420588284358,0.8844319845026689,0.6339031339031339,1.0,1.0,2/10,13.64%,POP7;POP4
prerank,transcription coactivator binding (GO:0001223),0.38162653678537956,0.8813433903308681,0.6526576019777504,1.0,1.0,1/20,0.13%,RPL23
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.42025798137804193,0.8800560015190925,0.6251788268955651,1.0,1.0,5/11,24.67%,NUDT3;NUDT4;NUDT16;NUDT10;NUDT11
prerank,deubiquitinase activity (GO:0101005),-0.21146830526765534,-0.8791808738761812,0.7045454545454546,0.8435162395298477,1.0,24/88,16.87%,USP3;USP47;OTUD4;USP24;USP11;MINDY3;USP34;OTUD7B;USP50;MYSM1;USP49;USP40;USP16;USP36;USP4;OTUD3;ZRANB1;USP28;USP46;UCHL5;STAMBPL1;USP45;USP53;USP37
prerank,cytokine receptor binding (GO:0005126),0.3133533148267623,0.8790579787808506,0.711395101171459,1.0,1.0,22/83,23.87%,CXCL12;CCL19;FKBP1A;MIF;DDT;IL2;KITLG;IL11;TIMM50;SDCBP;TLR5;CD300LF;ADAM17;SYK;IL6;IL1RAP;CRLF2;PYCARD;CRLF1;PRLR;IL12RB1;ERAP1
prerank,solute:proton symporter activity (GO:0015295),0.3931250934633727,0.8775746400570805,0.6357702349869452,1.0,1.0,4/16,15.37%,SLC15A4;SLC33A1;MFSD3;SLC15A2
prerank,ATP binding (GO:0005524),0.2947827176892228,0.8765008889205808,0.8092369477911646,1.0,1.0,77/266,26.65%,HSPA8;HSP90AA1;HSP90AB1;ATP5F1D;NDUFA13;HSPA5;AKT1;ATP5F1A;NME1;PINK1;PFKL;ACVRL1;HSPA1B;ABCG1;ABCB6;UHMK1;TAP2;PGK1;ATP1A3;EPB42;P2RX7;MAST1;SYN2;P2RY1;SARS2;AARS2;MYO1F;BCKDK;P2RX6;ATP1A1;SYN1;CARS1;HSPA1A;CDC42BPA;STK11;HNRNPU;ABCA2;TSSK6;TSSK4;PRPS1L1;PRPS1;PEX6;EIF4A3;BRSK2;GUK1;HSPA4L;VPS4A;ERCC6;OAS3;MAP4K2;AGAP2;MKNK1;PYGL;TWF1;HSPA2;HSPA9;YARS2;MTHFS;BLM;PMVK;TRNT1;LONP1;TWF2;PNKP;ACLY;LANCL2;DYRK2;GALK1;RAD51;HSPA14;ABCG5;PIF1;TRIB1;PIM1;CDK11B;OXSR1;PEX1
prerank,GDP binding (GO:0019003),0.3158107455588843,0.8758899680196324,0.7051835853131749,1.0,1.0,22/63,27.11%,RAN;RAB14;ARF6;GNAI1;HRAS;RHEBL1;NME2;RRAS;RRAGC;RRAGD;RAB5C;RAB31;RAB18;RAB4A;RERG;RALB;RAB27B;RAB28;RAB42;RAB8A;RAP2A;RAP1B
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.3521111460066054,0.8750879487583916,0.6722689075630253,1.0,1.0,7/29,17.04%,HSPB1;INKA2;YWHAG;PRKAR1A;PRKAR1B;HEXIM1;PRKAR2B
prerank,protein phosphorylated amino acid binding (GO:0045309),0.33413455793890223,0.8723721320695548,0.6719817767653758,1.0,1.0,12/42,21.94%,YWHAB;PIN1;YWHAE;SHC3;PFN1;HCK;VAV1;FBXW7;SYK;PTPN6;SHE;PTPN5
prerank,Wnt-activated receptor activity (GO:0042813),-0.30723198194701506,-0.8709839396778344,0.6477732793522267,0.8554221704592214,1.0,4/15,10.26%,ROR1;LRP5;FZD6;PKD1
prerank,RNA stem-loop binding (GO:0035613),-0.3310080598529539,-0.8708988411337851,0.6438356164383562,0.85053199852757,1.0,6/12,23.49%,MYH10;CPEB3;RC3H2;FMR1;METTL16;LARP6
prerank,phosphatidylglycerol binding (GO:1901611),0.4082672704061707,0.870207400614242,0.6643835616438356,1.0,1.0,2/13,12.42%,PLTP;NME4
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.31756789436791355,-0.8685916162930157,0.6384615384615384,0.8503698023728861,1.0,1/13,0.19%,BMP6
prerank,ion gated channel activity (GO:0022839),0.3587040155798006,0.8632668460543177,0.6328502415458938,1.0,1.0,6/24,19.98%,TMEM63B;TTYH1;TMEM63C;TTYH3;ANO4;PKD2L1
prerank,adenyl ribonucleotide binding (GO:0032559),0.29020881393979714,0.8625974693646105,0.845691382765531,1.0,1.0,85/291,26.65%,HSPA8;HSP90AA1;HSP90AB1;ATP5F1D;NDUFA13;HSPA5;AKT1;PDE4B;ATP5F1A;NME1;PINK1;PFKL;ACVRL1;HSPA1B;ABCG1;ABCB6;UHMK1;TAP2;PGK1;APRT;ATP1A3;MYO3A;EPB42;P2RX7;MAST1;SYN2;P2RY1;SARS2;AARS2;MYO1F;BCKDK;P2RX6;ATP1A1;SYN1;CARS1;HSPA1A;CDC42BPA;SLC19A1;STK11;HNRNPU;ABCA2;TSSK6;TSSK4;PRPS1L1;PRPS1;PEX6;HCN1;EIF4A3;BRSK2;GUK1;HSPA4L;VPS4A;ERCC6;OAS3;MAP4K2;GLUD1;AGAP2;MKNK1;PYGL;TWF1;HSPA2;HSPA9;YARS2;MTHFS;BLM;PMVK;TRNT1;LONP1;TWF2;PNKP;ACLY;POPDC3;LANCL2;DYRK2;GALK1;PDE2A;RAD51;HSPA14;ABCG5;PIF1;TRIB1;PIM1;CDK11B;OXSR1;PEX1
prerank,N-acyltransferase activity (GO:0016410),0.3425402608587107,0.8625088215664274,0.6479532163742691,1.0,1.0,6/32,17.72%,TGM2;CERS2;PLAAT3;NAA10;GLYAT;NAT8L
prerank,NAD binding (GO:0051287),-0.2667838273905434,-0.8595612901629037,0.7150837988826816,0.8639680461393275,1.0,8/26,16.17%,ALDH1A1;CRYL1;PARP9;BDH2;SIRT1;ME1;ZC3HAV1;NNT
prerank,microtubule binding (GO:0008017),0.28920911403947736,0.8555552633529929,0.8318227593152064,1.0,1.0,44/222,19.48%,RPS3;GAPDH;PRNP;MAP1LC3B;TERF1;MAP1LC3A;MAP1A;GABARAPL2;S100A8;S100A9;NEFH;DNM3;SBDS;NEFM;NAV3;NDRG1;ABRAXAS2;KIF26B;CLASP1;MAST1;MAPT;MAP2;KIF5A;REEP2;KIF26A;FHDC1;DCTN1;CLIP3;MTCL1;CCDC88A;KIF21B;CETN3;CDK5;MAPRE3;FGF13;DNM1L;HOOK1;TOGARAM2;KIF5C;FAM83D;RAE1;KIFC2;DCX;VAPA
prerank,cation channel activity (GO:0005261),0.30071684926443665,0.8549486469840513,0.7583682008368201,1.0,1.0,30/94,23.25%,SLC24A4;SLC24A2;GRIN1;HVCN1;TMEM63B;TMCO1;TMEM63C;AQP1;KCNA2;TRPM2;KCNK9;SEC61A1;KCNF1;ABCC8;TRPC1;KCNK3;KCNA1;HCN1;RYR2;ORAI1;UNC80;KCNK10;ANXA6;CALHM6;PKD2L1;TMEM38B;PKDREJ;PKD1L2;SLC24A5;CACNA1E
prerank,E-box binding (GO:0070888),-0.2529272539532438,-0.8547854369286333,0.7153284671532847,0.8684238922157458,1.0,2/34,1.00%,ZEB1;TCF4
prerank,calcium activated cation channel activity (GO:0005227),0.3813267075049456,0.8545344766559473,0.6804657179818887,1.0,1.0,7/17,27.02%,TMEM63B;TMEM63C;KCNN2;KCNMA1;PKD2L1;KCNMB4;KCNN4
prerank,phosphoric diester hydrolase activity (GO:0008081),0.33449319289112917,0.8536318951795151,0.6912442396313364,1.0,1.0,11/35,20.49%,PLD3;PDIA3;ENPP2;SMPD1;APEX1;GDE1;SMPDL3A;GPCPD1;GDPD1;ENPP6;PDE11A
prerank,BMP receptor binding (GO:0070700),-0.317568004713189,-0.8523749199734884,0.6308243727598566,0.8681408086551413,1.0,1/12,0.19%,BMP6
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.35915986890466783,0.8512899252380803,0.6850490196078431,1.0,1.0,8/24,29.03%,GLUL;YKT6;GOLGA7B;GOLGA7;ZDHHC12;ZDHHC8;ZDHHC2;ZDHHC14
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.390521234301873,0.8510113981277078,0.671523178807947,1.0,1.0,4/14,28.23%,KCNE4;KCNE5;KCNJ3;KCNQ1
prerank,pyrophosphatase activity (GO:0016462),0.3201008029975514,0.849765281129896,0.72271714922049,1.0,1.0,12/50,19.40%,BNIP2;ENTPD3;NUDT3;TRPM2;NUDT22;NUDT4;PPA1;NUDT16;PRUNE2;ATCAY;NUDT10;NUDT9
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.3390560124753773,-0.8497302848433509,0.6596491228070176,0.8636130522704308,1.0,3/10,10.61%,DUSP16;DUSP10;DUSP7
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.3390560124753773,-0.8497302848433509,0.6596491228070176,0.8636130522704308,1.0,3/10,10.61%,DUSP16;DUSP10;DUSP7
prerank,cyclic nucleotide binding (GO:0030551),0.36414861830122314,0.8489663614359158,0.6645807259073843,1.0,1.0,9/21,25.47%,PDE4B;CNGA3;CNGA4;SLC19A1;HCN1;CNGB1;PDE11A;POPDC3;PDE2A
prerank,phosphoric ester hydrolase activity (GO:0042578),0.3177762191363432,0.8488393661190614,0.7045203969128997,1.0,1.0,19/49,25.96%,PPP1CA;DUSP3;DUSP28;SMPD1;APEX1;SMPDL3A;GDPD1;ENPP6;PGP;PTPRO;DUSP23;DUSP12;DUSP15;GDPD3;SBF1;PPP1CB;ACP2;PGAM5;DUSP8
prerank,aminopeptidase activity (GO:0004177),0.3445374302838117,0.8475931664655338,0.6840148698884758,1.0,1.0,6/26,16.01%,METAP1;METAP2;LAP3;CTSH;MMP14;RNPEPL1
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.3386787889359363,-0.846405493605382,0.6709677419354839,0.8650269421368361,1.0,1/10,0.04%,PRKAG2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.4102361902246104,0.8419361263937252,0.703601108033241,1.0,1.0,4/11,34.69%,DDAH1;DDAH2;ARG2;PADI2
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.23823696316664206,-0.8409278718818155,0.7647058823529411,0.8715057579642127,1.0,8/34,13.61%,PAN3;CNOT1;PARN;ERI3;CNOT7;DIS3L;ERI2;ANGEL1
prerank,ionotropic glutamate receptor binding (GO:0035255),0.4164102477637609,0.8400608456923594,0.6815020862308763,1.0,1.0,6/10,37.09%,SHISA7;SQSTM1;SHISA6;SHANK1;NSF;GNAS
prerank,solute:anion antiporter activity (GO:0140323),-0.30481790667303965,-0.8394746791008003,0.6893939393939394,0.8696248511196395,1.0,3/14,12.06%,SLC26A7;SLC7A11;SLC26A2
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.2553805482328941,-0.8385923413256743,0.7225806451612903,0.866461527449155,1.0,4/28,9.78%,EDA;BABAM2;TRAF5;RIPK1
prerank,cardiolipin binding (GO:1901612),0.4070224558492156,0.8385776563391325,0.6760961810466761,1.0,1.0,3/10,26.04%,NME4;STOML2;PLEKHN1
prerank,receptor antagonist activity (GO:0048019),0.37561199858183125,0.8384276350661688,0.680794701986755,1.0,1.0,2/17,6.75%,LRPAP1;WFIKKN2
prerank,tropomyosin binding (GO:0005523),0.3723507820093148,0.8369949094752877,0.6631016042780749,1.0,1.0,1/16,0.64%,S100A6
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.2200568487266247,-0.8364963938801268,0.9010989010989011,0.8657557719764141,1.0,12/55,13.10%,SLC6A13;SLC38A9;SLC16A12;SLC7A2;SLC6A12;SLC16A9;SLC22A4;SLC38A6;SLC16A6;SLC16A13;SLC38A11;SLC36A4
prerank,cAMP binding (GO:0030552),-0.32634360511730043,-0.8364005246452199,0.6909722222222222,0.8611906580861247,1.0,3/11,9.32%,RAPGEF4;RAPGEF2;CNBD2
prerank,hyaluronic acid binding (GO:0005540),0.4220215406027959,0.8351310621977965,0.7071428571428572,1.0,1.0,3/10,23.84%,HYAL2;LYVE1;C1QBP
prerank,filamin binding (GO:0031005),-0.3327457252840387,-0.8347395356952296,0.6579925650557621,0.8598200272433658,1.0,2/11,3.45%,DPYSL3;NEBL
prerank,kinase activity (GO:0016301),0.2895639749843416,0.8338839367485221,0.8068535825545171,1.0,1.0,23/109,20.28%,CHKB;CKB;AKT1;RFK;PINK1;CKMT1A;PGK1;FN3KRP;DGKH;DGKI;CDK5R1;PIK3C2G;BCKDK;DOLK;CDK5;CCL3;PIK3CD;COASY;IP6K1;CERKL;SPHK2;MAPK15;NEK1
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.3361935678216104,-0.8330670717764742,0.68,0.857989860040903,1.0,2/10,6.05%,B4GALT1;B3GALT1
prerank,vinculin binding (GO:0017166),-0.31986512905017905,-0.8320962209499182,0.6678445229681979,0.8553282350191649,1.0,3/11,6.76%,SORBS3;PXN;UTRN
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.39843116126608175,0.8304082299275588,0.6873278236914601,1.0,1.0,3/11,22.11%,LRRC8A;SLC19A1;SLC25A23
prerank,voltage-gated ion channel activity (GO:0005244),0.38431828631378717,0.8295114761845096,0.7051792828685259,1.0,1.0,6/14,27.95%,KCND2;HVCN1;HCN1;VDAC2;CACNA1E;VDAC3
prerank,histone acetyltransferase binding (GO:0035035),0.35200471599615735,0.828643574189513,0.7031055900621118,1.0,1.0,8/21,23.20%,EID1;EPAS1;EGR1;ZBTB7A;PCNA;CITED2;SIRT2;TRIM68
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.3346639716920671,0.8278593477370947,0.713939393939394,1.0,1.0,4/31,6.21%,UBE2Z;UBE2G2;UBE2Q1;CDC34
prerank,epidermal growth factor receptor binding (GO:0005154),-0.2586177061518782,-0.8274160888493564,0.7771428571428571,0.8593689462226117,1.0,4/25,7.96%,FER;ATXN2;EFEMP1;HIP1
prerank,alkali metal ion binding (GO:0031420),-0.3090649046516562,-0.8272558357005,0.700374531835206,0.8550532865927342,1.0,3/13,8.81%,HDAC4;ATP1A2;TDG
prerank,phosphatidylcholine transporter activity (GO:0008525),0.3709118278289504,0.8272342839113904,0.7009102730819246,1.0,1.0,2/17,5.34%,PLTP;ABCG1
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.27218576377336146,-0.8265268070680978,0.7303921568627451,0.8519222471585344,1.0,5/21,12.48%,ARFGEF1;AKAP7;AKAP9;ARFGEF2;AKAP8L
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.3149403640929065,-0.8243460155041648,0.6906474820143885,0.851306320538619,1.0,12/12,68.54%,GPR52;RRH;OPN1MW3;OPN1MW;RHO;OPN5;OPN1SW;GNAT2;OPN4;OPN3;GPR88;ELOVL4
prerank,5'-nucleotidase activity (GO:0008253),-0.31233816733051656,-0.824326742844968,0.7272727272727273,0.8468051219873032,1.0,5/13,19.54%,NT5DC1;NT5C2;NT5C1A;NT5M;ACP3
prerank,transforming growth factor beta binding (GO:0050431),0.3414393648951582,0.8233785127992868,0.702801461632156,1.0,1.0,4/23,6.75%,LTBP4;ACVRL1;HYAL2;WFIKKN2
prerank,single-stranded RNA binding (GO:0003727),0.3194831144603795,0.8233624894010839,0.7595505617977528,1.0,1.0,13/43,25.01%,POLR2D;POLR2G;DDX11;L1TD1;HNRNPU;HNRNPA1;AGO1;CNBP;EIF4H;RBM7;HNRNPF;LONP1;TLR7
prerank,Notch binding (GO:0005112),0.34675720332890614,0.8227907726812633,0.7125,1.0,1.0,7/22,17.68%,KCTD10;NCOR2;DNER;SNW1;DLL1;JAG2;ADAM17
prerank,TBP-class protein binding (GO:0017025),0.347351153956035,0.8217702527114104,0.7284105131414268,1.0,1.0,9/21,33.49%,DRAP1;THRA;PSMC1;HHEX;RUVBL2;PSMC5;TAF13;PSMC2;TAF11
prerank,UDP-glycosyltransferase activity (GO:0008194),0.3000742525022217,0.8207034371799631,0.7925531914893617,1.0,1.0,18/70,24.63%,HEXB;HEXA;B4GALNT1;B4GALNT4;POGLUT3;B3GNT9;CHPF2;B3GAT3;CHPF;GCNT1;B3GNT3;RFNG;CHSY3;CSGALNACT2;B3GALT5;LFNG;B3GALT2;MGAT4B
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.403756051803323,0.820695904386876,0.7,1.0,1.0,6/10,29.82%,CRMP1;OPLAH;DPYS;DPYSL2;DPYSL5;CAD
prerank,general transcription initiation factor binding (GO:0140296),0.33622007733426135,0.8195389470246096,0.7166866746698679,1.0,1.0,10/25,30.70%,DRAP1;THRA;TBP;PSMC1;RELA;HHEX;RUVBL2;PSMC5;TAF13;PSMC2
prerank,lipid phosphatase activity (GO:0042577),-0.29202275391102334,-0.8189097555132815,0.7198275862068966,0.8521282099186772,1.0,7/14,22.30%,PLPP3;EPHX2;PLPP1;PLPP7;PLPP2;PLPPR1;PLPPR3
prerank,CARD domain binding (GO:0050700),-0.30261703589464256,-0.8159653270378571,0.69921875,0.8527956296755174,1.0,2/14,5.41%,CARD16;CARD14
prerank,O-acyltransferase activity (GO:0008374),0.32467290930207793,0.8136342757569522,0.7384066587395958,1.0,1.0,10/30,27.01%,PRDX6;MOGAT2;DGAT2L6;LRAT;SOAT2;DGAT1;MOGAT1;LPCAT2;GPAM;MBOAT7
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.3215638574688298,-0.8108872281362287,0.6764705882352942,0.857056205794164,1.0,1/10,0.55%,CACNA1C
prerank,ribosomal large subunit binding (GO:0043023),0.3940706543896285,0.8097063943342497,0.7088948787061995,1.0,1.0,1/11,3.02%,NPM1
prerank,metallopeptidase activity (GO:0008237),0.2797060307704934,0.8088236476624256,0.8263103802672148,1.0,1.0,22/113,17.68%,MMP3;RCE1;MMP27;COPS6;ADAM15;METAP1;ADAM23;ADAMTS4;ADAM12;OMA1;MMP21;METAP2;PMPCB;PRPF8;LAP3;ADAMTS16;SPG7;MMP14;NUDT16;ADAMTS1;ADAM18;ADAM17
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.339962633975358,0.8067493734613924,0.7385943279901356,1.0,1.0,10/22,25.96%,DUSP3;DUSP2;PPM1F;DUSP23;DUSP12;DUSP1;DUSP15;SBF1;DUSP6;DUSP8
prerank,syntaxin-1 binding (GO:0017075),0.3373600979525049,0.8066863744261742,0.7487684729064039,1.0,1.0,5/22,9.35%,SNAP25;SYT1;SYPL1;VAMP3;VAMP2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.3259245301870214,0.8038472203399244,0.7452830188679245,1.0,1.0,11/28,29.26%,AKT1;SGK1;PAK3;MAPK10;MAP2K2;MAP2K7;PRKACA;TNK2;MAP3K9;RPS6KA1;AURKB
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.39621669459179504,0.8023227678152715,0.734375,1.0,1.0,1/10,5.20%,SIRPA
prerank,phosphatase binding (GO:0019902),0.2809341974998522,0.8001428764160232,0.8371369294605809,1.0,1.0,21/105,18.76%,RACK1;MAPK3;RCAN3;HSP90B1;LGALS3;SIRPA;CTNNB1;VCP;RPA2;CD22;MTMR9;SYTL2;FLT4;BAD;SPTBN4;TRAF3;SKAP1;CDH5;CTSC;TERF2IP;CARHSP1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.3663330996167804,0.8000073835849791,0.7412398921832885,1.0,1.0,3/15,18.54%,CCR5;CX3CR1;CCR2
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.3049881631405255,-0.7987948941874392,0.7519685039370079,0.8725634962255111,1.0,7/13,23.40%,TRMT5;THUMPD3;FTSJ1;TRMT1L;TARBP1;TRMT1;TRMT10B
prerank,SH2 domain binding (GO:0042169),0.3208416445919183,0.798534738939454,0.7520858164481525,1.0,1.0,7/31,17.21%,RACK1;DLC1;SH2B2;LILRB1;CCDC88A;SQSTM1;SKAP1
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.3415280572519279,0.798373375824472,0.75,1.0,1.0,5/20,17.53%,DLG2;AK4;AK3;CMPK2;GUK1
prerank,phosphotyrosine residue binding (GO:0001784),-0.22516239165896282,-0.7964798375013817,0.8321167883211679,0.872447724105894,1.0,7/37,10.08%,ABL1;IRS1;PTPN3;YES1;VAV2;BCAR3;ABL2
prerank,store-operated calcium channel activity (GO:0015279),0.38970539304880936,0.7944523389565386,0.7311977715877437,1.0,1.0,3/10,16.63%,TRPC7;TRPC1;ORAI1
prerank,phospholipase C activity (GO:0004629),-0.2328206698428576,-0.7890163343347223,0.8260869565217391,0.8799895557635325,1.0,4/25,7.84%,PLCE1;PLCD3;PLCL1;EDNRA
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.37788137423404883,0.7888151932826302,0.7232267037552156,1.0,1.0,2/12,5.63%,PDE4B;PDE3B
prerank,RNA polymerase binding (GO:0070063),0.34726977604570425,0.7881338220885331,0.7425,1.0,1.0,3/18,10.29%,PPIB;TAF10;ZFP36
prerank,RNA polymerase core enzyme binding (GO:0043175),0.3122220217326157,0.7874053437391031,0.7669789227166276,1.0,1.0,9/33,19.72%,MAF1;ELOF1;RTRAF;SUPT4H1;HNRNPU;RECQL5;AGO1;CCAR2;ESRRB
prerank,methyl-CpG binding (GO:0008327),-0.2626184162019139,-0.7864658959869874,0.7904191616766467,0.8796718649929232,1.0,15/22,35.18%,TET3;ZBTB38;LRWD1;CXXC5;ZBTB21;MECP2;ZCWPW1;WDR77;CHTOP;CXXC4;ERH;LHX4;TET1;UHRF1;MBD2
prerank,adrenergic receptor binding (GO:0031690),0.35027398807787996,0.7855823017487046,0.7414012738853503,1.0,1.0,5/16,23.84%,UCHL1;APLP1;ARRDC3;GRK2;C1QBP
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.29429992598806265,0.7815511718205249,0.802675585284281,1.0,1.0,16/49,25.69%,UBXN1;TNFAIP3;VCP;ABRAXAS2;OTUD7A;PRPF8;UBQLN2;SQSTM1;RAD23A;FAAP20;TNIP1;ZFAND2B;UBQLN4;PSMD4;ATRIP;MINDY1
prerank,LRR domain binding (GO:0030275),0.35897835921054466,0.7813046593493831,0.7432065217391305,1.0,1.0,5/14,21.63%,ATF4;MRTFA;NRL;ZXDC;DDIT3
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.2953697099865923,0.7810569629166187,0.7951807228915663,1.0,1.0,13/46,24.63%,HEXB;HEXA;PIGQ;B3GNT9;MGAT2;GCNT1;B3GNT3;RFNG;B3GALT5;MGAT1;LFNG;B3GALT2;MGAT4B
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.3841079956459472,0.7802284083249569,0.7580872011251758,1.0,1.0,2/10,17.36%,PIK3C2G;PIK3CD
prerank,amino acid transmembrane transporter activity (GO:0015171),0.2935429739551545,0.7792447216981817,0.7785234899328859,1.0,1.0,6/47,11.61%,SLC38A5;SLC7A5;SLC25A29;SLC6A6;SLC3A2;SLC7A14
prerank,nuclear export signal receptor activity (GO:0005049),0.3703372809571149,0.7785539286786638,0.7472972972972973,1.0,1.0,3/11,17.50%,RAN;XPO1;EIF4ENIF1
prerank,frizzled binding (GO:0005109),-0.21917444395899446,-0.7776533500605707,0.9398496240601504,0.8885688758663935,1.0,12/34,22.07%,LRP6;WNT5B;WNT16;RNF43;DVL3;WNT11;WNT4;RYK;WNT9A;FZD7;ZNRF3;WNT2B
prerank,calcium:sodium antiporter activity (GO:0005432),0.38186243356138794,0.7771853568768021,0.7686781609195402,1.0,1.0,4/10,15.41%,SLC24A4;SLC24A2;SLC3A2;SLC8A1
prerank,symporter activity (GO:0015293),0.3854002626829518,0.7769506829323044,0.7453505007153076,1.0,1.0,2/10,20.80%,MFSD2A;SLC46A2
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.36528235916057444,0.7764921751068217,0.7700680272108843,1.0,1.0,4/12,17.22%,CADM4;CCDC88A;DAB2IP;CDH5
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.3795214566127978,0.7754413947734334,0.7647907647907648,1.0,1.0,4/11,25.38%,AKR1B10;DHRS13;AKR1A1;RDH14
prerank,insulin-like growth factor receptor binding (GO:0005159),0.36508133645317403,0.7737624688742353,0.774496644295302,1.0,1.0,3/12,15.76%,YWHAH;YWHAG;IGF2
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3051886314312872,0.7706220920193633,0.777122641509434,1.0,1.0,10/33,19.72%,ELOF1;DRAP1;RTRAF;SUPT4H1;HNRNPU;RECQL5;AGO1;CCAR2;TBP;ESRRB
prerank,histone deacetylase activity (GO:0004407),0.33462679648499716,0.7699376095578948,0.7828863346104725,1.0,1.0,6/19,21.92%,HDAC11;HDAC5;MIER2;HDAC9;SIRT2;SUDS3
prerank,antiporter activity (GO:0015297),0.32845089096596364,0.7695060350509522,0.7766367137355584,1.0,1.0,6/20,24.25%,ATP1A3;SLC25A11;SLC35E1;SLC35A1;SLC25A16;SLC25A14
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.3127723180004677,0.7673563319679723,0.8055893074119077,1.0,1.0,3/27,9.40%,LRRC8A;SLC26A4;SLC25A11
prerank,ribonuclease P activity (GO:0004526),0.3684027048193982,0.765038274227478,0.7597222222222222,1.0,1.0,2/11,13.64%,POP7;POP4
prerank,protein phosphatase binding (GO:0019903),0.2654953133613746,0.7615103802989756,0.9016393442622951,1.0,1.0,23/117,18.31%,RACK1;SOD1;HSP90B1;LGALS3;SIRPA;CTNNB1;VCP;RPA2;GRIN3A;MAPT;CD22;MTMR9;FLT4;LILRB1;BAD;TRAF3;ARPP19;DAB2IP;ADCY8;SKAP1;CDH5;PPP1R3D;PPP1R15A
prerank,phosphatase inhibitor activity (GO:0019212),0.3275196730300024,0.7592247940789171,0.7782002534854245,1.0,1.0,6/20,21.57%,LGALS3;PPP1R1B;SET;ARPP19;ANP32E;PTN
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.3098956102042886,-0.7584660025577049,0.7692307692307693,0.9120597171849585,1.0,3/10,17.90%,NAA40;ATF2;KAT8
prerank,nuclear import signal receptor activity (GO:0061608),-0.2760699724781948,-0.7570466982217648,0.8060836501901141,0.9095576045581873,1.0,10/15,34.81%,KPNA4;KPNA2;TNPO2;KPNA6;KPNA3;HIKESHI;IPO5;TNPO3;KPNA7;IPO9
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.29795105364413665,0.7550077203969267,0.808187134502924,1.0,1.0,7/34,18.67%,CALM1;CALM3;CDK5R1;CDK5R2;IGF2;MAP2K2;CALM2
prerank,phosphatase activity (GO:0016791),0.2744284635104088,0.7543338797829743,0.8704496788008566,1.0,1.0,25/73,29.51%,PPP1CA;DUSP3;BPNT2;DUSP28;DUSP26;NUDT16;NT5C;PLPP6;PLPPR2;PGP;PTPRO;PTPMT1;DUSP23;DUSP12;DUSP15;SBF1;PPP1CB;ACP2;PLPPR4;PGAM5;DUSP8;ENOPH1;ACP5;PLPP4;ACP4
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.28164967839678506,-0.753648641826491,0.7918367346938775,0.9096764559307433,1.0,9/13,28.98%,ITGA5;PDGFRB;IL1R1;VEGFD;PDGFC;PDGFRA;PDGFD;PTPRJ;ITGB3
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.2277234024319763,-0.7481884124698407,0.8918918918918919,0.9124108301285786,1.0,3/23,7.84%,PLCE1;PLCD3;EDNRA
prerank,chemokine receptor activity (GO:0004950),0.3118611799039215,0.7477766864668594,0.8109137055837563,1.0,1.0,7/24,31.38%,CCR5;CXCR4;CX3CR1;CCR2;GPR17;GPR35;ACKR3
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.27574541173774736,0.7444659333259168,0.852529601722282,1.0,1.0,16/60,19.83%,ERBB4;ACVRL1;NTRK2;LTK;MUSK;KDR;EPHA5;CSF1R;FLT4;TIE1;EPHB1;TYRO3;FLT1;DDR2;ERBB3;FLT3
prerank,DNA secondary structure binding (GO:0000217),-0.2207117559040624,-0.7441975407223711,0.9261744966442953,0.9133147918489362,1.0,11/31,22.06%,ABL1;KMT2A;RBBP8;ERCC5;RAD51B;CLSPN;FANCM;WRN;YY1;XRCC3;XRCC2
prerank,DNA-binding transcription factor binding (GO:0140297),0.25400170864865723,0.7436908406285165,0.9466800804828974,1.0,1.0,26/189,14.08%,PTMA;HSPB1;CHCHD2;PARK7;ATF4;NPM1;BEX1;HCLS1;SPI1;TLE5;CTNNB1;HES1;HIPK2;DUSP26;HES6;JUN;HMGB1;BHLHE41;ZBTB49;TAF9;CTBP1;ZBTB7A;KLF4;HDAC5;YWHAZ;MIER2
prerank,chloride transmembrane transporter activity (GO:0015108),0.3307893725804386,0.7408259211901481,0.8021108179419525,1.0,1.0,3/16,12.80%,SLC12A5;SLC26A4;SLC1A1
prerank,ligand-gated calcium channel activity (GO:0099604),0.3184426788293287,0.7384733320206456,0.7984886649874056,1.0,1.0,5/19,18.54%,GRIN1;GRIN2A;TRPM2;RYR2;GRIN2B
prerank,cGMP binding (GO:0030553),0.35516098643537675,0.7368204740965383,0.8002793296089385,1.0,1.0,5/11,25.47%,CNGA3;CNGA4;CNGB1;PDE11A;PDE2A
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.3420132129889865,0.7323671445834504,0.7837837837837838,1.0,1.0,6/12,38.28%,PIK3C2G;PIK3CD;IPMK;PIK3C2B;PIK3R6;PIK3CB
prerank,four-way junction DNA binding (GO:0000400),-0.24744593812124338,-0.7314729867984585,0.8858447488584474,0.9242879444686107,1.0,7/17,22.06%,ABL1;RAD51B;FANCM;WRN;YY1;XRCC3;XRCC2
prerank,transcription coregulator binding (GO:0001221),0.2777733938442061,0.7309033686378499,0.8593406593406593,1.0,1.0,6/50,11.44%,RPL23;NR1D1;CTNNB1;ZBTB49;CTBP1;ZBTB7A
prerank,vitamin D receptor binding (GO:0042809),-0.27202460209099966,-0.7253317360954669,0.8461538461538461,0.9268348428545978,1.0,2/14,4.48%,MED13;THRAP3
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.2484123137705073,0.7241656398335502,0.9495967741935484,1.0,1.0,31/181,18.91%,ACTB;HSPB1;ATF4;NPM1;BEX1;HCLS1;SPI1;GABARAPL1;CTNNB1;HES1;HIPK2;NCOR2;DUSP26;HES6;PROX1;JUN;BHLHE41;DNAJA1;SNW1;KLF4;HDAC5;MIER2;DLL1;GATA4;TRIM32;COMMD7;PPARGC1A;MTA2;TBP;PSMA6;DDRGK1
prerank,syntaxin binding (GO:0019905),0.2647512953963494,0.7224344806196817,0.8887677208287895,1.0,1.0,15/61,16.47%,SNAP25;CACNA1A;SYT1;SYPL1;SYT12;VAMP3;VAMP2;SYT6;STXBP5L;TMED9;VAMP8;SYT10;SYP;SYT2;NAPA
prerank,hexosyltransferase activity (GO:0016758),0.2552460135565801,0.7209048488992265,0.9204545454545454,1.0,1.0,24/101,24.63%,HEXB;HEXA;TMTC2;B4GALNT1;PIGZ;B4GALNT4;B4GALT6;POGLUT3;B3GNT9;CHPF2;B3GAT3;CHPF;GCNT1;FUT9;B3GNT3;DPY19L1;RFNG;CHSY3;CSGALNACT2;B3GALT5;LFNG;B4GALT3;B3GALT2;MGAT4B
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.292616466847304,-0.7200095658118019,0.8116438356164384,0.928501637224054,1.0,3/10,10.92%,ECHDC1;ECHDC3;AUH
prerank,voltage-gated anion channel activity (GO:0008308),-0.25017019611076335,-0.7167581626107449,0.8583690987124464,0.9278636579396908,1.0,1/15,1.65%,ANO6
prerank,phospholipid transfer activity (GO:0120014),0.307692116387516,0.71315040935216,0.8416458852867831,1.0,1.0,10/21,31.24%,PLTP;GLTP;PRELID1;MTTP;ABCA3;PRELID3B;CPTP;CERT1;C2CD2L;PRELID2
prerank,MAP kinase activity (GO:0004707),0.33413579883176864,0.7129521936144285,0.8221925133689839,1.0,1.0,4/14,20.03%,MAPK3;MAPK10;MAPK11;MAPK15
prerank,P-type ion transporter activity (GO:0015662),0.327802167042535,0.7108832261745481,0.8080110497237569,1.0,1.0,5/12,28.95%,ATP2B1;ATP2A2;ATP2C1;ATP2B4;ATP2B2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.3174868889636082,0.7099726152238737,0.8261997405966277,1.0,1.0,3/16,18.60%,TTYH1;TTYH3;ANO4
prerank,intracellular chloride channel activity (GO:0061778),0.3174868889636082,0.7099726152238737,0.8261997405966277,1.0,1.0,3/16,18.60%,TTYH1;TTYH3;ANO4
prerank,MAP kinase phosphatase activity (GO:0033549),0.3318403009586405,0.7068972235156173,0.8424657534246576,1.0,1.0,5/12,25.96%,DUSP3;DUSP2;DUSP1;DUSP6;DUSP8
prerank,3'-5' exonuclease activity (GO:0008408),0.2659607790096803,0.7066604885671703,0.8791946308724832,1.0,1.0,15/45,26.62%,EXOSC2;APEX1;TOE1;PDE12;USB1;EXOSC9;EXOSC4;POLG;ISG20;ERI1;POLD1;PNPT1;PAN2;TRIR;RAD9A
prerank,SH3 domain binding (GO:0017124),0.2582633189995421,0.7066365620145557,0.895947426067908,1.0,1.0,11/62,17.32%,GPX1;CYBA;ADAM15;ADAM12;ELMO1;MAPT;MICAL1;NCF1;DAB2IP;SKAP1;CRB3
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.3185451223962358,0.705695540801119,0.835357624831309,1.0,1.0,5/14,29.12%,SDHB;ISCU;RSAD2;EXO5;CIAO3
prerank,nucleotidase activity (GO:0008252),0.3184226962477247,0.7056289161806147,0.8315649867374005,1.0,1.0,2/15,6.14%,NT5C3A;BPNT2
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.29438439739311295,0.7052081465792774,0.8736059479553904,1.0,1.0,6/24,18.95%,PNCK;CAMK1D;CAMK1;CAMKV;CAMKK1;MKNK1
prerank,DNA replication origin binding (GO:0003688),0.30049538419008615,0.7050806435870077,0.863030303030303,1.0,1.0,7/23,28.61%,MCM5;HSPD1;DDX11;CDC45;MCM7;MCM2;DHX9
prerank,NF-kappaB binding (GO:0051059),0.29206700425164533,0.7045791980896905,0.8507281553398058,1.0,1.0,6/24,27.68%,NPM1;COMMD7;PSMA6;NFKBIA;RELA;HIF1AN
prerank,GTPase inhibitor activity (GO:0005095),0.3323425061540462,0.7033760808460646,0.8288043478260869,1.0,1.0,5/13,25.47%,IQGAP2;ARL2;CDC42SE1;RTKN;TNK2
prerank,dipeptidyl-peptidase activity (GO:0008239),0.34129835836257744,0.7017258852544737,0.8319209039548022,1.0,1.0,2/10,8.09%,DPP10;DPP6
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.24121416640524812,-0.700150915305719,0.9036144578313253,0.9416526841682666,1.0,10/15,38.36%,SLC26A7;SLC26A2;SLC39A8;SLC4A3;SLC4A11;SLC26A3;SLC26A5;SLC26A1;CFTR;SLC26A9
prerank,alpha-tubulin binding (GO:0043014),-0.20320137962868262,-0.6977708098703675,0.9358974358974359,0.9396154969945397,1.0,10/31,23.72%,EML4;SETD2;OFD1;INO80;WASHC1;TAOK1;RACGAP1;EFHC1;TRPV4;TBCE
prerank,exoribonuclease activity (GO:0004532),0.32817633098005494,0.6924498579098732,0.8391608391608392,1.0,1.0,3/12,20.65%,EXOSC2;EXOSC9;EXOSC4
prerank,inward rectifier potassium channel activity (GO:0005242),0.2883894814646863,0.6911298027633541,0.8553921568627451,1.0,1.0,5/24,24.70%,KCNJ10;KCNN2;ABCC8;KCNJ3;KCNJ6
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.2531123056761065,0.6870993889928904,0.9208791208791208,1.0,1.0,16/55,22.29%,SLC24A4;SLC24A2;GRIN1;TMCO1;ATP2B1;TRPM2;SEC61A1;TRPC1;RYR2;ORAI1;ANXA6;PKD2L1;PKDREJ;ATP2A2;PKD1L2;SLC24A5
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.2501667748138252,-0.6846119580154973,0.9030837004405287,0.948175157399024,1.0,2/14,4.55%,MINDY3;OTUD7B
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.3406387032634141,0.6826304471992694,0.8421787709497207,1.0,1.0,2/10,9.23%,SLCO1C1;SLCO4C1
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.23577797312570642,-0.6822002004388568,0.8869565217391304,0.9458345251842513,1.0,16/16,76.45%,SLC22A4;SLC25A26;SLC25A42;SLC22A5;SLC22A1;SLC22A3;SLC25A17;SLC22A16;SLC44A4;SLC22A2;SLC18A3;SLC29A4;SLC7A8;SLC44A1;SLC44A2;SLC5A7
prerank,anion transmembrane transporter activity (GO:0008509),0.3200954957210283,0.6799622973795726,0.8527027027027027,1.0,1.0,5/12,28.64%,SLC19A1;MFSD10;SLC4A2;ABCC5;SLC26A11
prerank,5'-3' exonuclease activity (GO:0008409),-0.23773956466072133,-0.676375078880845,0.8854961832061069,0.9467583420735733,1.0,8/14,35.54%,XRN1;EXOG;DXO;EXO1;DCLRE1A;CPSF3;DCP2;MRE11
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.30461875050945286,0.6744206478737159,0.8629776021080369,1.0,1.0,6/15,26.01%,HS6ST3;HS3ST6;HS3ST5;HS3ST2;HS6ST1;HS6ST2
prerank,microtubule motor activity (GO:0003777),0.2509131753527037,0.6720443395729979,0.9133333333333333,1.0,1.0,17/51,30.94%,DYNLRB1;KIF26B;KIF5A;KIF26A;DNAH1;DNAH2;DYNLRB2;KIF21B;KIF5C;KIFC2;KIF1A;KIF27;KIF20B;DNAH17;KIF6;KIF1B;KIF3A
prerank,diacylglycerol kinase activity (GO:0004143),0.322657520482743,0.6716804222728915,0.8571428571428571,1.0,1.0,6/11,31.61%,DGKH;DGKI;DGKK;DGKB;DGKZ;DGKG
prerank,glycerophospholipid flippase activity (GO:0140333),0.32295676705154597,0.6710372689323136,0.8515519568151148,1.0,1.0,2/11,11.39%,ATP8A2;ATP8A1
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.2549848023486303,-0.6672316638257404,0.9166666666666666,0.9503222612579724,1.0,2/12,5.99%,BABAM2;TRAF5
prerank,DNA binding (GO:0003677),0.22095965974763498,0.663647524199379,0.999,1.0,1.0,146/694,24.19%,RPS3;RPS15;RPS27;RPL6;RPL7;PCBP1;CALR;CHCHD2;PARK7;ATF4;KLF2;TERF1;POLR2D;LYL1;ETS2;DRAP1;MBD3;SYCP2;ANG;JUNB;EPAS1;GTF3C6;MCM5;HMGB3;CENPB;HES1;NUCKS1;RPA2;HMGN1;TBX22;FOXF2;CEBPB;ARID4A;PQBP1;TRIM28;HSPD1;CENPX;CREBZF;FOXL2;CEBPA;APLP2;PROX1;NR2F6;MAPT;YBX1;CSRNP3;NUPR1;IKZF1;MLXIPL;MLX;EGR1;DDB1;JUN;HMGB1;ZBTB49;TARDBP;TAF9;MYRF;H1-0;POLR2G;APEX1;ZBTB7A;ATF5;POU3F1;BANF1;DDX11;PCNA;SOX8;MAEL;THAP11;IRF7;SOX9;PAX3;NME2;FOXS1;HNRNPU;TSN;MAFA;IKZF3;HNRNPA1;SUB1;REPIN1;ZMYM3;NR1H2;E2F4;GATA4;DCLRE1C;PCID2;BRCA2;PPARGC1A;CNBP;CTC1;ERCC6;ZNF22;IMPDH1;NRL;RAD23A;TIGD4;ZBTB14;RNF11;HIC1;NLRP3;ESRRB;TFAP2B;WDR48;MLF1;CHD3;POU4F1;FOXA2;CDK9;MYC;TFAP4;FAM111A;POLG;CAMTA1;PHF1;ERCC1;CDC5L;TSNAX;MEIS2;FOXA1;SOX10;DDIT3;CEBPZ;POLR2H;IRF5;HLX;MEN1;SAFB;RADX;BLM;GRHL2;SOX1;MAFB;CSRNP1;CDC45;LONP1;ERF;PCBP2;PNKP;POLD1;PURB;RELA;TCF7L1;TCF3;OSR2
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.31414325453832354,0.6607224229695554,0.8699861687413555,1.0,1.0,1/11,7.17%,SLC25A29
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.26555776244910057,-0.6600972702027625,0.9063545150501672,0.9509685358686992,1.0,4/11,17.24%,SGMS2;PIGN;PIGO;PIGF
prerank,calcium channel activity (GO:0005262),0.23038992923246143,0.6565055586005338,0.9457202505219207,1.0,1.0,22/84,23.40%,SLC24A4;SLC24A2;CACNA1A;GRIN1;TMCO1;TRPM2;TRPC7;SEC61A1;TRPC1;RYR2;ORAI1;CACNG8;ANXA6;CACNG5;NCS1;PKD2L1;PKDREJ;CACNB4;PKD1L2;SLC24A5;CACNA1E;CACNA2D1
prerank,flavin adenine dinucleotide binding (GO:0050660),0.24254888137145197,0.6541956875191566,0.9287305122494433,1.0,1.0,14/53,24.31%,ACADVL;CYB5R3;STEAP4;CYBB;MICAL1;PPOX;KDM1B;NOS2;QSOX1;CYB5R1;SDHA;ILVBL;ACOX3;NQO2
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.3098718986533752,0.6539139010198753,0.8701986754966887,1.0,1.0,4/12,22.05%,SDHB;ISCU;CIAPIN1;CISD1
prerank,exonuclease activity (GO:0004527),0.24788672787823315,0.6532401498687577,0.9238521836506159,1.0,1.0,12/46,26.62%,ENPP2;EXOSC2;APEX1;PDE12;DCLRE1C;EXOSC9;EXOSC4;POLG;ISG20;ERI1;TRIR;RAD9A
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.2399407067707067,0.6528209721884276,0.9415584415584416,1.0,1.0,20/60,26.51%,PPP1CA;CTDSP2;CTDNEP1;CTDSP1;PHLPP1;TIMM50;PDP2;PPP1R3D;PPM1J;PDP1;PPP3CA;TAB1;PPEF1;PPM1F;DUSP1;PPP3R1;CAMK2G;PPP1CB;PGAM5;MTMR6
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.2304118138968917,-0.6526821062295833,0.9291666666666667,0.9518790923427107,1.0,2/15,12.57%,PI4KA;ATM
prerank,transcription cis-regulatory region binding (GO:0000976),0.21932404996796875,0.6522921819967109,0.999,1.0,1.0,78/406,22.58%,RPS3;JUND;PARK7;ATF4;SOX18;ERBB4;PRDX5;NPM1;TNF;DRAP1;NR1D1;SPI1;ENO1;EPAS1;NKX2-2;TBX22;KLF17;FOXF2;CEBPB;ARID4A;FOXD3;CREBZF;SALL2;CEBPA;BASP1;CREB3;PROX1;MLX;EGR1;HOXD4;JUN;HMGB1;TAF9;AEBP1;PHOX2A;NPAS3;ATF5;MSX1;SOX17;DBP;THRA;HOXD8;KLF4;SOX9;HDAC5;ZBTB43;ATMIN;NONO;IKZF5;GATA4;TWIST1;RBBP5;GLIS2;AGO1;ZNF22;TBP;SOX11;SNCA;ZBTB14;ZFP41;ESRRB;TFAP2B;KLF11;CHD3;FOXA2;MEF2C;MYC;TFAP4;CDC5L;FOSL2;FOXA1;SOX10;DDIT3;HOXB8;REST;MEN1;GRHL2;DACH1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.32113593213345104,0.6518304704432201,0.8834269662921348,1.0,1.0,2/10,19.65%,TNFAIP3;DESI2
prerank,N-acetyltransferase activity (GO:0008080),-0.21143119538276908,-0.6500959251547224,0.9240506329113924,0.9493621530723714,1.0,3/19,12.41%,KAT2B;SMARCE1;ESCO1
prerank,RNA polymerase II complex binding (GO:0000993),0.25715924329186435,0.6499700110671177,0.9079102715466352,1.0,1.0,9/32,19.72%,ELOF1;RTRAF;SUPT4H1;PCIF1;HNRNPU;RECQL5;AGO1;CCAR2;ESRRB
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.2775330710959643,0.6442895820611593,0.8894409937888199,1.0,1.0,1/20,1.82%,EIF3F
prerank,neuropeptide receptor binding (GO:0071855),0.29685490483913846,0.6434628829292693,0.8990825688073395,1.0,1.0,5/14,32.22%,PPY;NTS;NPY;NMU;SHANK1
prerank,RNA cap binding (GO:0000339),0.28758502875933245,0.639103750067353,0.9051948051948052,1.0,1.0,2/16,10.20%,EIF3D;EIF4A1
prerank,FMN binding (GO:0010181),0.30591160149481483,0.6369691924319922,0.9054054054054054,1.0,1.0,2/11,17.79%,PNPO;NOS2
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.27729209928993487,0.6326615958167183,0.9156010230179028,1.0,1.0,4/18,24.65%,CCKBR;AGAP2;SOCS3;PIK3R5
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.29957954034682543,0.63144686421036,0.8964088397790055,1.0,1.0,4/12,23.83%,B3GNT9;B3GNT3;B3GALT5;B3GALT2
prerank,C2H2 zinc finger domain binding (GO:0070742),0.30587584304043763,0.6260866826226602,0.9036144578313253,1.0,1.0,6/11,35.99%,GATA2;TAF9;ZXDC;LEF1;HMGA2;THAP7
prerank,muscle alpha-actinin binding (GO:0051371),0.2824417882612614,0.6249839714949574,0.9321148825065274,1.0,1.0,1/15,2.06%,PRICKLE4
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.2291994778815148,-0.6241599171182405,0.918918918918919,0.9620958508476904,1.0,1/15,3.66%,PLA2G4A
prerank,NADP binding (GO:0050661),0.24470154311234807,0.6156626327701976,0.9464922711058263,1.0,1.0,8/32,18.85%,SPR;GRHPR;CRYM;QDPR;CAT;PGD;NOS2;CBR3
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.2654427865839306,0.6105387064424568,0.9379042690815006,1.0,1.0,6/20,23.99%,MOGAT2;AGPAT5;DGAT1;MOGAT1;LPCAT2;AGPAT2
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.2891427369002476,0.6087910176456818,0.9093567251461988,1.0,1.0,4/11,22.02%,PRPF19;RBX1;STUB1;AMFR
prerank,sulfate transmembrane transporter activity (GO:0015116),0.2793287761836762,0.6081226843932552,0.9276773296244785,1.0,1.0,2/14,9.40%,SLC26A4;SLC25A11
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.23728043081767772,0.6043843478764311,0.9512195121951219,1.0,1.0,10/33,25.39%,EXOSC2;TOE1;PDE12;USB1;EXOSC9;EXOSC4;ISG20;ERI1;PNPT1;PAN2
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.22372517771961642,-0.6041839547251991,0.9598393574297188,0.9691915529716096,1.0,4/12,22.19%,NUDT5;ENTPD5;SLC25A42;ENTPD7
prerank,ephrin receptor binding (GO:0046875),0.25350828025480177,0.6032030471478911,0.9281210592686002,1.0,1.0,10/21,33.48%,ANKS1B;EFNB1;EFNA1;PTPN1;CRK;EFNA2;EFNB3;GRB2;ANKS1A;FYN
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.2250642029955618,0.6019036024951101,0.9615806805708014,1.0,1.0,8/48,19.98%,ATP6V1F;SLC39A1;AQP1;TRPM2;TRPC1;UNC80;CALHM6;PKD2L1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.21740642983288036,0.600108067146148,0.9648936170212766,1.0,1.0,22/69,31.11%,CERS2;SCP2;PLAAT3;ZDHHC5;NAA10;MOGAT2;ELP3;GLYAT;DGAT2L6;SOAT2;PORCN;ZDHHC12;DGAT1;ZDHHC8;MOGAT1;LIPT1;ZDHHC2;MBOAT7;ZDHHC14;ZDHHC16;CERS6;NMT1
prerank,microtubule plus-end binding (GO:0051010),0.25573166591467716,0.5999961497516831,0.935687263556116,1.0,1.0,4/20,15.98%,CLASP1;DCTN1;CLIP3;MAPRE3
prerank,N-methyltransferase activity (GO:0008170),0.25172304525292305,0.5981351051659742,0.9403726708074535,1.0,1.0,3/20,13.42%,ZCCHC4;PRMT1;METTL18
prerank,secondary active transmembrane transporter activity (GO:0015291),0.2248085952393396,0.5978617412723851,0.9688888888888889,1.0,1.0,11/51,24.25%,SLC7A5;SLCO1C1;MFSD2A;SLCO4C1;SLC25A11;SLC35E1;SLC35A1;SLCO1B1;SLC46A2;SLC25A16;SLC25A14
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.25268442834430394,0.5953248751241068,0.9265822784810127,1.0,1.0,7/21,26.23%,CDK8;CDK19;CDKL4;CDK5;CDK9;CDK10;CDK11B
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.25268442834430394,0.5953248751241068,0.9265822784810127,1.0,1.0,7/21,26.23%,CDK8;CDK19;CDKL4;CDK5;CDK9;CDK10;CDK11B
prerank,RNA methyltransferase activity (GO:0008173),0.25682075189518266,0.5937083333464449,0.9379746835443038,1.0,1.0,6/19,26.45%,FBL;MEPCE;FTSJ3;METTL3;LCMT2;TYW3
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.2895611686179491,0.5917869000331215,0.928169014084507,1.0,1.0,3/10,23.94%,APEX1;DCLRE1C;POLD1
prerank,telomeric DNA binding (GO:0042162),0.23411495626189732,0.5895651024073114,0.9664351851851852,1.0,1.0,12/32,32.93%,TERF1;NCL;APEX1;CTC1;TERF2IP;BLM;PIF1;XRCC6;HNRNPA2B1;HNRNPD;UPF1;ACD
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.2118039949600123,0.5843131858872626,0.9872881355932204,1.0,1.0,7/74,9.89%,CHKB;RFK;PKM;NT5C3A;DGKH;DGKI;PIK3C2G
prerank,carboxy-lyase activity (GO:0016831),0.24198304095909415,0.5793807446628534,0.9530864197530864,1.0,1.0,8/23,36.23%,ODC1;UROD;GAD1;FAHD1;ACOD1;PISD;AZIN1;BCKDHA
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.26326074933027344,0.5774106899748954,0.9419889502762431,1.0,1.0,4/15,23.99%,ABHD8;AGPAT5;LPCAT2;AGPAT2
prerank,solute:sodium symporter activity (GO:0015370),-0.17230875858598085,-0.5758137613070061,0.973404255319149,0.9777125936968951,1.0,1/27,1.82%,SLC4A10
prerank,clathrin adaptor activity (GO:0035615),0.2614984573574355,0.5729086144604122,0.9564643799472295,1.0,1.0,2/15,9.46%,AP2M1;AP2S1
prerank,chloride channel regulator activity (GO:0017081),0.2577093161222288,0.5635908468287001,0.9426666666666667,1.0,1.0,2/14,12.01%,SGK1;VAMP8
prerank,nucleotide diphosphatase activity (GO:0004551),0.2597403291966951,0.5635863990551946,0.9450402144772118,1.0,1.0,5/14,24.67%,NUDT3;NUDT4;ENPP5;NUDT10;NUDT11
prerank,growth factor receptor binding (GO:0070851),0.19790572569164755,0.5632393893924632,0.9937759336099585,1.0,1.0,21/95,25.47%,ERBB4;PDGFB;IL2;IL11;TIMM50;SDCBP;CCDC88A;TLR5;CD300LF;PDGFA;ARF4;ADAM17;KLB;IL6;IL1RAP;PYCARD;TGFA;IL12RB1;ERAP1;FGF22;TNK2
prerank,peptide N-acetyltransferase activity (GO:0034212),0.273339722342573,0.5538348807882111,0.9440459110473458,1.0,1.0,4/10,32.57%,NAA10;NAA25;NAA30;NAA60
prerank,MAP kinase kinase activity (GO:0004708),0.24935465798927067,0.5537499398458503,0.9504563233376793,1.0,1.0,5/15,26.11%,PAK3;MAPK10;MAP2K2;MAP2K7;MAP3K9
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.21683628189661386,0.552716945719172,0.9805269186712485,1.0,1.0,4/35,12.57%,ELAC2;NT5C3A;AARS2;MRPL58
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.24942008463333315,0.5506249384888681,0.950863213811421,1.0,1.0,3/15,24.65%,CCKBR;SOCS3;PIK3R5
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.25525495658854713,0.5493502577713726,0.9667590027700831,1.0,1.0,2/13,17.36%,PIK3C2G;PIK3CD
prerank,3'-5' DNA helicase activity (GO:0043138),0.2427406415510565,0.5419948183384032,0.9670619235836627,1.0,1.0,6/16,28.61%,MCM5;RECQL5;BLM;MCM7;MCM2;DHX9
prerank,nuclear localization sequence binding (GO:0008139),0.2343207264985542,0.5307847440972306,0.9826435246995995,1.0,1.0,6/18,28.87%,IPO4;CABP1;BRAP;NFKBIA;KPNB1;RANBP6
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.25664482093106994,0.5238804481722966,0.9610027855153204,1.0,1.0,6/10,39.73%,HEXIM1;CDKN2B;CDKN1A;CDKN2D;HEXIM2;CDKN2C
prerank,endoribonuclease activity (GO:0004521),0.20940571634537755,0.5194462649921562,0.9929494712103408,1.0,1.0,5/32,21.34%,ENDOG;RNASEK;SND1;AGO1;TSNAX
prerank,death receptor activity (GO:0005035),0.2408450297469764,0.51209177827908,0.9646892655367232,1.0,1.0,4/11,32.91%,TNFRSF1A;TNFRSF11A;TNFRSF1B;TNFRSF25
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.188960937662618,-0.5098782333971605,1.0,0.9917569824806743,1.0,4/13,20.92%,AGPAT4;GPAT3;ABHD5;PNPLA3
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.19222422475676276,0.5047457454687507,0.9932279909706546,1.0,1.0,6/40,19.92%,FBL;ICMT;METTL18;DNMT3B;MEPCE;GAMT
prerank,methyltransferase activity (GO:0008168),0.18479121011432356,0.4911195319296233,0.9966024915062288,1.0,1.0,16/46,34.93%,EEF1AKMT2;PRMT1;DNMT3B;MEPCE;GAMT;FTSJ3;EEF1AKMT4;METTL3;COMTD1;EEF1AKMT3;LCMT1;DNMT1;NSUN2;NNMT;PRMT5;GCSH
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.2109108380787893,0.48701977002481883,0.988833746898263,1.0,1.0,8/21,32.12%,POLE4;POLD4;POLG;POLD1;POLE3;POLN;POLD3;POLK
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.2158730194283514,0.48263525041081934,0.9867197875166003,0.9989705536916617,1.0,3/16,27.19%,IDO2;BCO2;ADI1
prerank,cation:chloride symporter activity (GO:0015377),0.2265127280180751,0.4613238742896471,0.9871060171919771,1.0,1.0,1/10,8.05%,SLC12A5
prerank,protein phosphatase 1 binding (GO:0008157),0.19455855498938207,0.4567162147781054,0.9911392405063291,0.9984864042490259,1.0,8/21,33.19%,LILRB1;PPP1R3D;PPP1R15A;PPP1R9B;KCNQ1;PPP1R11;PPP1R3E;PPP1R16B
prerank,steroid hydroxylase activity (GO:0008395),0.19153037082038712,0.4277007683145688,0.9972862957937585,0.9991084652619766,1.0,5/16,30.84%,CH25H;CYP2E1;CYP2U1;CYP39A1;CYP46A1
prerank,DNA polymerase activity (GO:0034061),0.1764424780775734,0.4118063386665854,0.9987730061349693,0.9980721520225508,1.0,8/22,32.12%,POLE4;POLD4;POLG;POLD1;POLE3;POLN;POLD3;POLK
